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Abstract 
Athletes seem compelled to include some forms of altitude training in their preparation expecting 
additional performance gains compared to equivalent training at sea-level. For the general 
population, altitude training often only consists in spending weeks at altitude to enhance red 
blood cell production, hemoglobin mass and thus oxygen delivery to the muscles. Over the past 
two decades, intermittent hypoxic training (IHT), that is, a method where athletes live at or near 
sea-level but train in hypobaric hypoxia (HH, real altitude) or normobaric hypoxia (NH, 
simulated altitude) was shown to induce exclusive adaptations directly at the muscular level that 
may support performance improvements. Our work first demonstrated significant differences 
between exposure and exercise in HH vs. NH that may help disentangling hypoxia and hypobaria 
for athletes or mountaineers who use NH to prepare for altitude competitions or expeditions. 
Second, we produced a comprehensive review of the strikingly poor and controversial benefits of 
IHT for performance enhancement in team or racket sports. Using evidence of peripheral 
muscular adaptations with the recruitment of fast-twitch fibers playing a major role, we then 
developed and assessed the potential of a new training method in hypoxia based on the 
repetitions of “all-out” sprints interspersed with incomplete recovery periods, the so called 
“repeated sprint training in hypoxia” (RSH). We have consequently shown RSH to delay fatigue 
when sprints with incomplete recoveries are repeated until exhaustion both in cycling and cross-
country ski double poling. We definitely outlined RSH as a promising training strategy and 
proposed new studies to judge the efficacy of RSH in team sports and determine the specific 
mechanisms that may enhance team game results. 
In conclusion, our work allowed updating the panorama over the contemporary hypoxic training 
possibilities. It provides an overview of the current scientific knowledge about intermittent 
hypoxic training and repeated sprint training in hypoxia (RSH). This will benefit athletes and 
teams in intermittent sports looking to include a hypoxic stimulus to their training to gain a 
specific competitive edge.  
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Résumé 
Athlètes et entraineurs sont généralement tentés d’inclure des formes d’entrainement en altitude à 
leur préparation, espérant ainsi améliorer leurs performances davantage que par un entrainement 
en plaine. Pour le grand public, l’entrainement en altitude consiste généralement à passer 
plusieurs semaines à la montagne pour augmenter le nombre de globules rouges, la masse en 
hémoglobine et potentiellement améliorer le transport d’oxygène vers les muscles. Toutefois, 
pendant les deux dernières décennies, des recherches sur diverses méthodes d’entrainement 
intermittent hypoxique (IHT), où les athlètes vivent en plaine mais s’entrainent en hypoxie 
hypobarique (HH, altitude réelle) ou en hypoxie normobarique (NH, altitude simulée) ont pu 
démontrer de réelles adaptations non-hématologiques directement à l’échelle musculaire qui 
laissent supposer des gains de performance spécifiques. 
Notre travail a tout d’abord permis de mettre en évidence des différences significatives lors de 
l’exposition et l’exercice physique entre HH et NH qui dénouent le lien entre hypoxie et 
hypobarie avec une importance certaine pour les athlètes ou alpinistes préparant en NH des 
expéditions ou compétitions sportives. Ensuite, par la publication d’une revue exhaustive nous 
avons mis en évidence les rares bénéfices controversés de l’IHT pour l’amélioration de la 
performance en sports d’équipe. Avec l’évidence d’adaptations périphériques musculaires liées au 
recrutement de fibres rapides, nous avons donc développé une nouvelle méthode d’entrainement 
en hypoxie reposant sur la répétition de sprints maximaux intercalés de récupérations 
incomplètes : l’entrainement de sprints répétés en hypoxie (RSH). Nous avons pu démontrer que 
le RSH permettait de retarder la fatigue tant en cyclisme que lors de la double poussée en ski de 
fond lors de sprints répétés jusqu’à épuisement. Notre travail a permis de définir le RSH comme 
méthode prometteuse en proposant de nouvelles études pour juger de son efficacité et des 
mécanismes sous-jacents dans les sports collectifs 
Finalement, notre mise à jour du panorama des méthodes d’entrainement hypoxiques actuelles 
fournit une vue d’ensemble des outils et méthodes utiles pour les athlètes souhaitant intégrer un 
stimulus hypoxique à leur entrainement pour gagner un avantage compétitif spécifique. 
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1. Introduction  
1.1 General introduction 
1.1.1 Altitude training 
 
Altitude training is a topic with persistent high interest among athletes, coaches and sport 
scientists. The effects of critical hypoxic conditions have been previously reported in mountain 
climbers (Barcroft, 1914; Haldane & Priestley, 1935). The 1968 Mexico Olympics were then a 
challenge for athletes, trainers, and scientists trying to prepare for competitions at 2300 m. For 
example, following a symposium on sport at mid altitude in 1965 in Magglingen (Weihe, 1965), a 
Swiss delegation headed by Dr. Kaspar Wolf sojourned in Mexico in November 1966 during pre-
Olympic events where athletes underwent specific performance tests, noticing strong individual 
differences in the responses to altitude during their prolonged stay at 2300 m (Acquadro et al., 
1966). This experience led to recommendations in terms of altitude acclimatization for the Swiss 
delegation with a 10 days stay in St-Moritz prior to travelling to Mexico, it was also an 
opportunity to highlight the undeniable lack of scientific knowledge to support an efficient 
preparation to perform at altitude. All in all, this event acted as a trigger for numerous studies 
assessing the effect of milder hypoxic conditions and altitude training strategies on physiological 
responses and athletic performance (Margaria, 1967; Keul & Cerny, 1974; Shephard, 1974).  
Nowadays, elite athletes extensively use altitude training in “real” (i.e. hypobaric hypoxia, HH) or 
“simulated” (i.e. normobaric hypoxia, NH) conditions in the belief that it will enhance their ability 
to compete successfully at the international level. Therefore, altitude training has become a 
widespread concept with numerous training combinations available. Contemporary altitude 
training possibilities for sea-level performance improvements were first summarized by Wilber 
(Fig. 1) helping to clarify the actual nomenclature (Wilber, 2007).  
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In spite of substantial differences between these various forms of hypoxic training and/or 
exposure, all these methods have the same goal of inducing physiological adaptations and 
enhancement in athletic performance. 
 
Figure 1 Contemporary altitude training models. IHE, intermittent hypoxic exposure; IHT, intermittent 
hypoxic training; LH + TH, live high + train high; LH + TL, live high + train low; LL + TH, live low + 
train high. From Wilber, 2007. 
A prolonged stay including training at moderate to high altitude (now known as the “Live High – 
Train High” LHTH approach) is undoubtedly of interest for subsequent optimal performance at 
altitude. Further, when considering putative benefits on subsequent sea-level performance the 
LHTH model has been largely investigated (at least 14 studies to date (Bonetti & Hopkins, 
2009)). However, with the decrement of the aerobic capacity at altitude (Wehrlin & Hallen, 2006), 
maximal training intensity could be limited during a LHTH training camp. The latter led scientists 
in the 1990s to explore the potential of training models allowing to maintain training 
power/speed for enhanced sea-level performance such as "live high-train low" (LHTL) (that is 
when athletes stay for a prolonged sojourn in hypoxic environment but train in normoxia) 
(Levine & Stray-Gundersen, 1997; Stray-Gundersen et al., 2001; Stray-Gundersen & Levine, 
2008). Again, different LHTL strategies have been abundantly analyzed with more than 30 
studies reported to date (Bonetti & Hopkins, 2009). In fact, the development of altitude 
simulation facilities (nitrogen house or hypoxic chamber) or portable devices (hypoxic tents or 
hypoxicators like the Altitrainer®) allowed a multitude of new combinations to design training 
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strategies combined with hypoxic exposure. Actually, the LHTL approach could combine night 
sleep in a normobaric hypoxic tent (or apartment) with training in normoxia (Rusko et al., 2004; 
Wilber, 2007) or even a prolonged stay at altitude and training with supplemental oxygen (Morris 
et al., 2000; Wilber et al., 2003). Finally, altitude simulation methods also allowed more recently to 
explore “Live Low – Train High” (LLTH) modalities. LLTH is characterized by short exposures 
to a hypoxic environment at rest (that is “intermittent hypoxic exposure” IHE) or during training 
(that is “intermittent hypoxic training” IHT). Consequently, a recent review (Millet et al., 2010) 
aggregated current knowledge to update the initial classification of contemporary altitude training 
models additionally including combinations using advanced technological methods to optimally 
improve peak performance in elite athletes (Fig. 2). 
 
Figure 2 Different hypoxic methods. LH: Living High; TH: Training High; TL: Training Low; LHTLH: 
Living High, Training Low and High; LL: Living Low; IHE: Intermittent Hypoxic Exposure; IHT: 
Intermittent Hypoxic Training; IHIT: Intermittent Hypoxic Interval-Training. From Millet et al., 2010. 
 
For instance, athletes in racket or teams sports have shown greater interest lately for IHT since 
the technological development of simulated altitude facilities allows for good training conditions 
without the hassle and cost of travelling to altitude sufficiently rapidly not to lose efficient 
training and/or recovery time. So, IHT in simulated altitude facilities could be of interest in 
intermittent sports. However, IHE seems probably inefficient and IHT disputable in improving 
sea-level aerobic performance (Bartsch et al., 2008b; Bergeron et al., 2012). To our knowledge, 
while IHT is regularly used by professional team sports in football (Liverpool FC, Tottenham 
Hotspurs), rugby (Wales national team), Australian football (Brisbane Lions, Melbourne FC) or in 
- 20 - 
combat sports like taekwondo and judo (Japanese and Chinese national teams; Beijing Sport 
University), it remains unclear whether and how training in hypoxia would enhance athletic 
performance (Millet et al., 2009; Millet et al., 2010). In addition, the utility of altitude/hypoxic 
training more specifically in team (or intermittent) sports was discussed very recently by 
renowned experts and a common statement underlines the lack of current consensus on the 
optimal strategies to elicit the best results from altitude training in a team-sport population 
although some approaches could be beneficial (Lundby et al., 2012; Girard et al., 2013a).  
Nevertheless, the induced underlying mechanisms for performance enhancement (both in 
endurance or intermittent sports) are still widely discussed in the scientific community (Gore & 
Hopkins, 2005; Levine & Stray-Gundersen, 2005; Millet et al., 2010; Billaut et al., 2012; 
Siebenmann et al., 2012; Jacobs, 2013; Wilber, 2013), and it creates opportunities for well 
designed specific controlled and blinded studies assessing putative additional effects of IHT (or 
other methods) compared to the same training in normoxia (Bergeron et al., 2012; Lundby et al., 
2012). 
1.1.2 Exercise physiology in hypoxia 
 
To interpret potential performance gains obtained by adding some form of hypoxic stress during 
training, one should understand which mechanisms are involved in the physiological responses to 
hypoxia. Hypoxic conditions can be defined as a combination of barometric pressure (PB) and an 
inspired fraction of oxygen (FIO2) that results in an inspired pressure of oxygen (PIO2) lower than 
a normoxic value of 150 mm Hg (Conkin & Wessel, 2008). Indeed, hypoxia can be achieved by 
reducing PB (i.e. hypobaric hypoxia (HH)) or by lowering the FIO2 while PB remains stable (i.e. 
normobaric hypoxia (NH)). For instance, altitude simulation devices developed in the past 20 
years are now consistent advanced technological tools reducing PIO2 by diluting inspired air with 
nitrogen, filtering oxygen (O2), or delivering low oxygen gas mixtures (Wilber, 2007). PIO2 is 
calculated by withdrawing water vapour pressure (47 mmHg) from barometric pressure and 
multiplying by the inspired oxygen pressure: PIO2 (mmHg) = FIO2 x (PB – 47). 
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For example, at an altitude of 3000 m (as in HH), PB approximately equals 525 mmHg and FIO2 
20.93%. The corresponding PIO2 thus equals 0.2093 x (525-47)=100 mmHg. A similar PIO2 is 
achieved in NH at sea level (PB=760 mmHg) by reducing FIO2 to 14.1 % (e.g., PIO2= 0.141 x 
(760-45)=100.5 mmHg). Figure 3 illustrates the reduction in PIO2 during a 24 h exposure in HH 
and in NH. The consequence of a reduced PIO2 is a diminution of the alveolar oxygen pressure 
(PAO2) and hence of the oxygen distribution to the tissues (Cerretelli, 1980) triggering important 
and rapid adaptive physiological responses. These concrete responses are the basis of putative 
additional positive effects expected when adding a hypoxic stress to any training strategy. Any 
potential benefit can thereafter hypothetically be related to the physiological responses induced 
by the added hypoxic stress during exercise.  
Cardiovascular responses  During an acute exposure to a hypoxic environment, the skeletal 
muscle blood flow is rapidly adjusted to preserve O2 delivery to respiring tissues during exercise 
(Gonzalez-Alonso et al., 2002). This mechanism, helped by a nitric oxide (NO) dependent local 
vasodilation with haemoglobin acting as a hypoxic sensor (Crawford et al., 2006), is easily 
observable since heart rate (HR) is increased during submaximal exercise (and also at rest) in 
hypoxia. Actually, the activation of the sympatho-adrenergic axis (with a release of 
catecholamines) increases the sympathetic tone to raise HR (Koller et al., 1988; Mazzeo et al., 
1994). The HR augmentation increases the cardiac output (!) and compensates for the decreased 
stroke volume (mainly due to reduced plasma volume) (Calbet & Lundby, 2009; Fukuda et al., 
2010). Then, at maximal exercise intensity, both stroke volume and ! are reduced in hypoxia 
(Wagner, 2000). The latter combined with a reduced PAO2 can in turn account for a reduced 
maximal aerobic performance in hypoxia (Ferretti et al., 1997). An adaptation occurs within days 
of exposure since ! and stroke volume were observed to return to pre-exposure (or even lower) 
levels, essentially because of a hemoconcentration (Grover et al., 1986). Besides, hypoxic 
exposure was shown to produce a sustained stimulation of the sympathetic nervous system, 
which in turn increases resting metabolic rate and stimulates the bone marrow to rise the red 
blood cell production (Grover et al., 1986). 
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Figure 3 Fraction of inspired oxygen (FIO2, %) (A), barometric pressure (BP, mbar) (B) and 
corresponding pressure of inspired oxygen (PIO2, mmHg) (C) before (PRE) and during a 24 h exposure in 
hypobaric hypoxia (HH) or normobaric hypoxia (NH). From Faiss et al., 2013c.  
 
 
Hematolog i ca l  responses  Indeed, tissue hypoxia is a primary stimuli for the production and 
release of erythropoietin (EPO), a glycoprotein hormone activating erythropoiesis (Gunga et al., 
2007). Thus, a decreased O2 availability stimulates EPO gene expression and serum EPO levels 
were shown to i) rise rapidly in acute hypoxia (Eckardt et al., 1989), ii) remain high during a 
prolonged hypoxic exposure and iii) return to initial values only after 22 days (Milledge & Cotes, 
1985). Interestingly, an elevated red blood cell mass was shown to be proportional to 
oxyhemoglobin saturation (Weil et al., 1968). An increase in red blood cells (and hence in the total 
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haemoglobin mass) could therefore improve O2 carrying capacity to the working muscles after 
sufficient hypoxic exposure (Berglund, 1992). However, one should remember that red blood 
cells are diluted in plasma and the total erythrocytes volume is expressed as a fraction (in %) of 
total blood volume by the hematocrit (Hct). Altitude exposure initiates a diminution of plasma 
volume caused by a fluid transfer outside of the vascular compartment. This leakage is a 
consequence of increased diuresis, greater respiratory loss of water (due to the dryer air at 
altitude) and augmented perspiration at altitude (Hogan et al., 1973; Maher et al., 1974; Butterfield 
et al., 1992). Consequently, [Hb] and Hct are increased, peripheral resistances are augmented due 
to the higher blood viscosity, and blood circulation is altered (Berglund, 1992). On the other 
hand, the affinity of oxygen for hemoglobin is reduced at high altitude by the 2,3 
diphosphoglycerate (2,3 DPG) to facilitate O2 delivery to the tissues (Mairbaurl, 1994). The 
compound 2,3 DPG is produced during a prolonged hypoxic exposure by the red blood cell 
metabolism (Mines, 1981) to counteract the left-shift of the oxyhemoglobin dissociation curve 
illustrated hereafter (Fig. 4). For example, an increase of 2,3 DPG was reported in a controlled 
study in athletes after 13 days of training at 2300 m (Mairbaurl et al., 1986).  
Finally, a direct connection between altitude training and any change in hematological parameters 
is hard to establish. Hence, there is still a vivid debate on the physiological mechanisms mediating 
performance gains after LHTL: some argue that hematological factors (e.g., augmented red cell 
mass) are of greatest influence (Levine & Stray-Gundersen, 2005) while others report non-
hematological factors (e.g., exercise economy or HIF-mediated changes at the muscular level) to 
predominate (Gore & Hopkins, 2005). In addition, recent results demonstrated a blunted 
erythropoietic response following LHTL in athletes with a high initial Hb mass (Siebenmann et 
al., 2012). 
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Respiratory responses  Another perceived consequence of a diminished PIO2 upon hypoxic 
exposure is an increase in pulmonary ventilation (that is the hypoxic ventilatory response HVR) 
to maintain O2 delivery to the tissues (Wagner et al., 1986). The increase in minute ventilation 
(VE) varies greatly individually and usually begins when PIO2 is reduced to at least 100 mmHg 
(approximately 3000 m) (Rahn & Otis, 1949). Actually, exposure to hypoxia stimulates peripheral 
chemoreceptors in the carotid bodies (sensitive to the drop in arterial O2 pressure (PaO2), but 
also to an increase in arterial CO2 pressure and decrease in arterial pH) to regulate ventilation 
centrally through the cortical respiratory centres (Teppema & Dahan, 2010). For instance during 
an exercise in hypoxia, hyperventilation partially counterbalances the drop of PAO2, PaO2 and 
arterial O2 saturation (SaO2). Concomitantly end-tidal carbon dioxide pressure (PETCO2) 
decreases with the consequence of a respiratory alkalosis due to the reduced plasma 
concentrations of CO2 and H
+ (Ursino et al., 2001). Blood pH is thus elevated and left shifts the 
oxyhemoglobin dissociation curve (Fig. 4) (Calbet et al., 2003).  
 
Figure 4 Effect of acute hypoxia on the O2 dissociation curve of the hemoglobin during exercise in 
normoxia (white triangles; fine line) and hypoxia (black triangles; thick line). From Calbet et al., 2003. 
 
  
- 25 - 
Interestingly, after training in hypoxia, higher HVR were observed in athletes presenting the 
highest increase in oxidative stress markers (Pialoux et al., 2009a). The latter corroborates findings 
in an animal model indicating a reactive-oxygen species (ROS) dependency of an increase of 
HVR (MacFarlane et al., 2008). Finally, HVR is correlated with VE and SaO2 during exercise in 
hypoxia (Benoit et al., 1995), thus, an increase of HVR should be considered as a positive 
adaptive response with the elevation of VE allowing to finally increase SaO2 (Huang et al., 1984). 
Muscular responses The hypoxic stimulus also induces significant peripheral and muscular 
adaptations. The aim at the muscular level is essentially to improve O2 delivery and diffusion to 
the mitochondria and improve its oxidative capacity to cope with the decreased O2 availability. A 
sustained exposure to severe hypoxia may lead to muscle atrophy (Hoppeler & Vogt, 2001). So it 
was thought that exposing subjects to intermittent hypoxia could potentially dissociate benefits 
from the hypoxic stimulus (e.g., short exposure only during training in hypoxia) from the 
negative effects of prolonged exposure to hypoxia. For example, hypoxic training was found to 
improve muscle capillary density in elite cyclists (Terrados et al., 1988) although such an 
improvement in capillarization may be due to a diminished muscular volume (Mizuno et al., 1990) 
thus questioning the presence of an actual angiogenesis after such a hypoxic stimulus. Besides, 
although it remains unclear whether sustained hypoxia may alter muscle oxidative capacity or 
improve mitochondrial enzyme activity (Green et al., 1989; Hoppeler et al., 1990; Hoppeler et al., 
2003), a combination of hypoxia with specific training modalities may enhance oxidative 
enzymatic activity more than the same training in normoxia (Terrados et al., 1990). It was also 
reported that altitude training could lead to an increased concentration in myoglobin, an 
important component of O2 transport to the mitochondrial membrane, compared to a similar 
training at sea level (Reynafarje, 1962; Hoppeler et al., 1990; Terrados et al., 1990). 
In addition, skeletal muscles play an important regulatory role in the acid-base balance in the 
exercising body by buffering the excess H+ ions. Muscle buffer capacity (ß) (depending on the 
inorganic phosphate (Pi), HCO3
- and proteins concentration (Cerretelli & Samaja, 2003)) is 
affected inter alia by exercise type and intensity, subjects’ training level, and altitude 
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acclimatization level. Interestingly, ß was significantly improved in endurance athletes after 
LHTH (Mizuno et al., 1990) and LHTL (Nummela & Rusko, 2000; Gore et al., 2001) whereas 
such an adaptation was not observed in other trained cyclists and triathletes after LHTL (Clark et 
al., 2004). An important issue is however, the individual variation and reproducibility of the 
responses following altitude training. A large individual variation in physiological and 
performance changes after normoxic LHTL was thus reported (Robertson et al., 2010). The exact 
reasons for such individual variability remain to be elucidated but differences in protein synthesis 
and degradation at the muscular level (Holm et al., 2010) or differences in buffer capacity (Gore et 
al., 2001; Mizuno et al., 2008) were evoqued. Besides, the current knowledge indicates only minor 
changes in oxidative enzymes and no skeletal muscle angiogenesis upon prolonged hypoxic 
exposure (Lundby et al., 2009). Nevertheless, interventional studies in athletes with controlled and 
blinded designs are still needed to prove that training in hypoxia induces a greater magnitude of 
the responses at the muscular level and additional effects on athletic performance (Lundby et al., 
2012). The latter emphasizes again equivocal benefits of adding hypoxia to a training stimulus in 
the actual responses at the muscular level.  
Molecular responses O2 sensing has been widely investigated (Taabazuing et al., 2014) and reveals 
that, in hypoxia, responses occur directly at the gene level. These molecular responses are 
mediated by O2-sensitive transcription factors, such as the so-called hypoxia inducible factors 
(HIF) family. HIF-1α/ß is a master regulator of hypoxia-induced gene expression. While 
undetectable in normoxic cells because it is degraded in presence of O2, in hypoxia HIF-1α can 
enter the cell nucleus, bind to HIF-1ß and constitute the functional transcription factor leading to 
the regulation of hundreds of genes (Semenza, 2007a). The HIF-1α pathway in normoxia and 
hypoxia is presented in Figure 5.  
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Figure 5 The HIF-1α pathway in normoxia and hypoxia. From Maes et al., 2012. 
HIF, hypoxia-inducible transcription factor; HRE, hypoxia response element; PHD, prolyl hydroxylase 
(Egl nine homologs 1 and 2); pVHL, von Hippel–Lindau protein; VEGF, vascular endothelial growth 
factor; VEGFR, VEGF receptor. 
 
The hypoxic condition in the muscular tissue accordingly leads to HIF-mediated adaptations at 
the molecular level (Hoppeler & Vogt, 2001; Zoll et al., 2006) with, for example, the regulation of 
genes coding for proteins involved in: 
-O2 transport (EPO, myoglobin (Mb) and vascular endothelial growth factor (VEGF)) 
-Glycolytic metabolism (phosphofructokinase (PFK) and glucose transporters (GLUT) 
- pH regulation (carbonic anhydrase 3 (CA3) and monocarboxylate transporters 1 and 4 (MCT1, 
MCT4)) 
-Mitochondrial biogenesis/metabolism (peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC1α), mitochondrial transcription factor A (TFAM) and citrate synthase 
(CS)) 
-Oxydative stress (superoxide dismutase (SOD)) 
-Contractile phenotype (myosin heavy chain (MHC). 
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Although this list is not exhaustive, the latter suggests strong responses to the hypoxic 
environment at the molecular level (with a key role of HIF) that may significantly influence 
exercise physiology in hypoxia and account for the tangible responses mentioned above. The 
means by which HIF initiates a cascade of mechanisms leading to the (up- or down-) regulation 
of hundreds of genes are well described elsewhere far beyond the scope of this introduction 
(Semenza et al., 2006; Semenza, 2007a, b). Nevertheless, one should realize that it is now accepted 
that exercising (and hence training) in hypoxia may lead to substantial responses at the molecular 
level leading potentially to systemic performance benefits in athletes aiming at a specific 
competitive edge (Bailey et al., 2000; Bangsbo et al., 2000; Bao et al., 2006; Bailey et al., 2009; 
Bartsch et al., 2009; He et al., 2012). 
 
1.1.3 Athletic performance capacity in hypoxia 
 
The metabolic dependence on O2 availability implies that performance capacity may be altered in 
hypoxia. In HH however reduced aerodynamic resistances might even improve anaerobic 
performances (Hahn & Gore, 2001). Similarly, performance is certainly maintained in hypoxia for 
very short efforts relying on the anaerobic glycolysis such as short maximal sprints or repeated 
sprints (RS) (Bogdanis et al., 1996). RS involve though a progressive rise in the contribution of 
the aerobic metabolism (Gaitanos et al., 1993) explaining the performance decrement observed in 
cycling RS even at a moderate altitude (Brosnan et al., 2000). Thus, performance for longer 
efforts (i.e. aerobic) is clearly degraded at altitude. Numerous studies have reported a decrease in 
aerobic performance and maximal oxygen uptake (VO!"#$) in hypoxia (Squires & Buskirk, 1982; 
Young et al., 1985; Lawler et al., 1988; Peltonen et al., 1995; Chapman et al., 1999; Peltonen et al., 
1999; Friedmann et al., 2005; Mollard et al., 2007; Peltonen et al., 2007; Chapman et al., 2011). In 
hypoxia, O2 diffusion is limited in the lung with the consequence of a reduced VO!"#$ (Calbet & 
Lundby, 2009). A linear decrease in VO!"#$  was hence shown in endurance trained athletes when 
exposed to altitudes increasing from 300 to 2800 m (Wehrlin & Hallen, 2006). For instance, in 
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that study, each 1000 m step was calculated to be associated with about 7.7% decrease in 
performance (Fig. 6) (Wehrlin & Hallen, 2006). However, such decrease of performance presents 
a great individual variability, particularly among elite level athletes (Schouweiler & Stray-
Gundersen, 2002). Indeed, a more important decrement of absolute VO!"#$ was observed in 
elite versus non-elite athletes (Lawler et al., 1988; Koistinen et al., 1995; Mollard et al., 2007) or in 
endurance trained versus sedentary subjects (Gavin et al., 1998; Chapman et al., 1999). 
Nevertheless, previous investigations were conducted on lowlanders (i.e. athletes training mostly 
at low altitude or sea-level) but acclimatization to hypoxia raises performance at altitude (Millet et 
al., 2010), and especially when it occurs in HH (Beidleman et al., 2004; Fulco et al., 2013) 
 
Figure 6 Reduction of maximal oxygen uptake (VO!"#$) with altitude increase compared to sea level. 
From Wehrlin & Hallen, 2006. 
 
Due to the specificity of the discipline, elite ski-mountaineers are thought to be the endurance 
athletes exposed to the highest “hypoxic dose” (i.e. time spent in hypoxic environment) and 
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could therefore be better acclimatized to hypoxia because of the repeated altitude exposures 
(MacNutt et al., 2012). We therefore designed a study (presented in Chapter 5, Article 1) to 
compare VO!"#$ and exercise responses in elite and recreational ski mountaineers in normoxia 
and hypoxia. We expected that elite and recreational ski mountaineers would have a similar 
performance decrement at altitude since acclimatization would compensate the larger impairment 
of aerobic capacity found in elite versus non-elite subjects. This study was particularly useful in 
better understanding physiological responses to hypoxia in elite athletes with the later aim to 
develop innovative training strategies for an elite population.  
1.2 Responses to hypobaric vs. normobaric hypoxia 
As mentioned above, hypoxic conditions are defined by the reduced PIO2 obtained either when 
reducing PB (i.e. hypobaric hypoxia (HH)) or by lowering the FIO2 while PB remains stable (i.e. 
normobaric hypoxia (NH). For long, both HH and NH were thought to produce similar 
physiological responses accordingly described as an “equivalent air altitude model” (Conkin & 
Wessel, 2008). However, a growing body of evidence highlights that HH and NH does not seem 
to induce strictly identical responses. For instance, in HH compared to NH, different ventilatory 
responses have been observed early with a higher respiratory frequency, lower tidal volume (Vt) 
and VE!during 2 h at 4750 m (Tucker et al., 1983). Similar differences in ventilation between HH 
and NH were then confirmed during 10 h at 4770 m (Loeppky et al., 1997) and during 40-min 
exposure at rest at 4500 m (Savourey et al., 2003). A trend for lower PETCO2 and PETO2 was also 
shown. The reduction of PB in HH (and by definition not in NH) could lead to a higher alveolar 
physiological dead space potentially explaining a specific ventilatory response in HH. PB drop 
may lead to a larger pulmonary vasoconstriction and thus alter O2 diffusion because it can modify 
both fluid circulation (e.g., pulmonary lymph) and the trans-alveoli-capillary membrane flux 
(Levine et al., 1988). A significant decrease in plasma volume was then observed in NH compared 
to HH (Loeppky et al., 2005). Again, PB is thought to account partly for this difference with a 
larger fluid retention (or lower diuresis) in HH. Any modification in plasma volume (e.g., 
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hemoconcentration and increased peripheral resistances) could alter O2 delivery to the muscles, 
therefore, physiological responses and training adaptations may substantially differ in NH and 
HH although these have never been investigated to date. 
Furthermore, acute mountain sickness (AMS) symptoms were systematically more pronounced in 
HH compared to NH (Roach et al., 1996; Loeppky et al., 2005; Conkin & Wessel, 2008). It also 
seems that intermittent HH exposure may be effective in the acclimatization to altitude and 
reduction of the AMS severity (Beidleman et al., 2004). A recent review reported differences in 
the relative effectiveness of different pre-acclimatization strategies in HH or NH on physiological 
responses (e.g., PETCO2, SaO2) and coherently concludes that HH and NH cannot be used 
interchangeably since HH seems far more effective in reducing AMS symptoms or optimizing 
exercise performance at altitude (Fulco et al., 2013). 
Furthermore, slight differences in physiological responses and NO have been reported at rest 
between HH and NH during short exposures (Hemmingsson & Linnarsson, 2009). NO plays a 
central role in the physiological responses in hypoxia. As mentioned earlier, when O2 declines in 
arterial blood, the carotid chemoreceptors trigger the HVR through the cortical respiratory 
centers (Dempsey & Forster, 1982). Simultaneously, when O2 tension falls, a nitrite-nitrate-NO 
pathway is gradually activated (Lundberg et al., 2008) to support HVR through vasodilatory 
mechanisms. Interestingly, when nitric oxide synthase (NOS) is inhibited, HVR is reduced (Gozal 
et al., 1996). Thus, a lower HVR observed in HH could potentially result (at least indirectly) from 
a lower NO bioavailability. Moreover, although NO in exhaled air (exNO) is known to decrease 
at altitude (Brown et al., 2006; Donnelly et al., 2011), nitric oxide blood metabolites (NOx) such as 
nitrate and nitrite had not been assessed in HH vs. NH yet. The exact mechanisms underlying 
any exNO (and NOx) difference between HH and NH remain unknown.  
Oxidative stress is a potential candidate. The oxidative stress appears when ROS production 
overcomes the cell’s capacity to neutralize the free radicals. This in turn defines the antioxidant 
capacity. The byproducts of the metabolic aerobic respiration are neutralized by active enzymatic 
antioxdiants (e.g., superoxide dismutase (SOD), catalase, or glutathione peroxidase (GPX) and 
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passive antioxidants (e.g., vitamin E, vitamin C or glutathione) (Powers & Hamilton, 1999). It is 
well established that physical exercise activity challenges the antioxidants capacity by 
overproducing free radicals (Niess & Simon, 2007; Powers et al., 2011). Markers of protein and 
lipid oxidation (e.g., F2-isoprostanes, carbonyls and advanced oxidative protein products (AOPP) 
are subsequently elevated (Urso & Clarkson, 2003). Similarly to acute exercise, hypoxic exposure 
was reported to increase oxidative stress (Pialoux et al., 2009b). In addition, oxidative stress is 
known i) to decrease the NO bioavailability in the vasculature (Thomas et al., 2008b) and ii) to 
modulate the acute ventilatory response to hypoxia after chronic hypoxic exposure (Pialoux et al., 
2009c). The latter suggests potential links between the oxidative stress, the NO metabolism and 
the physiological responses during hypoxic exposure. Surprisingly, this was never compared in 
HH vs. NH although hypothetical differences may help to support the discrepancies reported in 
both conditions. 
Moreover, from a recent meta-analysis (Bonetti & Hopkins, 2009) considering altitude training 
strategies it is also striking that exposure to HH doesn’t seem to produce the same effects than 
NH since “real” altitude protocols seem to better enhance sea-level performance. Therefore, for 
the efficiency of hypoxic training methods and especially for intermittent sports, major key-
questions related to the necessary hypoxic dose, the most beneficial hypoxic exposure (i.e. NH or 
HH) and the optimal training protocol for worthwhile adaptations and performance 
improvement still remain to be answered. 
Obviously, disentangling hypoxia and hypobaria is of importance for athletes or mountaineers 
who use NH to prepare for altitude competitions or expeditions (Kayser, 2009) and further 
investigations on the differences in mechanisms and the clinical significance of hypobaric vs. 
normobaric hypoxia are needed. 
In that context, we designed a study (presented in Chapter 6, Article 2) in order to determine if 
previously shown differences in ventilatory and nitrosative responses during short duration 
exposure in HH vs. NH were maintained over 24 hours at 3000 m in HH vs. NH and if these 
differences would be associated with different oxidative stress and plasma pH variations. The 
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experimental design was defined to assess for the first time the cardio-respiratory responses to 
moderate exercise but also analyze the time course of oxidative stress and NO metabolism at rest 
to discuss putative mechanisms in different physiological responses between HH and NH. 
1.3 Responses to intermittent hypoxic training 
The relevance of adding a hypoxic stress to any form of training mainly depends on the expected 
supplementary benefits in terms of performance. From the existing literature, Millet et al. 
presented the overall efficiency of various hypoxic training methods (Table 1, (Millet et al., 2010). 
Remarkably, most training strategies allowed an increased performance or at least positive 
mechanisms while others did not bring additional benefits or even triggered detrimental effects. 
For instance, negative mechanisms were found in almost one third of the LHTL protocols. 
Meanwhile, even though IHT often failed to enhance performance, no detrimental effects were 
reported. 
 
Table 1 Overall efficiency of various hypoxic methods. From Millet et al., 2010. 
LHTL, live high-train low ; IHT : intermittent hypoxic training. 
 
Interestingly performance improvements after specific altitude training were reported and 
attributed to non-hematological peripheral factors (e.g., increased muscle buffer capacity (Gore et 
al., 2007), better locomotion efficiency (Saunders et al., 2009). Then it seems clear that the 
hypoxic dose during IHT is insufficient to elicit polycythemia (Levine & Stray-Gundersen, 2006). 
Therefore, any putative additional benefit of adding a hypoxic stress to intermittent training (i.e. 
IHT) shall be associated with peripheral adaptations at the muscular level rather than improved 
oxygen transport due to an augmented Hb mass.  
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Nevertheless, before thinking about further benefits in the subsequent sea-level (or low altitude) 
performance when adding hypoxia to a training strategy one should find the specific training 
strategy improving performance in normoxia. Interval training (INT) may be a successful 
approach. INT methods have been extensively investigated (Billat, 2001a, b) and are widely used 
by athletes both in endurance and intermittent sports since tangible performance benefits arise 
after well thought INT. Although it is beyond the scope of this work to detail all mechanisms 
involved in performance improvement after INT, it challenges by definition the metabolic and 
neuromuscular systems because INT consists of “repeated short-to-long bouts of rather high-
intensity exercise interspersed with recovery periods” (Billat, 2001a). The optimal exercise 
intensity (Millet et al., 2003b) and work-to-rest ratio (Millet et al., 2003a) need to be determined to 
bring metabolic, cardiovascular, and other peripheral adaptive mechanisms to their limit. 
 The rationale of adding a hypoxic stimulus to INT (i.e. IHT) relies on the hypothesis that 
adaptations at the muscular level surpass those triggered by INT alone, with the evidence that 
IHT augments the physiological strain (Buchheit et al., 2012) and elicits specific molecular 
adaptations (Vogt et al., 2001; Kime et al., 2003; Zoll et al., 2006).   
Indeed, it has been shown in IHT that training intensity per se modulates molecular adaptations at 
muscular level in hypoxia (Hoppeler & Vogt, 2001) and systemic results seemed to confirm it, 
because the increase in performance varies extremely depending on the type of IHT used 
(Dufour et al., 2006; Roels et al., 2007). A significant increase in mRNA expression of genes 
involved in O2 transport (e.g., VEGF and Mb) appeared indeed only after high-intensity hypoxic 
training when compared to the same normoxic training (Vogt et al., 2001). In this way, results 
assess that IHT induces peripheral adaptations possibly not found with INT alone such as 
increase in muscle buffer activity or the mentioned specific molecular adaptations at muscular 
level (Geiser et al., 2001; Hoppeler & Vogt, 2001; Vogt et al., 2001; Hoppeler et al., 2003). In 
addition, including hypoxia sessions into the usual training of athletes was shown to qualitatively 
improve mitochondrial function (Ponsot et al., 2006). Hence, different high-intensity training 
methods in hypoxia could be advantageous for anaerobic glycolysis: significant changes 
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concerning pH regulation and lactate transportation at the muscular level after a 6-week IHT 
were found (Zoll et al., 2006). Improved anaerobic performance has previously been described 
after nine days after IHT with peak and average power output being significantly improved 
during a specific anaerobic cycling test while a control group performing INT did not improve 
(Meeuwsen et al., 2001). Thus, we mention here putative benefits of IHT for anaerobic 
performance. It is striking though that the advantages of IHT for anaerobic performance (in 
intermittent sports for example) have hardly been studied and that the mechanisms originating 
performance improvement are obscure. To the same extent, several controversial discussions 
addressed the usefulness of IHT for improving football performance (Bartsch et al., 2009; 
Gatterer et al., 2009). Actually, four studies were mentioned showing improvement in anaerobic 
performance after high altitude training (Bartsch et al., 2008a). However, all of these studies were 
uncontrolled and thus cannot distinguish between the effects of training and those of hypoxia. 
To have an insight of the potential of IHT vs. INT, we produced a comprehensive review of the 
existing IHT studies in the literature presented in Chapter 11, Article 7. The overview of existing 
LLTH methods was updated to gather data from 21 studies. To consider the recent update of the 
methods’ nomenclature (Millet et al., 2013a), we separated training containing either essentially 
continuous aerobic training bouts in hypoxia (CHT) (11 studies, Table 2) or intermittent hypoxic 
training with more intense repeated intervals (i.e., IHT) (10 studies, Table 3). Interestingly, an 
additional benefit on performance-related variables of LLTH compared to the same training 
performed in normoxia was present only in one CHT study and three of the IHT studies. It 
allowed us to highlight the role of training content and intensity in the subsequent performance 
improvement despite strikingly poor additional benefits of IHT vs. INT in promoting athletic 
performance (especially in the rare study involving team-sports athletes). It finally evoked the lack 
of well-designed controlled IHT studies including maximal intensity exercise training and helps to 
understand the orientation of our research towards a very specific and novel form of intensive 
hypoxic training, the so called repeated sprint training in hypoxia (RSH). 
 - 3
6 
- 
A
ut
ho
r 
(y
ea
r)
 
Su
bj
ec
ts
 
D
es
ig
n 
(n
um
be
r 
of
 tr
ai
ni
ng
 s
es
si
on
s,
 ty
pe
, a
lti
tu
de
, t
ra
in
in
g 
co
nt
en
t)
 
G
ro
up
s 
St
at
is
tic
al
ly
 s
ig
ni
fic
an
t r
es
ul
ts
 (P
<
0.
05
) 
R
os
ka
m
m
 et
 a
l. 
(1
96
9)
  
U
nt
ra
in
ed
 
24
 o
ve
r 
4 
w
ks
, c
yc
lin
g,
 2
25
0 
m
 (N
=
6)
 o
r 
34
50
 m
 (N
=
6)
 (H
H
). 
30
-m
in
 a
er
ob
ic
 tr
ai
ni
ng
 
C
H
T
, N
=
12
 
+
10
-1
7%
 V
O
2m
ax
  
 
 
 
C
N
T
, N
=
6 
+
6%
 V
O
2m
ax
 
E
m
on
so
n 
et 
al
. (
19
97
)  
U
nt
ra
in
ed
 
15
 o
ve
r 
5 
w
ks
, c
yc
lin
g,
 2
50
0 
m
 (H
H
). 
45
 m
in
 a
t 7
0%
 o
f V
O
2m
ax
 
C
H
T
, N
=
9 
+
12
%
 V
O
2m
ax
 
 
 
 
C
N
T
, N
=
9 
+
12
%
 V
O
2m
ax
 
K
at
ay
am
a 
et 
al
. (
19
99
)  
U
nt
ra
in
ed
 
10
 o
ve
r 
2 
w
ks
, c
yc
lin
g,
 4
50
0 
m
 (H
H
). 
30
 m
in
 a
t 7
0%
 o
f n
or
m
ox
ic
 V
O
2m
ax
 le
ve
l 
C
H
T
, N
=
7 
+
7%
 V
O
2m
ax
  
 
 
 
C
N
T
, N
=
7 
+
5%
 V
O
2m
ax
 
B
ai
le
y 
et 
al
. (
20
00
)  
R
un
ne
rs
 
4 
w
ks
 a
t ~
20
00
 m
 (N
H
). 
A
er
ob
ic
 tr
ai
ni
ng
, n
o 
de
ta
ils
 
C
H
T
, N
=
18
 
+
15
%
 V
O
2m
ax
  
 
 
 
C
N
T
, N
=
14
 
+
5%
 V
O
2m
ax
 
G
ei
se
r 
et 
al
. (
20
01
)  
U
nt
ra
in
ed
 
30
 o
ve
r 
6 
w
ks
, c
yc
lin
g,
 3
85
0 
m
 (N
H
). 
30
 m
in
 a
t 7
7-
85
%
 o
f m
ax
 h
ea
rt
 r
at
e 
C
H
T
, N
=
18
 
+
11
%
 V
O
2m
ax
, +
17
%
 3
0-
m
in
 T
T
 m
ea
n 
PO
 
 
 
 
C
N
T
, H
=
15
 
+
9%
 V
O
2m
ax
, +
19
%
 3
0-
m
in
 T
T
 m
ea
n 
PO
 
K
ar
ls
en
 et
 a
l. 
(2
00
2)
  
C
yc
lis
ts
 
9 
ov
er
 3
 w
ks
, c
yc
lin
g.
 3
00
0 
m
 (N
H
). 
12
0 
m
in
 a
er
ob
ic
 tr
ai
ni
ng
 
C
H
T
, N
=
8 
N
S 
ch
an
ge
s 
in
 V
O
2m
ax
 o
r 
30
-m
in
 T
T
 
 
 
 
C
N
T
, N
=
8 
N
S 
ch
an
ge
s 
in
 V
O
2m
ax
 o
r 
30
-m
in
 T
T
 
H
en
dr
ik
se
n 
  
T
ria
th
le
te
s 
10
 o
ve
r 
10
 d
ay
s,
 c
yc
lin
g,
 2
50
0 
m
 (H
H
). 
10
5 
m
in
 a
er
ob
ic
 tr
ai
ni
ng
  
C
H
T
, N
=
8 
+
5%
 P
P
O
 c
yc
lin
g 
W
in
ga
te
 
&
 M
ee
uw
se
n 
(2
00
3)
  
 
 
C
N
T
, N
=
8 
N
S 
in
cr
ea
se
 
V
en
tu
ra
 et
 a
l. 
(2
00
3)
  
C
yc
lis
ts
 
18
 o
ve
r 
6 
w
ks
, c
yc
lin
g,
 3
20
0 
m
 (N
H
). 
30
 m
in
 a
er
ob
ic
 tr
ai
ni
ng
  
C
H
T
, N
=
7 
N
S 
ch
an
ge
s 
in
 V
O
2m
ax
 o
r 
10
-m
in
 T
T
 
 
 
 
C
N
T
, N
=
5 
N
S 
ch
an
ge
s 
in
 V
O
2m
ax
 o
r 
10
-m
in
 T
T
 
D
uf
ou
r 
et 
al
. (
20
06
)  
R
un
ne
rs
 
12
 o
ve
r 
6 
w
ks
, r
un
ni
ng
, 3
00
0 
m
 (N
H
). 
24
-4
0 
m
in
 <
 V
O
2m
ax
. 
C
H
T
, N
=
9 
+
5%
 V
O
2m
ax
, +
35
%
 T
lim
 a
t v
V
O
2m
ax
   
 
 
 
C
N
T
, N
=
9 
N
S 
ch
an
ge
s 
H
am
lin
 et
 a
l. 
(2
00
9)
  
C
yc
lis
ts
 &
 tr
ia
th
le
te
s 
10
 o
ve
r 
10
 d
ay
s,
 c
yc
lin
g,
 3
20
0-
44
00
 m
 (N
H
). 
90
 m
in
 a
er
ob
ic
 tr
ai
ni
ng
 fo
llo
w
ed
 b
y 
C
H
T
, N
=
9 
+
3%
 P
O
 c
yc
lin
g 
W
in
ga
te
 
 
 
tw
o 
30
-s
 W
in
ga
te
 te
st
s 
C
N
T
, N
=
7 
N
S 
ch
an
ge
s 
M
ao
 et
 a
l. 
(2
01
1)
 
A
ct
iv
e 
m
al
es
 
25
 o
ve
r 
5w
ks
, c
yc
lin
g,
 2
75
0 
m
 (N
H
). 
30
 m
in
 a
er
ob
ic
 tr
ai
ni
ng
 
C
H
T
, N
=
12
 
+
16
%
 V
O
2m
ax
 
 
 
 
C
N
T
, N
=
12
 
+
10
%
 V
O
2m
ax
 
H
ol
is
s 
et 
al
. (
20
14
) 
R
un
ne
rs
 
16
 o
ve
r 
8 
w
ee
ks
, r
un
ni
ng
, 2
15
0 
m
, (
N
H
). 
40
 m
in
 <
 V
O
2m
ax
 
C
H
T
, N
=
5 
-3
%
 s
ub
m
ax
im
al
 V
O
2, 
-1
%
 V
O
2m
ax
 
 
 
 
C
N
T
, N
=
7 
+
2%
 s
ub
m
ax
im
al
 V
O
2, 
+
5%
 V
O
2m
ax
 
T
ab
le
 2
 S
um
m
ar
y 
of
 c
ur
re
nt
 r
es
ea
rc
h 
fin
di
ng
s 
re
la
tiv
e 
on
ly
 to
 th
e 
us
e 
of
 h
yp
ox
ic
 tr
ai
ni
ng
 in
cl
ud
in
g 
co
nt
in
uo
us
 a
er
ob
ic
 b
ou
ts
 in
 h
yp
ox
ia
 (C
H
T
) u
pd
at
ed
 fr
om
 (F
ai
ss
 et
 a
l.,
 2
01
3a
). 
Si
gn
ifi
ca
nt
 d
iff
er
en
ce
 b
et
w
ee
n 
gr
ou
ps
 is
 s
ho
w
n 
in
 b
ol
d 
(P
<
0.
05
). 
H
H
, h
yp
ob
ar
ic
 h
yp
ox
ia
; N
H
, n
or
m
ob
ar
ic
 h
yp
ox
ia
; C
N
T
, c
on
tin
uo
us
 n
or
m
ox
ic
 t
ra
in
in
g;
 N
S,
 n
on
 s
ig
ni
fic
an
t 
(P
 >
 0
.0
5)
; 
PP
O
, p
ea
k 
po
w
er
 o
ut
pu
t; 
PO
, p
ow
er
 o
ut
pu
t; 
T
T
, t
im
e 
tr
ia
l; 
V
O
2m
ax
, m
ax
im
al
 o
xy
ge
n 
up
ta
ke
; T
lim
, t
im
e 
to
 e
xh
au
st
io
n;
 v
V
O
2m
ax
, v
el
oc
ity
 a
ss
oc
ia
te
d 
to
 V
O
2m
ax
 . 
(R
os
ka
m
m
 et
 a
l.,
 1
96
6;
 T
er
ra
do
s 
et 
al
., 
19
88
; M
ar
tin
o 
et 
al
., 
19
95
; E
m
on
so
n 
et 
al
., 
19
97
; K
at
ay
am
a 
et 
al
., 
19
99
; B
ai
le
y 
et 
al
., 
20
00
; G
ei
se
r 
et 
al
., 
20
01
; K
ar
ls
en
 et
 a
l.,
 2
00
2;
 H
en
dr
ik
se
n 
&
 M
ee
uw
se
n,
 2
00
3;
 T
ru
ije
ns
 et
 a
l.,
 2
00
3;
 V
en
tu
ra
 et
 a
l.,
 2
00
3;
 M
or
to
n 
&
 C
ab
le
, 2
00
5;
 R
oe
ls
 et
 a
l.,
 2
00
5;
 D
uf
ou
r 
et 
al
., 
20
06
; R
oe
ls
 et
 a
l.,
 2
00
7;
 H
am
lin
 et
 a
l.,
 2
01
0;
 L
ec
ou
ltr
e 
et 
al
., 
20
10
; M
ao
 et
 a
l.,
 2
01
1;
 H
ol
lis
s 
et 
al
., 
20
13
; H
ol
lis
s 
et 
al
., 
20
14
) 
  
 
- 3
7 
- 
A
ut
ho
r 
(y
ea
r)
 
Su
bj
ec
ts
 
D
es
ig
n 
(n
um
be
r 
of
 tr
ai
ni
ng
 s
es
si
on
s,
 ty
pe
, a
lti
tu
de
, t
ra
in
in
g 
co
nt
en
t)
 
G
ro
up
s 
St
at
is
tic
al
ly
 s
ig
ni
fic
an
t r
es
ul
ts
 (P
<
0.
05
) 
T
er
ra
do
s 
et 
al
. (
19
88
)  
E
lit
e 
cy
cl
is
ts
 
12
-2
0 
ov
er
 3
-4
 w
ks
, c
yc
lin
g,
 2
30
0 
m
 (H
H
). 
A
er
ob
ic
 tr
ai
ni
ng
 a
nd
 s
om
e 
in
te
rv
al
s 
(1
5 
s 
 
IH
T
, N
=
4 
+
33
%
 P
PO
  
 
 
at
 1
30
%
 o
f a
er
ob
ic
 p
ea
k 
po
w
er
 o
ut
pu
t)
 
IN
T
, N
=
4 
+
22
%
 P
PO
 
M
ar
tin
o 
et 
al
. (
19
95
)  
E
lit
e 
sw
im
m
er
s 
Sw
im
 s
pr
in
ts
 a
t 2
80
0 
m
 (H
H
) d
ur
in
g 
21
 d
ay
s 
at
 a
lti
tu
de
. N
o 
de
ta
ils
 a
va
ila
bl
e 
IH
T
, N
=
20
 
-6
%
 1
00
 m
 s
w
im
 ti
m
e,
 +
34
%
 P
P
O
 a
rm
 W
in
ga
te
 
 
 
 
IN
T
, N
=
13
 
N
S 
ch
an
ge
s 
T
ru
ije
ns
 et
 a
l. 
(2
00
3)
  
Sw
im
m
er
s 
15
 o
ve
r 
5 
w
ks
, s
w
im
m
in
g,
 2
50
0 
m
 (N
H
). 
12
.5
 m
in
 >
 1
00
%
 V
O
2m
ax
  (
30
 s
 o
r 
60
 s
  
IH
T
, N
=
8 
N
S 
ch
an
ge
s 
 
 
bo
ut
s)
 
IN
T
, N
=
8 
+
6%
 V
O
2m
ax
  
M
or
to
n 
&
 C
ab
le
, (
20
05
)  
T
ea
m
 s
po
rt
 p
la
ye
rs
 
12
 o
ve
r 
4 
w
ks
, c
yc
lin
g,
 2
75
0 
m
 (N
H
). 
10
 x
 1
-m
in
 a
t 8
0%
 o
f 2
-m
in
 P
PO
 
IH
T
, N
=
8 
+
8%
 c
yc
lin
g 
W
in
ga
te
 P
PO
, +
 7
%
 V
O
2m
ax
  
 
 
 
IN
T
, N
=
8 
+
6.
5%
 c
yc
lin
g 
W
in
ga
te
 P
PO
,  
8%
 V
O
2m
ax
 
R
oe
ls
 et
 a
l. 
(2
00
5)
  
C
yc
lis
ts
 &
 tr
ia
th
le
te
s 
14
 o
ve
r 
7 
w
ks
, c
yc
lin
g,
 3
00
0 
m
 (N
H
). 
6-
8 
x 
2-
3 
m
in
 a
t 1
00
%
 o
f a
er
ob
ic
 P
PO
 
IH
T
, N
=
11
 
+
4%
 1
0-
m
in
 T
T
 m
ea
n 
PO
 
 
 
 
IH
IT
, N
=
11
 
 +
9%
 V
O
2m
ax
, +
5%
 1
0-
m
in
 T
T
 m
ea
n 
PO
 
 
 
 
IN
T
, N
=
11
 
+
5%
 1
0-
m
in
 T
T
 m
ea
n 
PO
 
D
uf
ou
r 
et 
al
. (
20
06
)  
R
un
ne
rs
 
12
 o
ve
r 
6 
w
ks
, r
un
ni
ng
, 3
00
0 
m
 (N
H
). 
24
-4
0 
m
in
 w
ith
 in
te
rv
al
s 
<
 V
O
2m
ax
. 
IH
T
, N
=
9 
+
5%
 V
O
2m
ax
, +
35
%
 T
lim
 a
t v
V
O
2m
ax
   
 
 
 
IN
T
, N
=
9 
N
S 
ch
an
ge
s 
R
oe
ls
 et
 a
l. 
(2
00
7)
  
C
yc
lis
ts
 &
 tr
ia
th
le
te
s 
15
 o
ve
r 
3 
w
ks
, c
yc
lin
g,
 3
00
0 
m
 (N
H
). 
9 
x 
60
 m
in
 a
t 6
0%
 V
O
2m
ax
 a
nd
 3
6 
m
in
 w
ith
  
IH
T
, N
=
10
 
+
7%
 a
er
ob
ic
 P
PO
  
 
 
in
te
rv
al
s 
of
 2
 m
in
 a
t 1
00
%
 a
er
ob
ic
 P
PO
 (2
 m
in
 b
ou
ts
) 
IN
T
, N
=
9 
+
7%
 a
er
ob
ic
 P
PO
, +
8%
 1
0-
m
in
 T
T
 m
ea
n 
PO
 
Le
co
ul
tr
e 
et 
al
. (
20
10
)  
 C
yc
lis
ts
 
12
 o
ve
r 
4 
w
ks
, c
yc
lin
g,
 3
00
0 
m
 (N
H
). 
4 
x 
12
-1
8 
m
in
 a
t 1
00
-1
20
%
 o
f a
er
ob
ic
 P
PO
, 4
 x
  
IH
T
, N
=
7 
+
7%
 4
0 
km
 T
T
 m
ea
n 
PO
  
 
 
30
-4
8 
m
in
 <
 V
O
2m
ax
 a
nd
 4
 x
 1
00
-m
in
 a
er
ob
ic
 tr
ai
ni
ng
. 
IN
T
, N
=
7 
+
6%
 4
0 
km
 T
T
 m
ea
n 
PO
 
M
an
im
m
an
ak
or
n 
et 
al
. 
Fe
m
al
e 
te
am
-s
po
rt
 
15
 o
ve
r 
5 
w
ks
, k
ne
e 
fle
xi
on
 a
nd
 e
xt
en
si
on
, ~
45
00
 m
 (N
H
). 
6 
se
ts
 o
f l
ow
 r
es
is
ta
nc
e 
 
IH
T
, N
=
10
 
+
15
%
 M
V
C
3,
 +
17
%
 M
V
C
30
, +
12
9%
 R
E
P
20
1R
M
 
(2
01
2)
  
pl
ay
er
s 
kn
ee
 e
xt
en
si
on
s 
an
d 
fle
xi
on
s 
to
 fa
ilu
re
 w
ith
 3
0 
s 
be
tw
ee
n 
se
ts
 
IN
T
, N
=
10
 
+
 8
6%
 R
E
P2
01
R
M
 
H
ol
lis
s 
et 
al
. (
20
13
) 
A
ct
iv
e 
m
al
es
 
15
 o
ve
r 
3 
w
ks
, l
eg
-e
xt
en
si
on
, 3
00
0 
m
 (N
H
). 
10
 x
 6
0-
70
 s
 in
te
ns
e 
ex
er
ci
se
 w
ith
 2
0-
30
 s
  
IH
T
, N
=
9 
+
25
%
 le
g-
ex
te
ns
io
n 
in
cr
em
en
ta
l T
lim
 
 
 
pa
ss
iv
e 
re
co
ve
ry
. O
ne
 le
g 
IH
T
, t
he
 o
th
er
 le
g 
IN
T
. 
IN
T
, N
=
9 
+
27
%
 le
g-
ex
te
ns
io
n 
in
cr
em
en
ta
l T
lim
 
T
ab
le
 3
 S
um
m
ar
y 
of
 c
ur
re
nt
 r
es
ea
rc
h 
fin
di
ng
s 
re
la
tiv
e 
on
ly
 to
 th
e 
us
e 
of
 in
te
rm
itt
en
t h
yp
ox
ic
 tr
ai
ni
ng
 (I
H
T
) u
pd
at
ed
 fr
om
 (F
ai
ss
 et
 a
l.,
 2
01
3a
). 
Si
gn
ifi
ca
nt
 d
iff
er
en
ce
 b
et
w
ee
n 
gr
ou
ps
 i
s 
sh
ow
n 
in
 b
ol
d 
(P
<
0.
05
). 
H
H
, 
hy
po
ba
ric
 h
yp
ox
ia
; 
N
H
, 
no
rm
ob
ar
ic
 h
yp
ox
ia
; 
C
N
T
, 
co
nt
in
uo
us
 n
or
m
ox
ic
 t
ra
in
in
g;
 I
H
IT
, 
in
te
rm
itt
en
t 
hy
po
xi
a 
in
te
rv
al
 tr
ai
ni
ng
, C
O
N
; c
on
tr
ol
 g
ro
up
N
S,
 n
on
 s
ig
ni
fic
an
t (
P 
>
 0
.0
5)
; P
PO
, p
ea
k 
po
w
er
 o
ut
pu
t; 
PO
, p
ow
er
 o
ut
pu
t; 
T
T
, t
im
e 
tr
ia
l; 
V
O
2m
ax
, m
ax
im
al
 o
xy
ge
n 
up
ta
ke
; T
lim
, t
im
e 
to
 e
xh
au
st
io
n;
 
vV
O
2m
ax
, 
ve
lo
ci
ty
 a
ss
oc
ia
te
d 
to
 V
O
2m
ax
 ; 
M
V
C
3,
 p
ea
k 
m
ax
im
um
 v
ol
un
ta
ry
 c
on
tr
ac
tio
n 
in
 3
 s
; 
M
V
C
30
, 
ar
ea
 u
nd
er
 t
he
 p
ea
k 
30
 s
 m
ax
im
al
 v
ol
un
ta
ry
 c
on
tr
ac
tio
n 
cu
rv
e;
 R
E
PS
20
1R
M
, 
re
pe
tit
io
ns
 a
t 2
0%
 o
f 1
 r
ep
et
iti
on
 m
ax
im
al
 lo
ad
; R
SA
, r
ep
ea
te
d 
sp
rin
t a
bi
lit
y 
te
st
 to
 e
xh
au
st
io
n;
 L
T
4,
 p
ow
er
 o
ut
pu
t c
or
re
sp
on
di
ng
 to
 4
 m
m
ol
 b
lo
od
 la
ct
at
e 
  - 38 -  
1.4 The Repeated Sprint training in Hypoxia (RSH) model 
Methodological flaws associated with IHT were recently overcome with studies investigating a 
new hypoxic training strategy named RSH (Faiss et al., 2013b; Galvin et al., 2013; Puype et al., 
2013; Brocherie et al., 2014; Faiss et al., 2014b). Indeed, the major problem related to IHT 
(compared to similar training in normoxia) is that hypoxia lowers the stimulus for the active 
musculature because of a lowered oxygen flux and degraded power output (Brosnan et al., 2000; 
Levine, 2002). By definition, RSH is a training method in hypoxia based on the repetition of 
short “all-out” efforts (≤30 s) interspersed with short incomplete recoveries. Interestingly, single 
sprint performance (<10 s) is preserved up to high altitudes (<3800 m) (Bowtell et al., 2013) and 
fatigue resistance is then decreased when sprints are repeated with large decrement in mechanical 
work at the maximal effort intensity (Balsom et al., 1994; Smith & Billaut, 2012). RSH therefore 
substantially differs from IHT with the maximal intensity of the training stimulus forcing the 
utmost recruitment of fast-twitch fibers (FT) required during all-out efforts. Adding a hypoxic 
stimulus (i.e. reducing systemic O2 availability) to this type of training stimulus may not impair 
the maximal performance being essentially anaerobic but positively stimulate HIF-mediated 
adaptive mechanisms at the muscular level. 
Repeated sprint training in normoxia (RSN) (i.e. traditional repeated sprint training) is very 
commonly used in team or racket sports. Overall performance during a repeated-sprint ability 
test (RSA) was shown for example to predict total sprint distance during a professional soccer 
match (Rampinini et al., 2007). Thus, improving RSA performance may lead to a greater team-
sport related global performance (Bishop et al., 2011). Practically, RSA performance will highly 
depend on i) the ability to maintain energy supply (e.g., phosphocreatine (PCr) resynthesis), ii) 
metabolite accumulation (e.g., Pi and H+) and iii) neural factors (e.g., neural drive and muscle 
activation) (Girard et al., 2011). Among these factors, PCr resynthesis is a key determinant of 
RSA performance. Thus, the decrease in PCr stimulates the contribution of the anaerobic 
glycolotic metabolism at the start of a sprint but then the oxidative pathway is determinant in the 
- 39 - 
PCr resynthesis rate (Haseler et al., 1999). In this context, accumulation of H+ (and thus the 
subsequent recovery in muscle pH) may be secondary to the primordial restoration of the energy 
supply to produce power during RSA (Mendez-Villanueva et al., 2012). Limiting the O2 supply -
with RSH for instance- could thus lead to an adaptation in the mechanisms ensuring energy and 
O2 supply in the tissue working in normoxia. In fact, during an effort in hypoxia, a compensatory 
vasodilation associated with an increase in blood flow ensures an adjusted O2 delivery to the 
muscle and this vasodilation is likely maximal during sprinting in hypoxia since exercise intensity 
modulates its amplitude (Casey & Joyner, 2012). Additionally, FT, preferentially recruited while 
sprinting (Hautier et al., 1996) may better adjust to a high energetic demand with a greater 
fractional O2 extraction than slow twitch fibers (ST) if oxygen tension falls in the muscle (e.g., in 
hypoxia) (McDonough et al., 2005). 
The latter suggests that RSH could be more beneficial than RSN for subsequent performance 
improvement due to the particular combination of repeated maximal exercise bouts combined 
with O2 deprivation. Interestingly, a performance enhancement was confirmed recently by Puype 
et al. showing that power output corresponding to 4 mmol of lactate during an incremental test 
improved by 7% after RSH but did not change after RSN (Puype et al., 2013).  Similarly, an 
additional benefit of RSH compared to RSN was recently described in rugby players with a 19% 
gain in high-intensity intermittent running performance (Galvin et al., 2013). This substantially 
higher performance improvement is particularly interesting since the test used (Yo-Yo IR1 test 
(Bangsbo et al., 2008)) correlates well with physical performance and amount of high-intensity 
running in several team sports such as soccer, basketball, rugby and handball (Galvin et al., 2013). 
Finally, our research group reported that RSH improved sprinting times in young well-trained 
football players to a greater extent than RSN (Brocherie et al., 2014). 
It is important to note that even though these results seem to confirm the potential of RSH vs. 
RSN, we should mention that our group published the first results assessing the effects of RSH 
on subsequent normoxic RSA performance improvement and adaptations at the muscular level. 
This study is presented in Chapter 8, Article 4. 
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Our blinded design included a large sample size of 20 subjects in a RSH group, 20 subjects in a 
RSN group and 10 subjects not training (control group (CON)) because we were well aware of 
potential methodological flaws (e.g., placebo or nocebo effects) affecting hypoxic training studies 
(Bergeron et al., 2012). We tested RSA performance on a cycle ergometer before (Pre-) and after 
(Post-) training to determine putative additional benefits of RSH vs. RSN. 
To discuss potential mechanisms behind any difference in performance gains, we assessed muscle 
oxygenation by using a near-infrared spectroscopy (NIRS) technique and molecular responses by 
analyzing mRNA expression of HIF-mediated genes from muscular biopsies. In brief, NIRS 
allows having an insight in O2 utilization in the muscle by measuring concentrations of 
hemoglobin saturated in O2 (oxyhemoglobin concentration, [O2Hb]) or unsaturated in O2 
(deoxyhemoglobin concentration, [HHb]) and total hemoglobin/myoglobin concentration 
([tHb]). The up- or down-regulation of the mRNA expression of genes may reflect both the 
changes in muscular protein content and training based muscle performance improvements 
(Egan & Zierath, 2013).  
We also considered our initial hypothesis of fiber-type selective mechanisms supporting 
additional benefits of RSH compared to RSN. In other words, if FT and their maximal 
recruitment play a key role in adaptive mechanism during RSH, activities or exercises involving a 
higher proportion of FT could potentially benefit more from RSH. Indeed in cross-country 
double poling, upper body muscles are largely contributing to power production (Holmberg et al., 
2005), and upper arms muscle comprise a high proportion of FT (Klein et al., 2003). We 
consequently tested the effects of RSH vs. RSN on cross-country double poling performance 
during a RSA test to confirm our first hypothesis and further explore the mechanisms underlying 
the projected efficiency of RSH. This original research is presented in Chapter 10, Article 6. 
Table 4 summarizes the results of all RSH studies to date complementary to traditional IHT 
studies mentioned before (Tables 2 & 3). 
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Author'(year)' Subjects' Study'design' Groups' Satistically'significant'results'(p<0.05)'
Puype et al. (2013)  Moderately trained   18 over 6 wks, cycling, 3000 m (NH). 4-9 sprints  RSH, N=10 +6% sprint PO, +6% VO2max, +6% 10-min PO, +7% LT4 
 cyclists of 30 s interspersed with 4.5 min recovery RSN, N=10 +5% sprint PO, +6% VO2max, +6% 10-min PO, NS 
   CON, N=10 NS changes 
Galvin et al. (2013) Rugby players 12 over 4 wks, treadmill running, 3500 m (NH).  RSH, N=15 +33% Yo-Yo Intermittent Recovery Test performance 
  10 sprints of 6 s interspersed with 30 s recovery RSN, N=15 +14% Yo-Yo Intermittent Recovery Test performance 
Faiss et al. (2013)  Moderately trained 8 over 4wks, cycling, 3000 m (NH). 3 x 5 all-out  RSH, N=20 +6% sprint PO, +38% completed sprints in RSA test  
 cyclists 10 s sprints interspersed with 20 s recovery  RSN, N=20 +7% sprint PO, no change in completed sprints 
   CON, N=10 NS changes 
Brocherie et al.  Football players' 10 over 5wks, running, 2900 m (NH). 5 x 4 all-out ' RSH, N=8' -4% first sprint time, -4% cumulated sprint time !
(2014)' ' 5 s sprints interspersed wth 45 s recovery' RSN, N=8' -2% first sprint time, -2% cumulated sprint time'
Table 4 Summary of current research findings for repeated sprint training in hypoxia (RSH) adapted from Faiss et al., 
2013a. 
Altitude described as either hypobaric hypoxia (HH) or normobaric hypoxia (NH). Significant difference between 
groups is shown in bold (P<0.05). PO, power output; VO2max, maximal oxygen uptake, LT4, power output 
corresponding to 4 mmol blood lactate
 
 
A recent review questioned again the relevance of altitude training for performance enhancement 
in team-sport athletes (Billaut et al., 2012). Although there was a comprehensive review of the 
scarce literature, our results allowed us to comment it on two points of importance i) the 
previously mentioned relative differences between HH and NH, ii) the exercise intensity and 
work-to-rest ratio during IHT (or RSH for instance) since we believe that these two points are 
paramount for understanding the possible benefits of hypoxic training in team-sport athlete 
performance (Chapter 9, Article 5; Millet & Faiss, 2012). 
  
  
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
Summary of experimental results
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2. Summary of experimental results 
2.1 Larger aerobic performance decrement at altitude in elite vs. recreational 
ski-mountaineers 
With a study design comparing physiological responses to normobaric hypoxia at rest and 
performance decrement during maximal treadmill running, we highlighted a significantly (p<0.05) 
higher HVR in elite (E) vs. recreational (R) ski-mountaineers (1.58 ± 1.9 vs. 0.23 ± 0.49 l.min-1.   
% -1.kg-1).  
At maximal intensity, SpO2 was significantly lower (p<0.01) in E than in R, both in N (91.1 ± 3.3 
vs. 94.3 ± 2.3%) and in H (76.4 ± 5.4 vs. 82.3 ± 3.5%). In both groups, SpO2 was lower (p<0.01) 
in H. Between N and H,!VO!"#$ decreased to a greater extent (p<0.05) in E than in R (-18% and 
-12%, p<0.01). In E only, VO!"#$  decrement was significantly correlated with the SpO2 
decrement (r=0.74, p<0.01) but also with VO!"#$ measured in normoxia (r=0.64, p<0.05). We 
concluded that despite a probable better acclimatization to altitude, VO!"#$ was more reduced in 
E than in R ski-mountaineers, confirming previous results observed in lowlander E athletes. 
2.2 Conclusive differences between hypobaric and normobaric hypoxia  
The aim of the study was to investigate the time course in oxidative stress and NO metabolism at 
rest and cardio-respiratory responses to moderate exercise during 24 hours at 3000 m in HH vs. 
NH. 
When compared to normoxic values before exposure, during exercise, tidal volume (Fig 7A), and 
minute ventilation (Fig. 7B) were lower (p<0.05) while PETCO2 (Fig. 7C) higher (p<0.05) in HH 
compared to NH. SpO2, HR, oxygen consumption, breathing frequency, and end-tidal O2 
pressure showed similar adaptations in HH and NH. At rest, exNO and NOx decreased in HH  
(-21% and -36% after 24 h respectively, p<0.05) but remained stable in NH (Fig. 8A and B). By 
contrast, advanced oxidation protein products and superoxide dismutase were higher in HH than 
in NH after 24 h (+295%, p<0.05 and +37%, p<0.01, respectively). Here we demonstrated for 
the first time that the different adaptations to an equivalent hypoxic stimulus in HH vs. NH were 
sustained over 24 hours and associated with impaired NO biodisponibility and exaggerated 
oxidative stress. 
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Figure 7 (A) Tidal volume (Vt, l. min-1 (BTPS)), (B) minute ventilation (VE, l . min-1 (BTPS)) and (C) end-
tidal CO2 pressure (PETCO2, mmHg) during moderate exercise in hypobaric hypoxia (HH) and 
normobaric hypoxia (NH). 
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Figure 8 (A) Exhaled nitric oxide (exNO, % of baseline) and (B) Blood nitric oxide metabolites (NOx, % 
of baseline) at rest during the 24 h in hypobaric hypoxia (HH) and normobaric hypoxia (NH). 
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2.3 Significant molecular and systemic adaptations after repeated sprint 
training in hypoxia 
We investigated for the first time the additional benefits for repeated sprint performance after 
repeated sprint training performed in hypoxia (RSH) compared to normoxia. RSH delayed 
fatigue during a repeated sprint test to exhaustion with larger muscle perfusion variations in 
active muscles and significant molecular adaptations.  
From Pre- to Post-, the average power output of all sprints in RSA was increased (p<0.01) to the 
same extent (+6% vs. +7%, NS) in RSH and in RSN but the number of sprints to exhaustion 
was increased in RSH (9.4 ± 4.8 vs. 13.0 ± 6.2 sprints, p<0.01) but not in RSN (9.3 ± 4.2 vs. 8.9 
± 3.5 sprints, NS) (Fig. 9). mRNA concentrations of HIF-1a (+55%), CA3 (+35%) and 
monocarboxylate transporter-4 (MCT-4) (+20%) were augmented (p<0.05) whereas TFAM 
(-40%), PGC-1α (-23%) and monocarboxylate transporter-1 (MCT-1) (-36%) were decreased 
(p<0.01) in RSH only (Fig. 10). Further, the successive changes in total hemoglobin variations 
(∆[tHb]) during sprints throughout the RSA test increased to a greater extent (p<0.01) in RSH  
(Fig. 11).  
Our findings resulted in larger improvement in cycling repeated sprint performance in RSH than 
in RSN with significant molecular adaptations and larger blood perfusion variations in active 
muscles. 
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Figure 9 Average power output (W) in successive sprints during the repeated sprint test before (Pre-) and 
after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group 
(CON). 
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Figure 10 Relative mRNA expression of selected gene transcripts after 4 weeks of specific repeated sprint 
training before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia 
(RSN) or in control group (CON). Open bars represent Pre- values and solid bars Post- values of mRNA 
concentrations in vastus lateralis muscle. Post- values were expressed in % compared to Pre- values (set to 
100%). HIF-1a, hypoxia inducible factor-1a; VEGF, vascular endothelial growth factor; MB, myoglobin; 
PGC1-a, proliferator-activated receptor gamma coactivator-1a; TFAM, mitochondrial transcription factor 
A; CA3, carbonic anhydrase III; MCT-1, monocarboxylate transporter-1; MCT-4, monocarboxylate 
transporter-4. 
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Figure 11 (A) ∆[tHb]: successive changes in total hemoglobin concentrations’ amplitude during sprints 
(expressed in percent compared to the first sprint) measured by near infrared-spectroscopy and (B) 
∆[tHb]av: average of all changes during the repeated sprint test to exhaustion before (Pre-) and after  
(Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group 
(CON). 
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2.4 Repeated sprint training in hypoxia in upper-body muscles 
Successively, we designed a second research protocol to evaluate the efficiency of RSH in cross-
country skiing double poling performance. We demonstrated that RSH was a potent training 
stimulus to improve sprinting and aerobic performance in cross-country ski double poling: 
fatigue was delayed during repeated sprints in normoxia after RSH but not after RSN. 
From Pre- to Post-, power output in the RSA was increased (p<0.01) to the same extent (25% vs. 
21%, NS) in RSH and in RSN while the number of sprints performed was enhanced in RSH 
(10.9 ± 5.2 vs. 17.1 ± 6.8, p<0.01) but not in RSN (11.6 ± 5.3 vs. 11.7 ± 4.3) (Fig. 12). After 
both types of training, average power output during a 3 times 3 min “all-out” team sprint was 
improved by 10%. 
Successive changes in total hemoglobin concentrations’ amplitude during sprints (∆[tHb]) are 
then displayed in Figure 13. After training, ∆[tHb]av increased to a greater extent (F=35.9, 
p<0.001) in RSH than in RSN (Figure 5B). From Pre- to Post-, ∆[HHb]av increased significantly 
in RSH (+225%, p<0.01) but decreased in RSN (-27 %, p<0.01). There was a significant training 
group x time interaction (F=551.8, p<0.001). 
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Figure 12 Peak power output (W) in successive sprints during the repeated sprint test before (Pre-) and 
after (Post-) specific repeated sprint training in hypoxia (RSH, A) or in normoxia (RSN, B). 
0 
100 
200 
300 
400 
500 
600 
700 
800 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
A
** 
** 
** ** 
** ** ** ** ** ** ** 
#
0 
100 
200 
300 
400 
500 
600 
700 
800 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
B
Pre- 
Post- 
** 
** 
** 
** 
** ** ** ** ** ** ** 
** p<0.01 for difference with Pre- # p<0.05 for difference with Pre- Sprint #11 
** 
 - 54 - 
 
 
Figure 13 ∆[tHb]: successive changes in total hemoglobin concentrations’ amplitude during sprints 
(expressed in percent compared to the resting baseline set to 100%) measured by near-infrared 
spectroscopy (A) and ∆[tHb]av: average of all changes during the repeated sprint test to exhaustion (B) 
before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) 
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3. Discussion and perspectives  
The difference between winning and losing in competitive sports is often minuscule. Athletes 
engage in assiduous training and sacrifices to gain the worthwhile performance improvement that 
will bring them from the shade to the light. Adding a hypoxic stress to regular training programs 
is accordingly often thought to make the significant positive difference. 
Scientific evidence however tends to support only minor benefits of altitude training strategies 
unless the employed training paradigms specifically aim at particular adaptive mechanisms 
supported by correct fundamental theoretical concepts and an appropriate methodology (Lundby 
et al., 2012). 
Our work therefore first focused on physiological responses to hypoxia that may support the 
rationale for altitude training strategies. With a particular interest for putative different individual 
responses in physiological adaptations between an elite and recreational population, we 
highlighted that elite ski-mountaineers had a larger impairment in maximal aerobic performance 
than their lower level counterparts despite markers of a better acclimatization status (e.g., higher 
HVR at rest) (Faiss et al., 2014a). We had hypothesized that elite and recreational ski 
mountaineers would exhibit similar performance decrement at altitude since the effects of 
acclimatization would compensate the diffusion impairment of aerobic capacity. Our results 
confirmed that the desaturation level observed both in normoxia (e.g., exercise-induced 
hypoxemia) and hypoxia is likely the main trigger of aerobic performance decrement at altitude. 
Although we may only speculate on the underlying mechanisms, our results for such a specific 
elite population support the relationship between a drop in SpO2 and a proportional decrement 
in aerobic performance in hypoxia in accordance with Chapman et al. (Chapman et al., 1999). 
Indeed, diffusion limitations in the lungs impairs pulmonary gas exchanges (Torre-Bueno et al., 
1985; Wagner, 1996) and account for the lower SpO2 observed because of interstitial edemas or 
too short transit times of the red blood cells through the pulmonary capillaries (due to an 
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elevated cardiac output) (Dempsey et al., 1982; Wagner et al., 1986; Schaffartzik et al., 1992; 
Hopkins et al., 1996). Nevertheless, other factors should be mentioned that may explain the lower 
SpO2 observed like intra- and extra-pulmonary shunts (Dempsey et al., 1984; Powers et al., 1992) 
or ventilation-perfusion inequalities (Torre-Bueno et al., 1985; Hammond et al., 1986; Wagner et 
al., 1986; Schaffartzik et al., 1992; Hopkins et al., 1994). The reported decrease in VO!"#$ was 
negatively correlated with the decrement of V!"#$. In other words, athletes with lower maximal 
minute ventilation increase in hypoxia compared to normoxia presented lower V!!"#$ 
decrements in hypoxia. This latter result suggests that too large of an increase in minute 
ventilation in hypoxia may be inefficient for inducing the classicaly associated increases in PAO2 
and alveolar–arterial pressure gradient and consequently for limiting the drop of SpO2 and VO!"#$.  Eventually, besides the remarkable variability in terms of HVR observed among 
subjects, our study confirmed the rather unpredictable individual effect of altitude in terms of 
performance decrement during hypoxic exposures (Bartsch & Swenson, 2013). 
Second, we questioned the equivalent altitude air model (Conkin & Wessel, 2008) with the 
evidence for differences between HH and NH in terms of ventilatory responses, fluid balance, 
AMS symptoms and NO metabolism (Millet et al., 2013b). We concluded that the exercise-
induced increase in ventilation throughout 24h of hypoxic exposure was less in HH than NH and 
associated with a decrease in NO bioavailability in HH (Faiss et al., 2013c).  
Indeed, the important new point is that plasma nitric oxide (i.e. nitrate and nitrite) concentration 
was lower in HH than in NH, suggesting the altered systemic NO bioavailability by HH.  
Nitrate and nitrite are physiologically converted back in blood and tissues to form NO and, 
remarkably, the nitrate–nitrite–NO pathway is gradually activated as oxygen tensions falls 
(Lundberg et al., 2008). Simultaneously, a decline of O2 in arterial blood and respiratory cortical 
centers stimulates the carotid chemoreceptors and triggers HVR (Dempsey & Forster, 1982). 
Interestingly, lower HVR was observed in rats when NO production was inhibited (Gozal et al., 
1996). Similarly, Haxhiu et al. found that NO synthase (NOS) blockade attenuated the hypoxia-
induced increase in respiratory activity in rats and that the increased respiratory output observed 
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in HVR resulted from the oxygen deprivation leading to the activation of NO-cGMP dependent 
pathway in the central nervous system (Haxhiu et al., 1995). 
The results of these studies suggest that the lower minute ventilation in HH in our subjects could 
be due to a decrease in NO bioavailability. NOx was lowered in HH and it could be explained by 
the increase in oxidative stress in HH. Indeed, the larger oxidative stress revealed by higher 
plasma concentration of AOPP and SOD in HH might inhibit NO formation and reduce its 
bioavailability. This phenomenon of NO metabolism down-regulation associated with oxidative 
stress increase was already known (Pialoux et al., 2011). Mechanistically, reactive oxygen species 
(ROS) inducing oxidative stress impair the bioavailability of NO (Thomas et al., 2008a). Then, 
plasma pH was higher in NH compared to HH. Free radicals are likely overproduced in case of a 
lower pH (Bernheim, 1963; Siesjo, 1985). The increased ventilatory drive in NH (as revealed by 
the lower PETCO2 during exercise) may decrease the blood H
+ concentration. The proton being 
known as a pro-oxidant particle, that respiratory alkalosis in NH may accordingly reduce the 
ROS production and explain the higher plasma oxidative stress measured in HH. 
Undeniably, the new findings we reported may have important potential consequences for 
adaptations and physical performance at altitude, since different responses in ventilation and 
oxidative stress may influence benefits to athletes training or living at altitude for performance 
improvement (Millet et al., 2012b). However, it is still unclear whether the differences we 
reported in pH, ventilatory responses as well as nitrosative and oxidative stress between HH and 
NH have a clinical relevance (Millet et al., 2012b). With the recent report showing HH to be more 
effective than NH as pre-acclimatization treatment in order to minimize AMS symptoms (Fulco 
et al., 2013), we believe that further clinical investigations are worth of interest in the differences 
between HH and NH.   
Our findings also led us to highlight differences in postural control between HH and NH with a 
degraded postural stability only in HH that was likely attributed to hypobaria (Degache et al., 
2012). In addition, our group currently explores further mechanisms at the origin of differences 
during a prolonged exposure to either HH (Jungfraujoch, 3470 m) or NH (hypoxic chamber) 
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with additional measurements (e.g., cerebral activation and oxygenation, muscular oxygenation, 
fatigue and performance) to have a better insight of putative mechanisms involved in the 
differences we observed.  
In addition, the efficiency of the LHTL paradigm in HH vs. NH is presently being analyzed. 
Preliminary results underline higher performance gains 21 days after LHTL in HH compared to 
NH (Saugy et al., 2014).  
Athletes and mountaineers should definitely consider the individual adaptive responses to the 
different HH and NH environments when including altitude training to their preparation. 
 
The second major goal of our work was aimed at innovation in altitude training and development 
of original training strategies oriented towards intermittent sports performance. With increasing 
media coverage presenting high profile clubs or national squads in team-sport disciplines 
including altitude training in their preparation, it was striking that only 3 studies assessed the 
effects of hypoxic exposure or training in a team-sport population (Morton & Cable, 2005; 
Hamlin et al., 2008; Manimmanakorn et al., 2013). Although we did not analyze a team sport-
specific population, our work contributed to advance hypoxic training methods from more 
traditional IHT to the innovative RSH method (Faiss et al., 2013a). Only few studies assessed the 
potential and mechanisms related to RSH (Faiss et al., 2013b; Galvin et al., 2013; Puype et al., 
2013; Faiss et al., 2014b; Goods et al., 2014), therefore, there is an urgent need for mechanistic 
and applied studies to investigate performance changes following RSH.  
Nevertheless, the latter studies may provide some clues on the mechanisms underpinning 
superior performance improvement after RSH rather than RSN. Our results, for instance, 
suggested an improved vascular conductance in repeated sprints to exhaustion where fast-twitch 
fibers are likely better utilized (Faiss et al., 2013b). RSH may therefore be potent because it 
recruits by definition FT fiber maximally. In fact, an increased sympathetic vasoconstrictor 
activity directed towards skeletal muscle (Hanada et al., 2003) occurs in hypoxia but to a greater 
extent within FT (glycolytic type II fibers in rat) (Ferguson et al., 2012). But a NO-mediated 
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compensatory vasodilation prevails over this vasoconstriction to increase blood flow and match 
O2 delivery to the working muscle (Casey & Joyner, 2012). Though muscle fatigue attenuates the 
vasodilatory responsiveness (Jacobs & Segal, 2000), a delayed fatigue during RSA test after RSH 
could then partly be related with an improved responsiveness of the vascular bed. Interestingly, 
blood flow and vascular conductance were shown to be augmented mostly in FT after dietary 
nitrate supplementation (Ferguson et al., 2012).  
To further, the proposed mechanism based on the preferential recruitment and modified 
behavior of FT with an enhanced vasodilatory compensation induced during RSH is appealing as 
it could also explain why previous IHT studies (Truijens et al., 2003; Roels et al., 2007; Lundby et 
al., 2012) with lower exercise intensities failed to demonstrate additional benefits to endurance 
performance when compared to similar normoxic training. If FT fibers recruitment is not 
sufficient (like in the latter studies), hyoxic training may not trigger (or only partially) the 
improvement in muscle blood perfusion observed both in upper- and lower-body muscles after 
RSH (Faiss et al., 2013b; Faiss et al., 2014b). Conclusively, fatigue could potentially be delayed 
after RSH through FT working with less anaerobic energy dependence.  
Furthermore, modifications at the molecular level support a shift towards an improved anaerobic 
glycolytic activity following RSH only, in parallel to the increased blood perfusion and potentially 
better waste metabolites removal. Besides the expected upregulation of HIF-1α, we observed a 
decrease in mRNA expression of genes implicated in mitochondrial biogenesis such TFAM and 
PGC‐1a while LDH concentration was increased. Moreover, citrate synthase activity was not 
different between RSH and RSN suggesting that oxidative capacity was not different. Our results 
therefore indicated a shift from aerobic to anaerobic glycolytic activity in the muscle not in line 
with the previously suggested enhanced oxidative capacity after IHT (Vogt et al., 2001; Zoll et al., 
2006; He et al., 2012). In addition, we observed an upregulation of MCT-4 and a downregulation 
of MCT-1 in RSH. MCT-4 is predominantly expressed in FT where it mediates lactic acid efflux 
(Ullah et al., 2006) from the cells whereas MCT-1 rather supplies lactate to the cells for aerobic 
energy production (Dimmer et al., 2000). Again, as MCT-4 (but not MCT-1) is upregulated by 
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hypoxia (Ullah et al., 2006), our results attributed the delayed fatigue after RSH mainly to 
modified FT behavior and improved anaerobic glycolysis. 
Interestingly, Puype et al. showed that the phosphofructokinase activity was markedly increased 
(+59%), quite likely reflecting an upregulation of muscle glycolytic capacity only after RSH 
(Puype et al., 2013).  
Then, maintenance of power production during sustained RSA performance may be associated 
with the rate of PCr resynthesis. If RSH allows increasing muscle blood perfusion and vascular 
conductance as mentioned above, it may in turn also elevate locally microvascular PO2 that is 
known to reduce PCr breakdown and speed up PCr resynthesis (Haseler et al., 1999). Since 
hypoxia per se was shown to modulate PCr recovery (Holliss et al., 2013), RSH may accordingly 
optimally delay fatigue during RSA being by definition the combination of repeated sprint efforts 
and hypoxia. In addition, the exercise-to-rest ratio during high-intensity or maximal exercise likely 
modifies the energetic contribution of glycolysis (Balsom et al., 1992; Tabata et al., 1997). Since it 
substantially varies between activities (e.g., in team or racket sports), exercise-to-rest is thought to 
be a key component associated to the relative putative effect of RSH in sports and should be 
further investigated. Measuring PCr recovery kinetics by 31P magnetic resonance spectroscopy on 
an isolated muscle during repeated bouts of maximal efforts with incomplete recoveries would 
thus allow a direct insight to the mechanisms potentially influenced by RSH in vivo. Although this 
remains to be investigated, it could strengthen the RSH as a promising training strategy 
influencing directly team-sport performance and supporting indirectly performance optimization 
in other sports. RSH efficiency is likely to induce fiber-type selective and intensity dependent 
adaptations at the muscular level and therefore triggers different mechanisms than those usually 
expected with traditional IHT (e.g., modification of the oxidative capacity or buffer capacity).  
Our review of the IHT studies to date indicated that the “IHT” acronym refers to numerous 
training methods in hypoxia from continuous low-intensity to very long exercise versus interval 
training in hypoxia (Faiss et al., 2013a; Millet et al., 2013a).  
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Hence, in the literature of altitude training strategies, more clarity may be needed to meet the 
athletes’ and trainers’ expectations that may substantially differ depending on their performance 
goals. Our work therefore finally allowed to propose an updated classification of the training 
methods currently available (Fig. 14) (Millet et al., 2013a). 
 
 
Figure 14 Updated panorama of the contemporary hypoxic methods currently available. From Millet et 
al., 2013a. LHTH, live high–train high; LHTL, live high–train low; LHTLH, live high–train low and high; 
LLTH, live low–train high; IHE, intermittent hypoxic exposure; CHT, continuous hypoxic training; IHT, 
interval hypoxic training; RSH, repeated sprint training in hypoxia; IHIT, IHE during interval-training; 
NH, normobaric hypoxia; HH, hypobaric hypoxia. 
 
The new proposed classification clearly distinguishes LLTH methods depending on the 
mechanisms thought to alter performance gains: increased oxidative capacity for continuous 
hypoxic training (CHT), buffering capacity for IHT or modified behavior of FT for enhanced O2 
utilization (RSH). 
Moreover LHTL and LHTH may enhance performance in some (but not all) endurance athletes 
(Lundby et al., 2012). Resulting sea-level performance improvements may differ when done in 
HH or NH (Saugy et al., 2014) and this consequently remains to be further investigated in that 
context. If the difference between “natural/terrestrial” and simulated altitude was mentioned for 
the LHTL/LHTH strategies in the initial classification of altitude training methods (Fig. 1) 
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(Wilber, 2007) this distinction was not made for the LLTH methods. With the increasing 
evidence for different physiological responses to HH and NH our work contributed to support 
(Millet et al., 2012b, a; Faiss et al., 2013c; Millet et al., 2013b), we believe its paramount to consider 
these differences in designing or analyzing hypoxic training related data.  
It is still safe to conclude that IHT does not enhance sea-level performance in endurance athletes 
further than the same training in normoxia (Lundby et al., 2012). The role of exercise intensity per 
se in the training induced responses in hypoxia should now be recognized and RSH may indeed 
potentiate the effects of adding a hypoxic stress to a training stimulus by challenging at most the 
adaptive mechanisms of the tissue working in hypoxia to promote subsequent performance gains 
in normoxia. RSH may irrefutably be considered as a promising hypoxic training strategy to 
enhance anaerobic as well as team sport performance. 
In conclusion, our work intended to bring innovations in contemporary altitude training. We first 
highlighted conclusive differences between HH and NH, so that the type of hypoxia (hypobaric 
or normobaric) may now systematically be reported and taken into consideration in the analysis 
and preparation of altitude training or prolonged hypoxic exposure. Secondly, we developed and 
investigated a new and very innovative form of training with the promising “repeated sprint 
training in hypoxia” method. This model defied traditional altitude training strategies by 
hypothesizing that the benefits of exercise training and those of adding a hypoxic environment 
may not cumulate unless exercise intensity during training is maximal in order to challenge 
muscular adaptive mechanisms. Overall, our experimental results supported this hypothesis and 
enabled us to suggest causal mechanisms with fiber-type selective optimization of O2 delivery to 
the working muscles. Nonetheless there is only limited evidence for the benefits of RSH in team 
or racket sports. Our findings however legitimize further well-designed controlled and blinded 
studies. We are for instance using recent technological advances with mobile inflatable hypoxic 
marquees to investigate RSH directly in team sport activities (Girard et al., 2013b). Our 
investigations are now also exploring the potentially paramount role of the exercise-to-rest ratio 
during RSH. The implementation of RSH in professional athletes (e.g., cyclists of the IAM 
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professional cycling team; Wales’s rugby team, Orlando Magic NBA Basketball team) with 
positive feedbacks from trainers and athletes embodies the potential of this original and 
innovative method. Then, with regards to the strong metabolic adaptive responses at the 
muscular level, our work undeniably leads to clinical implications and therapeutical opportunities 
with RSH if the underlying mechanisms can be better comprehended. 
In future perspectives, adding RSH to traditional LHTL models or performing RSH in HH may 
later on enable us to further materialize the benefits of that method. 
Finally, we hope to substantiate and validate our innovations in altitude training with our 
continued exploration and description of the putative mechanisms behind additional 
performance benefits of RSH.   
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Abstract 
 
Purpose Hypoxia is known to reduce maximal oxygen uptake (VO!!"#) more in trained than in 
untrained subjects in several lowland sports. Ski mountaineering is practiced mainly at altitude. So 
elite ski-mountaineers spend significantly longer training duration at altitude than their lower level 
counterparts. Since acclimatization in hypobaric hypoxia is effective, we hypothesized that elite 
would exhibit a similar VO!!"# decrement in hypoxia than recreational ski-mountaineers. 
Methods Eleven elite (E, Swiss national team) and twelve recreational (R) ski-mountaineers 
completed an incremental treadmill test to exhaustion in normobaric hypoxia (H, 3000 m, FIO2 
14.6 ± 0.1%) and in normoxia (N, 485m, FIO2 20.9 ± 0.0%). Pulse oxygen saturation in blood 
(SpO2), VO!!"#, minute ventilation (V!) and heart rate (HR) were recorded.  
Results At rest, hypoxic ventilatory response was higher (p<0.05) in E than in R (1.58 ± 1.9 vs. 
0.23 ± 0.49 l.min-1.%-1.kg-1). 
At maximal intensity, SpO2 was significantly lower (p<0.01) in E than in R, both in N (91.1 ± 3.3 
vs. 94.3 ± 2.3%) and in H (76.4 ± 5.4 vs. 82.3 ± 3.5%). In both groups, SpO2 was lower (p<0.01) 
in H. Between N and H, VO!!"#decreased to a greater extent (p<0.05) in E than in R (-18% and 
-12%, p<0.01). In E only, VO!!"# decrement was significantly correlated with the SpO2 
decrement (r=0.74, p<0.01) but also with VO!!"#measured in normoxia (r=0.64, p<0.05). 
Conclusion Despite a probable better acclimatization to altitude, VO!!"#was more reduced in E 
than in R ski-mountaineers, confirming previous results observed in lowlander E athletes. 
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Introduction 
Since 2002 and the first World championships of ski mountaineering, the number of 
competitions and the level of the elite (E) athletes have constantly increased. At a 
competitive level, it requires a high degree of physical fitness due to the important 
cardiopulmonary strain of the effort with more than 20% of the race time spent near 
maximal intensity1. Due to the necessary equipment, energy cost of ski-mountaineering was 
shown to be higher compared to walking or snowshoeing2 and, more interestingly,  racing 
performance was shown to be correlated with maximal oxygen uptake (VO!"#$)3. Besides, 
ski mountaineering requires a mountainous and snowy environment; it is therefore usually 
practiced at an altitude over 2000 m. Numerous studies have reported a decrease in 
performance and VO!"#$  with altitude4-13. In hypoxia, O2 diffusion is limited in the lung 
with the consequence of a reduced VO!"#$14. In addition, a strong relationship between VO!"#$  in normoxic conditions and its decline in hypoxic conditions has been 
described15,16. More recently, a linear decrease in VO!"#$  was shown in endurance-trained 
athletes when exposed to altitudes increasing from 300 to 2800 m16. For instance, in that 
study, each 1000 m step was associated with about 6.3% decrease in performance (ranging 
from 4.6% to 7.5%), close to the 7.7% decrease per 1000 m the same authors calculated 
from other existing studies16. Accordingly ski mountaineers competing at 3000 m could 
then expect a decrement of their aerobic performance or VO!"#$  of approximately 22-
25%. However, this latter variable presents a great individual variability, particularly among 
elite level athletes17. Interestingly, a more important decrement of absolute VO!"#$ was 
observed in elite versus non-elite athletes7,8,18 or in endurance trained versus sedentary 
subjects4,19.  For instance, Koistinen et al observed the largest reduction of VO!"#$ in the 
fittest ice-hockey players and cross-country skiers18. Lawler et al. underlined likewise a more 
severe impairment of VO!"!" in endurance-trained cyclists, triathletes and distance runners 
compared to untrained subjects7.  Such difference was also reported in male20 and female 
triathletes21 exercising at moderate to high altitude. 
Mollard et al. reported, for example, a larger decrement of VO!"#$  in trained triathletes vs. 
untrained subjects (-20% vs. -15%, respectively, p<0.05) at 3500 m20. Interestingly, in that 
study, the drop of arterial oxygen saturation in (SaO2) was a strong predictor of the VO!"#$  decrement in hypoxia. A relative hypoventilation (i.e. lower increase of ventilation) 
in response to hypoxia supports the higher sensitivity observed in trained athletes8,22. 
Actually, this putative hypoventilation during exercise23 combined with a higher limitation 
of O2 diffusion in pulmonary capillaries when cardiac output is near maximal
24,25 could 
explain the higher decrease in SaO2 during maximal exercise at altitude in trained vs. 
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untrained athletes but also the individual variability in VO!"#$  decrement at altitude26. 
Despite these observations, all previous investigations were conducted on lowlanders (i.e. 
athletes training mostly at low altitude or sea-level), which suggests that highly trained ski 
mountaineers would exhibit more severe impairment of their aerobic capacity compared to 
their recreational counterparts. 
However, it is also known that acclimatization to hypoxia optimizes the performance at 
altitude27. Due to the specificity of their discipline, elite ski-mountaineers are thought to be 
the endurance athletes exposed to the highest “hypoxic dose” (i.e. time spent in hypoxic 
environment) amongst all sports. For example, an elite athlete can be expected to train for 
up to 1000 h yearly and for more than 50% of the time above 1500 m (trail running and ski 
mountaineering). Elite ski-mountaineers could therefore be better acclimatized to hypoxia 
because of the repeated altitude exposures28 and finally an important total hypoxic dose29 
that may induce a lower decrease in VO!"#$ than in lowland elite athletes. Of interest is 
that the larger “hypoxic dose” in E is due to training in hypobaric hypoxia and 
acclimatization to hypobaric hypoxia has been shown recently to be more effective than in 
normobaric hypoxia30,31. Taken together all these results, the VO!"#$ of elite endurance ski-
mountaineers was postulated to decrease less in acute hypoxia than their recreational 
counterparts.  
The aim of the present study was to compare VO!"#$and exercise responses in elite and 
recreational ski mountaineers in normoxia and in hypoxia. We expected that elite and 
recreational ski mountaineers would have a similar performance decrement at altitude since 
better acclimatization would compensate the larger impairment of aerobic capacity found 
in elite versus non-elite subjects.  
Methods 
Subjects Eleven elite ski mountaineers (E, 5 males, 6 females) and twelve healthy lowland 
recreational ski mountaineers (R, 6 males, 6 females) volunteered in the study. Participants 
in the E group were all member of the Swiss national ski mountaineering team and 
competing at an international level (7 of them could boast of at least one world cup or 
world championship victory). Subjects in the R group were recruited among participants of 
the World most prestigious ski-mountaineering competition, Patrouille des Glaciers 
(www.pdg.ch) in the Swiss province of Valais. Inclusion criteria were: 1. to be finisher but 
in the second half of the ranking; 2. to have a  VO!"#$ not exceeding 50 or 55 ml.kg-1.min-1 
for females and males, respectively. Subject characteristics are shown in Table 1. Since the 
aim of our study was to compare E and R athletes, the training and anthropometrical 
characteristics are representative of each group. Subjects were all non-smokers and not 
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recently exposed to an altitude above 1600 m for more than 6 hours per day (i.e. no 
overnight sleep at altitude) during the three weeks preceding the testing procedure. 
Volunteers signed an informed written consent. The experiment was approved by the local 
Medical Ethics Committee (CVEM, agreement 007/10, Sion, Switzerland) and performed 
in accordance with the Declaration of Helsinki. 
 
 
Elite Recreational 
 
Males (n=5) 
Females 
(n=6) 
Males (n=6) 
Females 
(n=6) 
Age (yrs) 28 ± 6 28 ± 10 27 ± 5 27 ± 3 
Height (cm) 177 ± 3 169 ± 3 183 ± 4* 167 ± 6 
Body mass (kg) 67.6 ± 5.1 58.6 ± 5.5 77.7 ± 8.6* 61.0 ± 5.3 VO!"#$ (ml.kg-1.min-1) 69.3 ± 4.0 57.8 ± 8.8 48.6 ± 4.5** 46.0 ± 3.9** 
Body fat (%) 10.1 ± 3.2 20.1 ± 8.1 14.9 ± 7.1 24.7 ± 6.1 
Altitude of residence (m) 818 ± 367 837 ± 321 597 ± 154 742 ± 304 
Table 1 Subjects’ characteristics VO!"#$, maximal oxygen uptake.   * p< 0.05, ** p<0.01 for difference with E. Means ± SD 
 
Study design Experimental design consisted of two incremental running test to exhaustion on 
a motorized treadmill (HP Cosmos Mercury, Nussdorf-Traunstein, Germany) performed in 
a random order either in normoxia (N, 485 m, FIO2 20.9 ± 0.0%, T 25 ± 1 °C) or in 
normobaric hypoxia (H, 3000 m, FIO2 14.6 ± 0.1%, T 27 ± 2 °C) in a hypoxic chamber 
(ATS Altitude, Sydney, Australia) built in our laboratory (Sion, Switzerland). For each 
subject, tests were performed at the same time of the day and separated by 14 days in order 
to avoid any acclimatization effect. Recruited subjects were familiar with treadmill running 
and physiology tests with gas exchange measurements to prevent any learning effect during 
the protocol. Twenty-four hours prior to each trial, subjects were asked to refrain from any 
physical training and caffeine intake. A self-reported training diary and a questionnaire were 
used to estimate training volume and training time spent above 1500 m for eight weeks 
outside of the competitive season in autumn (October-December). Body fat percentage 
was determined during the first visit to the laboratory by air-displacement plethysmography 
(Bod Pod, Concord, USA). 
Experimental procedure After 5 min measurement at rest seated, the incremental running test 
started at a speed of 1.5 m.s-1 with further increments of 0.5 m.s-1 every 3 min until 4 m.s-1 
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with the slope of the treadmill set at 2%. When 4 m.s-1 was reached, only the slope was 
increased by 2% for every additional step until exhaustion.  
Measurements The following measurements were performed at rest and maximal intensities in 
normoxic and hypoxic conditions: 
Gas exchanges Subjects were equipped with an oro-nasal mask (VmaskTM, 7500 series, Hans 
Rudolph Inc., Shawnee, KS; deadspace 41 ml) to measure gas exchange with an indirect 
calorimeter (Metamax 3B, Cortex, Leipzig, Germany)32 calibrated according to 
manufacturers’ recommendations before each measurement. This device measured volume 
using a bidirectional digital turbine. Oxygen uptake and carbon dioxide production were 
determined in inspired and expired air successively with an electrochemical cell and an 
infrared analyser, respectively, from the air drawn through a Nafion® sampling tube 
attached to the turbine at the output of the mask. Minute ventilation (!!) and end-tidal 
carbon dioxide pressure (PETCO2) at rest were calculated the average values of the three last 
minutes of the resting period. Maximal minute ventilation (!!"#$)  and VO!"#$  were 
recorded as the highest 30 s averages measured.  
Hypoxic ventilatory response (HVR) was calculated at rest according to the following 
formula as defined in Richalet et al.33: Hypoxic ventilatory response (HVR)= ((!!"  -!!")/(SpO2N – SpO2H)) / BM) x 100 (l.min-1.%-1.kg-1). Where BM stands for body mass (kg) 
and the H and N indices indicate hypoxic or normoxic condition. 
Heart rate was recorded continuously at 1 Hz with a heart rate belt and receiver (Suunto 
T6D, Vantaa, Finland). Pulse oxygen saturation (SpO2) was recorded continuously at 1 Hz 
during the whole test; subjects were equipped before the test with a wrist worn fingertip 
pulse oximeter (Nonin Wristox 3100 with 8000SM-WO Sensor, Plymouth, USA). The 
recorded SpO2 signal was visually checked to exclude putative artefacts and HR measured 
with the pulse oximeter was controlled and compared to HR measured by the HR monitor. 
Data analysis and statistics Data are presented as means (standard deviations). After data were 
tested for normality (Shapiro-Wilk test) and equality of variance (Fisher-Snedecor F-test), 
independent two-sample t-tests and paired t-tests were used to compare variables of each 
group in both conditions. To investigate the group x condition interaction two-way 
analyses of variance for repeated measures were then performed with all pairwise multiple 
comparison procedures (Holm-Sidak method). Pearson’s product-moment correlation 
coefficient was used to evaluate the associations between variables. Null hypothesis was 
rejected at p<0.05. All analyses were made using Sigmaplot 11.0 software (Systat Software, 
CA, USA). 
Conflicts of interest We have no conflict of interest or any financial tie to disclose. 
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Results 
Table 1 displays subject's characteristics. Altitude of residence was not different between 
groups. Weekly training volume was significantly higher in E compared to R (12.2 ± 2.4 h 
and 4.6 ± 1.6 h, respectively, p<0.01). Training was mostly performed at moderate to high 
altitude in E but not in R (74 ± 19% and 27 ± 23% above 1500 m, respectively, p<0.01). 
The yearly exposure to altitude above 1500 m (including training camps and overnights) 
was estimated to be of 2285 ± 446 h vs. 589 ± 306 h in E and R, respectively (p<0.01). 
Table 2 summarizes all variables measured at rest and during incremental tests at maximal 
intensity. 
At rest 
In H compared to N, only SpO2 varied significantly at rest where it was lowered similarly in 
E and R (-5% and -6%, respectively, p<0.01). HVR was significantly higher in E compared 
to R (1.4 ± 1.9 vs. 0.3 ± 0.6 l.min-1.%-1.kg-1, p<0.05) 
At maximal intensity 
SpO2 was significantly lower in E compared to R both in N (3.5% lower, p<0.01) and in H 
(7.2% lower, p<0.01) where it was significantly decreased (17% and 13% lower for E and R 
respectively, p<0.01). In H compared to N, VO!"#$ was significantly lowered in E and R (-
18% and -12%, respectively, p<0.01) but to a greater extent in E (F=5.6, p=0.02). In E, the 
decrement of VO!"#$ in H was significantly correlated with the SpO2 decrement in H 
(r=0.74, p<0.01) (Figure 1A) but also with VO!"#$  measured in normoxia (r=0.64, 
p=0.03) (Figure 1B). In addition, a significant negative correlation was found between the 
relative decrement of VO!"#$  in H and the decrement of maximal minute ventilation 
(V!"#$) in H (r=-0.60, p=0.049) (Figure 1C).  
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  Elite (n=11) Recreational (n=12) 
  N H N H 
Rest 
!!!  (ml.kg-1.min-1) 4.8 ± 0.8 4.7 ± 4.7 4.4 ± 0.8 4.6 ± 0.6 !E (l.min-1) 10.4 ±  2.75 10.9 ± 3.4 9.8 ± 2.6 10.7 ± 1.9 
PETCO2 (mmHg) 34.8 ± 2.6 30.8 ± 3.6## 33.5 ± 2.6 30.9 ± 2.2## 
SpO2 (%) 99.2 ± 0.9 94.2 ± 3.2## 98.8 ± 1.2 93.1 ± 3.4## 
HR (b.min-1) 66 ± 14 66 ± 10 71 ± 12 75 ± 15 
Maximal 
effort 
!!!max (ml.kg-1.min-1) 63.0 ± 9.0 51.8 ± 7.0## 47.3 ± 4.3** 41.8 ± 6.6##** !Emax (l.min-1) 141.2 ± 31.7 143.7 ± 27.4 122.7 ± 
28.1 
128.3 ± 30.5 
SpO2 (%) 91.1 ± 3.3 76.4 ± 5.3## 94.3 ± 2.3* 82.3 ± 3.6##** 
HRmax (b.min-1) 185 ± 13 180 ± 12 193 ± 11 187 ± 11 
Table 2 Variables measured in normoxia (N) and hypoxia (H) at rest and during submaximal and maximal 
efforts in Elite (E) and Recreational (R) ski mountaineers VO!, oxygen uptake ; VE, minute ventilation ; PETCO2, end-tidal carbon dioxide pressure; SpO2, pulse 
oxygen saturation ; HR, heart rate. Means ± SD 
# p<0.05, ## p<0.01 for difference with N * p<0.05, ** p<0.01 for difference with E   
 - 95 -   
 
Figure 1 Correlations in elite (E) and recreational (R) ski mountaineers between VO!"#$ decrease 
in hypoxia and (A) SpO2 decrease (B) VO!"#$ in normoxia and (C) VEmax decrease in hypoxia  
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Discussion 
The main finding of this study is that, in contrast to our hypothesis, despite a better 
acclimatization status at rest, elite ski-mountaineers had a larger impairment in maximal 
aerobic performance than their lower level counterparts; that is VO!"#$ decreased both in 
E and R, but to a greater extent in E compared to R when performing a maximal intensity 
effort in normobaric hypoxia. In accordance with existing results7,8,20,34, this decrement was 
correlated with the level of desaturation (i.e. drop of SpO2 in hypoxia) but only in E (fig. 
1A). Overall, our results confirm that the extent of desaturation may trigger of aerobic 
performance decrement in altitude. Moreover, it appears that altitude acclimatization may 
not compensate for such desaturation, strongly influenced by alveolar diffusion limitations, 
already observed in normoxia in elite endurance athletes. In accordance with earlier 
results7,18, we observed that elite athletes developed a larger arterial hypoxemia at maximal 
intensity than recreational athletes. Interestingly, Chapman et al. underlines that the 
decrease in VO!"#$ in well-trained athletes during an effort in hypoxia may also be related 
to the degree of exercise-induced arterial hypoxemia in normoxia4. Actually 7 athletes out 
of 11 in our E group presented a SpO2 ≤ 92% (defined as exercise-induced hypoxemia
35) 
during the maximal effort in normoxia and interestingly these subjects presented also the 
highest decrease in VO!"#$ (up to -32%) and the lowest SpO2 during hypoxic exercise. It is 
well known that in hypoxemic athletes (with SpO2 on the steeper part of the HbSpO2 
curve) a drop in PO2 has a larger influence on the decrease in SpO2. Although we may only 
speculate on the underlying mechanisms, our results for this specific elite population (Fig. 
1A) support the relationship between a drop in SpO2 and a proportional decrement in 
aerobic performance in hypoxia in accordance with Chapman et al.4. Mechanistically, when 
exercising in hypoxia (or when arterial oxygen pressure drops below 60 mmHg24), oxygen 
sensing by the peripheral chemo-receptors in the carotid body36 triggers a pulmonary 
hyperventilation that improves blood oxygenation14. This hyperventilation shifts to the left 
the O2 dissociation curve and with a resulting increase in SpO2 (reflecting SaO2)
37. 
However, during exercise at high altitude, respiratory factors may limit exercise 
performance capacity38. Diffusion limitation in the lungs impairs pulmonary gas 
exchanges39,40 because of interstitial edema or too short transit times of the red blood cells 
through the pulmonary capillaries (due to an elevated cardiac output)25,41-43. Since maximal 
cardiac output sets a limit to VO!"#$ 44, such a diffusion limitation may account for the 
lower SpO2 values observed in the elite ski mountaineers in our study performing by 
definition at a higher absolute intensity compared to the recreational ones. Still, the lower 
SpO2 in E could also depend on other mechanisms, such as intra- and extra-pulmonary 
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shunts45,46 or ventilation-perfusion inequalities25,40,42,47,48.  Besides, it is striking to note that 
the relative decrease in VO!"#$ was negatively correlated with the decrement of V!"#$ 
(Fig. 1C). In other words, athletes with lower maximal minute ventilation increase in 
hypoxia compared to normoxia presented lower V!!"#$ decrements in hypoxia. This latter 
result suggests that a too large increase in minute ventilation in hypoxia might be inefficient 
for inducing the classicaly associated increases in PAO2 and alveolar–arterial pressure 
gradient and consequently for limiting the drop of SpO2 and V!!"#$. This is supported by the 
negative correlation between SpO2 and V!!"#$ decrements (Fig. 1A). 
A similar mechanism was however not observed in recreational subjects presenting lesser 
hypoxemia during maximal efforts and may consequently partly explain the difference 
between E and R. 
We hypothesized that elite and recreational ski mountaineers would exhibit similar 
performance decrement at altitude since the effects of acclimatization would compensate 
the diffusion impairment of aerobic capacity. If ventilation increases within seconds upon 
exposure to hypoxia (acute ventilatory response to hypoxia) the altitude acclimatization 
process takes several days but then persists for several years when residing in hypoxic 
environment49. This process results in work performance enhancement at altitude29 due to 
physiological adaptive mechanisms such as increased ventilation50. In this context, HVR 
measured as a ratio between the ventilation increase and the SpO2 decrease in hypoxia
51, 
can be considered as a good index of peripheral chemosensitivity to hypoxia49, despite the 
fact that ventilatory responses to normobaric hypoxia is likely different than to hypobaric 
hypoxia30,52. Interestingly, Katayama et al. underlined that HVR is increased after high 
altitude sojourns or intermittent hypoxic exposures53 although endurance training during 
intermittent hypoxia may blunt this increase54. For instance, the elite ski mountaineers 
presented notably higher training volume mostly performed at moderate to high altitudes 
thus indicating repeated hypoxic exposures. This suggest a long lasting enhanced activation 
of the chemosensitive carotid bodies55 and that such athletes could retain some 
acclimatization benefits upon altitude re-exposure56 by maintaining a high level of aerobic 
performance concomitantly to their improved HVR57. Consequently, our belief is that elite 
ski mountaineers would benefit from prior recurrent hypoxic exposures. Our results 
confirmed that HVR at rest was significantly higher in E compared to R. However, in 
contrast to our hypothesis, we observed a larger decrease in maximal aerobic performance 
in E compared to R associated with larger desaturation levels. The latter suggest that a high 
resting HVR as a characteristic of acclimatization has little effect on the decrement of 
maximal aerobic performance in hypoxia. The increased cardiac output during exercise in 
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hypoxia when SpO2 is lowered
58 may account for shortened alveolar transit time, limitation 
of oxygen diffusion and hence large decrease in SpO2.. The higher V!!"#$  decrease 
observed in E compared to R may thus essentially depend on this limitation of alveolar O2 
diffusion in hypoxia that directly influences the level of hypoxemia. As a consequence, in 
elite mountaineers, prior recurring exposures to hypobaric hypoxia (during training for 
instance) do not seem to overcome the pulmonary limitations. The fact the acclimatization 
was due to larger exposure to hypobaric hypoxia reinforces this latter point. 
Acclimatization was shown to be more effective in hypobaric than normobaric hypoxia and 
the ventilatory adaptations are specific to the hypoxic conditions31,59. Elite mountaineers are 
a unique elite athletes group exposed to extremely large training in hypobaric hypoxia. 
However, this seems to have rather limited influence to the differences with sub-elite 
athletes in responses to hypoxia already reported in lowland athletes. 
Practical applications 
Besides the remarkable variability in terms of hypoxic ventilatory response observed among 
subjects, our study confirms the rather unpredictable individual effect of altitude in terms 
of performance decrement during hypoxic exposures60. This also precludes the translation 
of our results in other subjects since a “selection” bias may exist in the participants’ panel 
with ski mountaineers maybe engaging with pleasure in such an activity because they know 
by own experiences that they tolerate altitude exposures well. In fact, it may also explain 
the relatively low V!!"#$ decrement observed in our study (that is -18% and -12% in E 
and R, respectively) while a higher drop had been observed in lowland athletes (up to -
23%16). Nevertheless our study supports a screening of athletes’ SpO2 (or SaO2) and 
ventilatory responses during efforts at altitude that may help athletes and coaches preparing 
competitions at high or rather moderate altitudes depending on their individual sensibility61. 
Conclusions 
In conclusion, VO!"#$ decrement at altitude and acute responses to hypoxia in elite vs. 
recreational ski-mountaineers are described for the first time in this study. Our results 
confirm that the desaturation level observed both in normoxia (e.g., exercise-induced 
hypoxemia) and in hypoxia is likely the main trigger of aerobic performance decrement at 
altitude. Despite potential acclimatization due to large dose of training in hypoxia, elite ski 
mountaineers presented a larger impairment in aerobic performance than their recreational 
level counterparts; e.g., VO!"#$ decreased to a greater extent in E compared to R when 
performing a maximal intensity effort in normobaric hypoxia.  
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Abstract 
Purpose Slight differences in physiological responses and nitric oxide (NO) have been reported 
at rest between hypobaric hypoxia (HH) and normobaric hypoxia (NH) during short exposure 
Our study reports nitric oxide and oxidative stress at rest and physiological responses during 
moderate exercise in hypobaric hypoxia (HH) vs. normobaric hypoxia (NH). 
Methods Ten subjects were randomly exposed for 24 h to HH (3000 m, FIO2 20.9 %, BP 530 ± 
6 mmHg) or to NH (FIO2 14.7 %, BP 720 ± 1 mmHg). PRE- and every 8 h during the hypoxic 
exposures, pulse oxygen saturation (SpO2), heart rate (HR) and gas exchanges were measured 
during a 6-min submaximal cycling exercise. At rest, partial pressure of exhaled NO [exNO], 
blood nitrate and nitrite [NOx], plasma levels of oxidative stress and pH were additionally 
measured.  
Results During exercise, minute ventilation was lower in HH compared to NH (-13% after 8 h, 
p<0.05). End-tidal CO2 pressure was lower (p<0.01) than PRE both in HH and NH but 
decreased less in HH than in NH (-25% vs. -37%, p<0.05).  
At rest, exNO and NOx decreased in HH (-46% and -36% after 24 h respectively, p<0.05) 
whilst stable in NH. By contrast, oxidative stress was higher in HH than in NH after 24 h 
(p<0.05). Plasma pH was stable in HH but increased in NH (p<0.01). When compared to PRE- 
normoxic values, SpO2, HR, oxygen consumption, breathing frequency and end-tidal O2 
pressure showed similar changes in HH and NH. 
Conclusion Lower ventilatory responses to a similar hypoxic stimulus during rest and exercise 
in HH vs. NH were sustained over 24 hours and associated with lower plasma pH, exaggerated 
oxidative stress and impaired NO bioavailability.  
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Introduction 
Exposure to hypoxia triggers rapid and important adaptive physiological responses. Hypoxic 
conditions can be defined as a combination of barometric pressure (BP) and an inspired fraction 
of oxygen (FIO2) that results in an inspired pressure of oxygen (PIO2) lower than a normoxic 
value of 150 mmHg (5). The subsequent diminished arterial oxygen pressure (PaO2) induces an 
increased pulmonary ventilation (!!) in order to maintain O2 delivery to the tissues (42). It has 
been suggested that exposure to hypobaric hypoxia (HH) or normobaric hypoxia (NH) inducing 
the same PIO2 may elicit different physiological responses (5, 18, 25, 28, 36).  
Savourey et al. reported greater breathing frequency (f), lower tidal volume (Vt) and !! in HH 
compared to NH during a 40-min acute hypoxic exposure at rest (36). Similar differences in !! 
and Vt between HH and NH have been shown during 2 hours at 4750 m (40) or during 10 hours 
at 4770 m (25). However, the differences in cardio-ventilatory responses to exercise between HH 
and NH during longer exposure (i.e. more than a few hours) are not known.  
Nitric oxide (NO) plays a significant role in the physiological responses to hypoxia. Partial 
pressure of exhaled NO (exNO) was shown to decrease at high altitude (4, 8) although the 
putative effect of this decrease on pulmonary vasoconstriction remains debated (8, 9). 
Accordingly, recent work reported lower levels of NO in exhaled air when measured at high-
altitude (HH) compared to an equivalent simulated altitude (NH) (18). The mechanisms 
underlying the observed differences are not known. Oxidative stress is a potential candidate. 
Hypoxic exposure increased oxidative stress (33). Oxidative stress is known i) to decrease the 
NO bioavailability in the vasculature (39) and ii) to increase the acute ventilatory response to 
hypoxia (31) after chronic hypoxic exposure. However, to date, differences in oxidative stress 
between HH and NH have never been studied. 
The aim of the present study was therefore to extend prior work demonstrating different 
ventilatory and nitrosative responses during short duration exposure in HH vs. NH by 
determining if putative changes in ventilation and NO metabolism over 24 hours at 3000 m in 
HH vs. NH could be associated with different oxidative stress and pH variations. 
Methods 
Subjec ts  Ten healthy lowland well-trained men (35 ± 8 years, 179 ± 7 cm, 74 ± 8 kg and VO!max 60.9 ± 6.6 ml.kg-1.min-1 range [48-70 ml.kg-1.min-1]) active in recreational and endurance 
sports (2-5 training sessions per week) participated in the study. 
Volunteers signed an informed written consent. Subjects were all non-smokers, and neither 
acclimatized nor recently exposed to altitude. The experiment was approved by the local Medical 
Ethics Committee (CVEM, agreement 051/09, Sion, Switzerland) and performed in accordance 
with the Declaration of Helsinki.  
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Study des ign  Experimental design consisted of two different 24-hour periods of exposure to 
hypobaric hypoxia (HH), normobaric hypoxia (NH), in a random order with two groups of 3 
subjects and one group of 4 subjects. For each subject, experiments were separated by 23 days in 
average (range 15-32) allowing sufficient elimination of any acclimatization effect. 
Measurements at altitude were taken either at 3000 m in a quiet and warmed room in the 
mountains (HH, FIO2 20.9 ± 0.04%, BP 530 ± 6 mmHg, PIO2 102 ± 0.3 mmHg, temperature 
(T) 25 ± 2 °C, Col des Gentianes, Nendaz, Switzerland) or in a hypoxic chamber (ATS Altitude, 
Sydney, Australia) built in our laboratory (NH, FIO2 14.7 ± 0.13%, BP 720 ± 1 mmHg, PIO2 99 
± 0.4 mmHg, T 27 ± 2 °C, Sion, Switzerland). Normoxic measurements were completed outside 
the hypoxic chamber at an altitude of 485 m (FIO2 20.9%, BP 720 ± 1 mmHg, PIO2 140 ± 1.2 
mmHg, T 24 ± 1 °C, Sion, Switzerland). BP and FIO2 were controlled every hour using precise 
electronic oximeter (GOX 100, Greisinger, Regenstauf, Germany) and barometer (GPB 2300, 
Greisinger, Regenstauf, Germany), respectively.  
Prior to any hypoxic trial, participants performed an incremental test with 3 min exercise steps 
on a cycle ergometer (Ergoline 900, Sensormedics, USA) to determine maximal aerobic power 
(Pmax) and maximal oxygen consumption (VO!max) using a portable indirect calorimeter 
(Metamax 3B, Cortex, Leipzig, Germany) (41).  
Pulse oxygen saturation (SpO2) was recorded continuously at 0.25 Hz at the finger (Wristox 
3100TM with 8000SM-WO Sensor, Nonin, Plymouth, MN) and averaged for the last 3 minutes 
preceding each moderate exercise (in seated position, at rest) and the last 3 minutes of each 6-
min cycling bout (at exercise). 
Experimental  procedure  5 testing sessions were performed in HH and NH: 
- PRE: baseline testing in normobaric normoxic condition in the morning before exposure 
to altitude.  
- H+1, H+8, H+16 and H+24: measurement after respectively 1, 8, 16 and 24 h of 
exposure at altitude.  
In HH condition, H+1 measures were performed upon arrival after 1 h of travel by car and 
cable car between the laboratory (485m) and the building at altitude (3000 m) approximately 2 
hours after PRE measurement, corresponding to an exposure of about 45 minutes above 2000 m 
and 30 minutes at 3000 m. In NH condition, H+1 measures were performed after 60 min in the 
hypoxic chamber where the corresponding altitude was 2000 m on entering and 3000 m (FIO2 
14.7%) after 15 min. 
The same nitrate- and nitrite-free meals and drinks, standardized for nutritional and caloric 
content were provided to the subjects and ingested after H+1, 90 min before H+8 and 180 min 
before H+24. Twenty-four hours prior to each trial, subjects were asked to refrain from any 
physical training and caffeine intake and reported their food intake (being replicated before the 
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second trial). They were instructed to follow a low nitrate/nitrite diet for 4 days, avoiding fruits, 
salads and cured meats as recommended by Wang et al. (43). Subjects started each 24 hours 
hypoxic exposure exactly at the same time at approximately 1 pm. They were allowed to talk, 
read, watch television and shortly walk inside the room but did not have any other physical 
activity than during the tests. Sleep time was asked to be of 8 hours but only within the 10 pm – 
9 am timeframe.  
Based on previous research (27) we estimated that the prevalence of acute mountain sickness 
(AMS) would be relatively low (less than 13%), at the altitude of the experiment (3000 m) with 
our subjects exposed effortless to each hypoxic condition and exercising moderately only during 
4 x 6 min over 24 h. Consequently, we did not include an evaluation of AMS symptoms. 
However, few subjects (2 out of 10) reported some symptoms of light discomfort (e.g., headache 
and dizziness) in HH whereas none in NH. Since this difference might be of clinical relevance, 
future research at this altitude or higher should definitely assess the AMS severity. 
Measurements at rest and during a 6 min submaximal cycling exercise in HH or NH condition at 
PRE, H+1, H+8, H+16 and H+24 were as follows:  
Heart rate and gas exchanges Subjects were equipped with an oro-nasal mask (VmaskTM, 7500 
series, Hans Rudolph Inc., Shawnee, KS; deadspace 41 ml) to measure gas exchange with the 
same analyser than during preliminary testing. This device measures volume using a bidirectional 
digital turbine. Oxygen uptake and carbon dioxide production are then determined in inspired 
and expired air successively with an electrochemical cell and an infrared analyser, respectively, 
from the air drawn through a Nafion® sampling tube attached to the turbine at the output of 
the mask. FiO2 and FiCO2 are continuously measured, in order to account for putative deviation 
in ambient conditions. Distorted O2 and CO2 measurement for 2 subjects were excluded due to 
defective calibration of the gas sensor prior to measurement. Heart rate (HR) was recorded 
(RS800, Polar Electro, Finland). After a 6 min seated measurement period in a quiet 
environment, subjects started pedaling for 6 min on the subject-adjusted bicycle ergometer at a 
workload equal to 50% of their previously determined Pmax. Parameters at exercise were 
calculated as the average of the last 3 min of the 6 min cycling bout. At the 5th minute of 
exercise, the rate of perceived exertion (RPE) was evaluated using a 6-20 Borg scale. 
Blood pressure  Blood pressure was measured at rest seated using an automatic device (BP A100, 
Microlife AG, Wildnau, Switzerland). Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were manually reported. 
Biochemical  analyses   
Exhaled Nitr i c  Oxide (exNO)  Fraction of NO in the exhaled air was measured in standing 
position with a handheld electrochemical analyzer (NIOX MINO®, Aerocrine, Solna, Sweden) 
(19) following standard quality criteria (1) and a previously published procedure (8). For 
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comparison across conditions, fraction of exhaled NO displayed by the device (in ppb) was 
expressed as partial pressure of exhaled NO (in nmHg) (8). According to recent 
recommendations for measurements at altitude (17, 20), data obtained in HH at 3000 m were 
additionally corrected by applying a correction factor to adjust for the mass flow deviation and 
the higher sensitivity of the sensor at high altitude (see table 2 in Donnelly et al. (8) and table 1 in 
Hemmingsson et al. (17)).  
Plasma nitr i c  oxide ,  pH, oxidat ive s tress  and enzymatic  ant ioxidants  
A 5 ml blood sample was taken at rest from the antecubital vein at PRE, H+1, H+8, H+16 and 
H+24. After centrifugation, 400 uL aliquots of plasma were immediately frozen and stored at -
80 °C until blinded analysis less than 6 month after the experiment in the same laboratory. This 
warrants the perfect reproducibility of the analytic methods. Plasma total nitric oxide end-
products (NOx) (nitrate + nitrite + nitrosothiols) were measured with a chemiluminescence NO 
analyzer (Sievers 280 NOA, General Electric, Boulder, USA) after reduction of NOx to NO 
using VCl3 in hydrochloric acid at 90 °C (3) as previously performed in our laboratory (6). 
Plasma pH was measured at 37° C using the laboratory pH-meter inoLab 720 (WTW, Weilheim, 
Germany). The accuracy of this pH meter is ± 0.004 (according to the manufacturer). 
Plasma advanced oxidation protein products (AOPP) were measured according to the semi-
automated methods developed by Witko-Sarsat et al (44). The plasma concentrations were 
determined by spectrophotometry and were calibrated with a chloramine-T solution that absorbs 
at 340 nm in the presence of potassium iodide. The absorbance of the reaction was read at 340 
nm. AOPP concentrations were expressed as µmol L-1 of chloramine-T equivalents. The intra-
assay coefficient of variation is 5.4%. The quantitative determination of the Superoxide 
dismutase (SOD) activity was performed using the method described by Oberley and Spitz (29). 
SOD activity was determined by the degree of inhibition of the reaction between superoxide 
radicals, produced by a hypoxanthine - xanthine oxydase system, and nitroblue tetrazolium. The 
intra-assay coefficient of variation is 5.6%.  
Glutathione Peroxidase (GPX) activity was determined by the modified method of Paglia and 
Valentine (30) as the rate of oxidation of NADPH to NADP+ after addition of glutathione 
reductase (GR), reduced glutathione (GSH) and NADPH, using H2O2 as a substrate. The intra-
assay coefficient of variation is 4.6%. Concentrations of plasma malondialdehyde (MDA), as 
thiobarbituric reactive substances, were determined as previously described (34). The pink 
chromogen was extracted with n-butanol and its absorbance was measured at 532 nm by 
spectrophotometry using 1,1,3,3-tetraethoxypropan as standard. The intra-assay coefficient of 
variation is 2.2%.  
Concentrations of plasma nitrotyrosine, as end product of protein nitration by ONOO⋅-, were 
measured by ELISA as previously described (12). The intra-assay coefficient of variation is 6.8% 
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Our research team routinely performs oxidative stress and antioxidants measurements as 
previously published (32). 
Data analys is  and stat i s t i c s  
Data are reported as means and standard deviations. Data were tested for normality (Shapiro-
Wilk test) and equality of variance (Fisher-Snedecor F-test). When both conditions were met, a 
one-way analysis of variance for repeated measures was performed for each condition (HH and 
NH) for the time effect with all pairwise multiple comparison procedures (Holm-Sidak method). 
Differences to baseline between HH and NH at the same time were then compared using a 
paired t-test. When normality or equality of variance were not met, variables were analyzed in 
each condition using a Friedman test for repeated measures on ranks for the time effect with all 
pairwise multiple comparison procedures (Bonferroni test). In this case, differences to baseline 
between NH and HH at identical times were then compared using a Mann-Whitney rank sum 
test. Null hypothesis was rejected at p<0.05. All analyses were made using Sigmaplot 11.0 
software (Systat Software, CA, USA). 
Results 
Maximal aerobic power (Pmax) determined during pre experimental tests was Pmax 354 ± 50 W, 
ranging from 280 to 420 W. 
Venti latory and cardiovascular parameters  At rest, minute ventilation ( !! ) increased 
significantly in HH only after 1h (+24%, p<0.05) and in NH after 1h, 8h and 24h (+29% +45% 
and +38%, respectively, p<0.05). Tidal volume (Vt) increased significantly only in NH after 8h 
and 24h (+24% and +25%, respectively, p<0.05). Eupneic end tidal CO2 pressure (PETCO2) 
decreased immediately after 1h in HH and NH (-13 % and -20%, p<0.05, respectively) and 
remained lower than baseline until 24 h in both conditions. Parameters at the different times at 
rest are summarized in Table 1.  
During moderate exercise, !! and Vt were lower in HH compared to NH after 8h and 16h 
(p<0.05) (Fig. 1 A & B). PETCO2 was lower (p<0.01) than PRE both in HH and NH after 1h 
until 24h (Fig. 1 C). In addition, PETCO2 decrease was lower in HH than in NH (-25% vs. -37%, 
p<0.05). 
HR during exercise was not significantly different between HH and NH and higher than PRE 
from H+1 to H+24 (p<0.05). Breathing frequency, end tidal O2 pressure and SpO2 were not 
significantly different in HH and NH, both at rest and during exercise. Parameters at the 
different times during moderate exercise are summarized in Table 2. 
Nitri c  oxide  During the 24-hour exposure exNO decreased (p<0.01) in HH (-43%, -49%, 53% 
and -46% after 1 h, 8 h, 16 h and 24 h) but remained stable in NH (Fig. 2 A). Compared to NH, 
exNO was lower in HH after 1 h (-36%, p<0.01), 8h (-38%, p<0.01), 16h (-46%, p<0.01) and 
24h (-43%, p<0.05). 
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Similarly, NOx decreased over 24 h in HH (-37% at 24h, p<0.01) whilst stable in NH (+1%, 
NS). (Fig. 2 B).  
Oxidat ive s tress ,  enzymatic  ant ioxidants and pH  During the 24-hour exposure, advanced 
oxidation protein products (AOPP) were higher (p<0.05) in HH (+120% and +260% after 1 h 
and 24 h) than in NH (+13% and +88% after 1 h and 24 h) (Fig. 3 A). SOD was significantly 
higher in HH than in NH after 24 h (37%, p<0.01) (Fig. 3 B). 
Plasma pH was stable in HH but increased in NH (p<0.01) where it remained higher than HH 
(p<0.01) until 24 h (Fig. 3 C). 
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Variable Condition PRE H+1 H+8 H+16 H+24 
SpO2  HH 98 ± 1 93 ± 1** 91 ± 3** 92 ± 2** 93 ± 2** 
(%) NH 97 ± 1 90 ± 3** 91 ± 2** 91 ± 2** 92 ± 1** 
SBP 
(mmHg) 
HH 
NH 
126 ± 8 
126 ± 10 
124 ± 9 
129 ± 13 
124 ± 9 
123 ± 7 
121 ± 9 
118 ± 9 
131 ± 10 
129 ± 9 
DBP 
(mmHg) 
HH 
NH 
75 ± 9 
81 ± 8 
75 ± 5 
74 ± 5 
78 ± 9 
77 ± 6 
77 ± 7 
77 ± 7 
76 ± 6 
77 ± 7 
HR  HH 57 ± 7 62 ± 8 68 ± 13* 61 ± 10 65 ± 9 
(bpm) NH 57 ± 9 63 ± 10 69 ± 13* 66 ± 7 71 ± 10* !!  HH 11.0 ± 1.8 13.6 ± 1.8* 11.8 ± 1.9# 10.7 ± 1.8† 12.7 ± 2.3# 
(l.min-1) NH 10.3 ± 1.6 13.3 ± 3.3* 14.9 ± 3.5* 12.2 ± 1.6* 14.2 ± 1.5* 
Vt  HH 0.75 ± 0.15 0.88 ± 0.21 0.75 ± 0.21† 0.75 ± 0.23# 0.86 ± 0.25† 
(l.min-1) NH 0.76 ± 0.18 0.89 ± 0.26 0.94 ± 0.3* 0.84 ± 0.24 0.95 ± 0.23* 
f  HH 15.5 ± 3.1 16.8 ± 3.4 16.8 ± 2.7 16.1 ± 3 16.8 ± 3.8 
(1/min) NH 14.3 ± 2.7 15.9 ± 4.2 17.1 ± 4.4 15.8 ± 3.7 16.2 ± 3.8 
PETO2 
(mmHg) (n=8) 
HH 
NH 
97.6  ± 4.0 
98.6  ± 2.8 
66.4 ±4.1** 
62.3 ±2.8** 
61.9 ±6.0** 
61.6 ±2.2** 
65.0  ±5.4** 
62.7  ±2.6** 
65.6  ±5.5** 
65.6 ±2.8** 
PETCO2 
(mmHg) (n=8) 
HH 
NH 
38.5 ± 3.5 
36.8 ± 1.4 
33.4 ± 2.5*# 
29.4 ± 2.4* 
33.8 ± 2.1*†† 
27.5 ± 1.3* 
33.1 ± 1.3*†† 
27.9 ± 0.9* 
30.8 ± 1.4*†† 
26.5 ± 1.5* !!! !
(mlO2.min
-1.kg-1) 
(n=8) 
HH 
NH 
4.6 ± 0.6 
4.5± 0.6 
6.7 ± 1.2 
5.4 ± 0.9 
7.0 ± 1.2* 
6.1 ± 1.2* 
5.9 ± 0.4* 
5.1+ 0.4 
5.9 ± 1.2 
5.4±0.6 !!"! !
(mlO2.min
-1.kg-1) 
(n=8) 
HH 
NH 
3.5 ± 0.7 
3.7± 0.7 
5.2 ± 0.9 
4.1 ± 0.8 
4.9 ± 1.0 
4.2 ± 0.8 
4.6 ± 0.4 
3.9 ± 0.2 
4.4 ± 1.2 
4.1 ± 0.6 
RER 
(n=8) 
HH 
NH 
0.76 ± 0.14 
0.82 ± 0.05 
0.78 ± 0.06 
0.76 ± 0.06 
0.71 ± 0.03 
0.70 ± 0.05* 
0.77 ± 0.02 
0.76 ± 0.06 
0.74 ± 0.07 
0.76 ± 0.04* 
Displayed exNO 
(ppb) 
HH 
NH 
25 ± 14 
23 ± 13 
27 ± 14 
22 ± 14 
25 ± 15 
21 ± 11 
22 ± 13 
22 ± 13 
25 ± 15 
23 ± 9 
Corrected exNO 
(nmHg) 
HH 
NH 
16.9 ± 9.8 
15.2 ± 8.5 
9.5 ±5.0**†† 
14.9 ± 9.2 
8.8 ±5.3**†† 
14.1 ± 7.4 
7.9 ±4.5**†† 
14.7 ± 8.6 
8.9 ±5.4**†† 
15.7 ± 8.7 
NOx  
(uM) 
HH 
NH 
40.6 ± 25.1 
29.6 ± 9.7 
31.6 ±19.6†† 
27.7 ± 7.3 
28.1 ±18.9†† 
32.7 ± 9.7 
24.2 ±16.3*†† 
30.2 ± 7.1 
22.85 ±16.2*†† 
28.9 ± 6.9 
GPX  
(% of baseline) 
HH 
NH 
100 
100 
114 ± 26 
111 ± 30 
85 ± 27 
123 ± 23 
105 ± 43 
107 ± 21 
103 ± 41 
121 ± 33 
MDA 
(% of baseline) 
HH 
NH 
100 
100 
117 ± 40 
92 ± 36 
103 ± 62 
111 ± 35 
111 ± 56 
116 ± 55 
108 ± 52 
97 ± 51 
Nitrotyrosine 
(% of baseline) 
HH 
NH 
100 
100 
86 ± 16 
105 ± 26 
77 ± 35 
75 ± 37 
91 ± 20 
98 ± 16 
75 ± 40 
87 ± 25 
 
Table 1 Time course of measured parameters at rest over 24 h in hypobaric hypoxia (HH) and 
normobaric hypoxia (NH) 
 
SpO2, pulse oxygen saturation; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart 
rate; !! , minute ventilation (BTPS); Vt, tidal volume; f, breathing frequency; PETO2, end tidal O2 pressure; 
PETCO2, end tidal CO2 pressure; !!!, relative oxygen uptake; !!"!, relative carbon dioxide produced; 
RER, respiratory exchange ratio; exNO, exhaled nitric oxide; NOx, blood nitric oxide metabolites, GPX, 
glutathione peroxidase; MDA, malondialdehyde. 
n=10 unless otherwise stated 
**p<0.01, * p<0.05  for difference with PRE 
†† p<0.01 , † p<0.05, # p<0.1 for difference with NH 
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Variable Condition PRE H+1 H+8 H+16 H+24 
HR HH 116 ± 6 127 ± 7** 134 ± 11** 129 ± 9** 133 ± 8** 
(bpm) NH 117 ± 9 130 ± 6** 138 ± 9** 133 ± 7** 136 ± 6** 
f  HH 26.8 ± 7.9 31.0 ± 6.0 34.0 ± 6.9* 32.0 ± 7.7* 32.8 ± 8.4* 
(1/min) NH 24.1 ± 2.9 31.2 ± 6.6* 33.4 ± 6.3* 31.6 ± 6.9* 34.2 ± 6.5* 
PETO2  HH 97.0 ± 3.4 64.9 ± 2.5 ** 66.1 ± 4.1** 66.2 ± 2.4** 66.1 ± 4.4** 
(mmHg) (n=8) NH 95.1 ± 3.5 65.0 ± 1.5** 67.0 ± 2.9** 65.9 ± 3.4** 67.8 ± 3.4** VO! !
(mlO2.min
-1.kg-1) 
(n=8) 
HH 
NH 
34.0 ± 7.7 
36.2 ± 5.7 
37.0 ± 6.3 
37.4 ± 5.0 
41.4 ± 5.0§ 
39.2 ± 5.6* 
40.5 ± 5.2* 
38.0 ± 4.4* 
40.9 ± 5.3§ 
39.3 ± 4.3* VCO! !
(mlCO2.min
-1.kg-1) 
(n=8) 
HH 
NH 
32.2 ± 7.0 
33.2 ± 5.8 
31.1 ± 8.2 
31.9 ± 5.3 
35.8 ± 6.2§ 
32.3 ± 5.2 
35.5 ± 8.0§ 
32.3 ± 4.2 
35.0 ± 4.9 
32.5 ± 3.5 
RER 
(n=8) 
HH 
NH 
0.95 ± 0.03 
0.92 ± 0.04 
0.83 ± 0.09* 
0.82 ± 0.06* 
0.86 ± 0.06# 
0.82 ± 0.05* 
0.87 ± 0.11 
0.85 ± 0.06* 
0.85 ± 0.03* 
0.83 ± 0.03* 
SpO2  
(%) 
HH 97.7 ± 0.7 82.6 ± 4.2** 78.6 ± 5.5** 82.1 ± 4.6** 82.4 ± 4.1** 
NH 97.8 ± 0.8 83.1 ± 3.4** 78.1 ± 3.3** 81.5 ± 2.0** 82.6 ± 3.2** 
RPE HH 11 ± 1 13 ± 1* 14 ± 1 *† 13 ± 1* 13 ± 1* 
 NH 11 ± 1 13 ± 1* 15 ± 1* 13 ± 1* 13 ± 1* 
 
Table 2 Time course of measured parameters during moderate exercise in hypobaric hypoxia (HH) and 
normobaric hypoxia (NH) 
 
HR, heart rate; f, breathing frequency; PETO2, end tidal O2 pressure; VO!, relative oxygen uptake; VCO!, 
relative carbon dioxide produced; RER, respiratory exchange ratio; SpO2, pulse oxygen saturation; RPE, 
rate of perceived exertion (Borg scale 6-20) 
n=10 unless otherwise stated 
**p<0.01 , * p<0.05, § p<0.1 for difference with PRE  
† p<0.05, # p<0.1 for difference with NH 
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Figure 1 (A) Tidal volume (Vt, l . min-1 (BTPS)), (B) minute ventilation (VE, l . min-1 (BTPS)) and (C) 
end-tidal CO2 pressure (PETCO2, mmHg) during moderate exercise in hypobaric hypoxia (HH) and 
normobaric hypoxia (NH). n=10 unless otherwise stated 
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Figure 2 (A) Exhaled nitric oxide (exNO, % of baseline) and (B) Blood nitric oxide metabolites (NOx, % 
of baseline) at rest during the 24 h in hypobaric hypoxia (HH) and normobaric hypoxia (NH)  
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Figure 3 (A) Blood advanced oxidation protein products (AOPP, % of baseline), (B) Superoxide 
dismutase (SOD, % of baseline) at rest during the 24 h in hypobaric hypoxia (HH) and normobaric 
hypoxia (NH) and (C) Plasma pH at rest during the 24 h in hypobaric hypoxia (HH) and normobaric 
hypoxia (NH) 
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Discussion 
Here we show for the first time different responses to an equivalent hypoxic stimulus in HH vs. 
NH sustained over 24 hours and associated with impaired NO bioavailability and exaggerated 
oxidative stress. 
Primarily, the acute ventilatory response to hypoxia (AHVR), usually associated with rapid 
ascents to high altitude (21), was lower in HH compared to NH in our study, in agreement with 
previous observations done during shorter hypoxic exposures (36).  
Secondly, lower amounts of NO in the exhaled air (exNO) have also been reported in HH 
compared to NH and ascribed to differences in barometric pressure (10, 18, 20). Accordingly, 
our data show significantly less exNO in HH compared to NH. By comparison with the results 
of Hemmingson et al. (18) who reported lower exNO in HH than in NH during an acute 
exposure to very high altitude (10 min at 5000 m), the present data additionally show that the 
exNO can decrease in HH up to 24 hours of exposure at an altitude of 3000 m. As proposed, 
the increased axial back diffusion of NO in the alveolar compartment when BP is decreased (37) 
coupled with the strong affinity of NO to hemoglobin (23) or pressure-induced suppression of 
the NO formation in the airways (20) may explain the lower exNO observed in HH. However, 
exNO should be interpreted with care because values were corrected for flow deviation and 
sensor sensitivity with correction factors of Hemmingsson et al. (17) that may vary due to 
different subject and/or sensor. Nevertheless, our results are in accordance with previously 
published results (18) but suggest other mechanisms for differences in ventilatory responses 
between HH and NH based on the interplay between exaggerated oxidative stress and impaired 
NO bioavailability in blood and tissue. 
Indeed, the important new point is that plasma nitric oxide (i.e. nitrate and nitrite) concentration 
was lower in HH than in NH, suggesting altered systemic NO bioavailability by HH.  
Nitrate and nitrite are physiologically converted back in blood and tissues to form NO and, 
remarkably, the nitrate–nitrite–NO pathway is gradually activated as oxygen tensions falls (26). 
Simultaneously, a decline of O2 in arterial blood and respiratory cortical centers stimulates the 
carotid chemoreceptors and triggers AHVR (7). Interestingly, lower AHVR was observed in rats 
when NO production was inhibited (13). Similarly, Haxhiu et al. found that NO synthase (NOS) 
blockade attenuated the hypoxia-induced increase in respiratory activity in rats and that the 
increased respiratory output observed in AHVR resulted from the oxygen deprivation leading to 
the activation of NO-cGMP dependent pathway in the central nervous system (16). 
Taken together, the results of these studies suggest that the lower minute ventilation in HH in 
our subjects could be due to a decrease in NO bioavailability. Yet, our results show an increased 
oxidative stress in HH compared to NH supporting the speculation that exaggerated oxidative 
stress may both affect ventilation and NO bioavailability.  
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In the present study, NOx decreased in HH and remained stable in NH. This lowered NOx 
observed in HH could be explained by the increase in oxidative stress. Indeed, the increased 
oxidative stress revealed by higher plasma concentration of AOPP and SOD in HH might 
inhibit NO formation and reduce its bioavailability. This phenomenon of NO metabolism 
down-regulation associated with oxidative stress increase was observed recently (32). 
Mechanistically, reactive oxygen species (ROS) inducing oxidative stress impair the bioavailability 
of NO (39). More specifically, the superoxide anion (O2
°-) likely overproduced during hypoxia 
(14) can react with NO to form peroxynitrite (ONOO-) thereby inducing NO inactivation and 
eNOS uncoupling. In this context, it was clearly shown that oxidative stress was increased during 
a similar normobaric hypoxic stimulus (12 h at a PETO2 of 60 mmHg) (31) strongly suggesting an 
overgeneration of ROS.  
Interestingly, plasma pH was higher in NH compared to HH and the higher SOD activity and 
levels of AOPP during HH suggests that ROS is likely more generated during HH by 
comparison with NH. This is in accordance with the enhanced free radical formation in case of a 
lower pH (2, 38). A relative acidosis can induce oxidative stress by causing protonation of the 
peroxynitrite anion (ONOO-) leading to radical hydroxyl (OH•) generation and by promoting 
delocalization of protein-bound iron stores thereby accentuating redox stress induced by Fenton 
reaction (15, 22). Actually, the increased ventilatory drive (as shown by the lower PETCO2 during 
exercise) observed in NH likely decreases the blood H+ concentration in line with our reported 
pH values. The proton being known as a pro-oxidant particle, this respiratory alkalosis in NH 
may thus reduce the ROS production and explain the higher plasma oxidative stress measured in 
HH. 
We also acknowledge that only half of the oxidative stress markers suggest higher ROS 
production. However, different oxidative pathways specific for each marker with respect to 
hypoxia exposure could explain these discrepancies. MDA was shown to be much less sensitive 
than other oxidative stress markers (24) since it represents the end product of the 
polyunsaturated fatty acid (PUFA) oxidation pathway. In the context of our slight physiological 
difference between HH and NH, it would be unlikely that MDA was able to detect such 
difference. Similarly, we already reported such observation (AOPP increase without MDA 
change) in athletes submitted to hypoxic training (vs. identical normoxic training) (35). In 
addition AOPP and MDA do not reflect the same oxidative stress pathways, AOPP resulting 
from the myeloperoxidase pathway (44) via monocytes activation while MDA from PUFA 
oxidation. These results may suggest that hypoxia-induced oxidative stress could be more related 
to superoxide generation from NADPH oxidase activation than to an extracellular ROS 
production. In this present study SOD was significantly higher at H+24 but GPX was not 
affected during the 24h of hypoxic exposure.  SOD represents the first line of antioxidant 
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enzyme in reducing the superoxides produced in the cell whereas GPX share with catalase the 
reduction of H2O2. In addition, H2O2 is less reactive than superoxide. These antioxidant enzyme 
characteristics may suggest that SOD could be less stimulated than GPX for a similar superoxide 
production.  
Finally, the lack of nitrotyrosine change despite higher oxidative stress in HH could result of the 
observed decreased NO bioavailability (demonstrated by lower NOx and exNO).  
In conclusion, we strongly believe that increase of AOPP and SOD may reflect a higher ROS 
overgeneration in HH compared to NH. 
In conclusion, the exercise-induced increase in ventilation throughout 24h of hypoxic exposure 
was less in HH than NH and was associated with a decrease in NO bioavailability in HH. 
Furthermore, we observed increased oxidative stress and enzymatic antioxidants in HH. It can be 
hypothesized that the difference in oxidative stress and NO observed between HH and NH 
could explain the higher normobaric ventilatory responses to hypoxia. Although further 
investigation is needed to clarify how decreased NO bioavailability and increased oxidative stress 
could impact the lower ventilatory responses to hypoxia observed in HH, These new findings 
may have important potential consequences for adaptation and physical performance at altitude, 
since different responses in ventilation and oxidative stress may influence benefits to athletes 
training or living at altitude for performance improvement (28) 
It is still unclear if the reported differences in pH, ventilatory responses as well as nitrosative and 
oxidative stress between HH and NH have a clinical relevance (28). However, since it was 
recently shown that HH was more effective than NH as pre-acclimatization treatment in order 
to minimize AMS symptoms (11), we believe that further clinical investigation are worth of 
interest. 
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Letter to the editor 
In a recent review (3) on the relative effectiveness of different pre-acclimatization strategies on 
physiological responses (e.g., PETCO2, SaO2) and endurance performance of previously non- 
acclimatized subjects, Fulco et al. provided sets of data highlighting the potential differences in 
physiological mechanisms of acclimatization and exercise between hypobaric (HH) and 
normobaric (NH) hypoxia.  
The authors are to be commended for the consistency (e.g., investigators’ team, subject 
characteristics, assessment protocols, target altitude) among dozens of studies (most of them 
conducted at Pikes Peaks Laboratory, CO, 4300 m) over two decades, which enabled a robust 
comparison of benefits and effectiveness of different HH vs. NH pre-acclimatization strategies. 
Their conclusions are convincing enough to recommend HH instead of NH for pre- 
acclimatization due to the more developed ventilatory acclimatization and lesser decrease in 
performance when assessed at 4300 m. 
However, stricto sensus, the review by Fulco et al. did not clarify if the differences observed 
between HH and NH (4, 6) are clinically relevant and lead to a higher severity of acute mountain 
sickness (AMS) in HH than in NH, a topic highly debated [(4) vs. (7)] where, to date, there is not 
well-controlled comparative cross-over study. 
To our view, the most striking and novel finding arising from Fulco et al. (3) is the very low (or 
lack of) transfer of the benefits induced by the NH-acclimatization to the HH condition: When 
transported to 4300 m (HH), subjects who were pre-acclimatized in NH had a minimal benefit 
(e.g., no or <1 mmHg decrease in PETCO2 or AMS prevalence of 50%-64% instead of 80- 100% 
in non-acclimatized subjects). In addition, the NH pre-acclimatization did not induce 
any acclimatization can be effective in NH, but not in HH, and that the light ventilatory and 
AMS benefits retained in HH for the NH pre-acclimatized groups did not translate to 
performance benefits. 
These data raise many questions about the mechanisms because they “remain elusive” (3) and 
cannot be explained by the slight differences in ventilation, fluid balance and nitric oxide 
metabolism already described between NH and HH (4, 6). In a recent study (2), we confirmed 
the differences in ventilation (e.g., higher PETCO2) and the impaired NO bioavailability in HH vs. 
NH, but reported also a higher oxidative stress that may be explained by a lower plasma pH. 
Obviously, disentangling hypoxia and hypobaria is of importance for athletes or mountaineers 
who use NH to prepare for altitude competitions or expeditions. Moreover, the role 
of barometric pressure on oxidative and nitrosative stress during exposure to hypoxia might have 
interesting medical implications, as suggested by recent developments of therapeutic intermittent 
hypoxic methods (1, 8) in several pathologies (e.g., ischemic heart disease, stroke, cancer, chronic 
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lung disease, hypertension). Indeed, oxidative stress pathway has been recognized to regulate the 
Hypoxia Inducible Factor 1 (5), known to have a pivotal role in such disease 
progression/treatment. In conclusion, the review by Fulco et al. suggests further investigations 
on the differences in mechanisms and therapeutic use of hypobaric vs. normobaric hypoxia are 
needed. 
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Abstract 
 
While intermittent hypoxic training (IHT) has been reported to evoke cellular responses via 
hypoxia inducible factors (HIFs) but without substantial performance benefits in endurance 
athletes, we hypothesized that repeated sprint training in hypoxia could enhance repeated sprint 
ability (RSA) performed in normoxia via improved glycolysis and O2 utilization. 40 trained 
subjects completed 8 cycling repeated sprint sessions in hypoxia (RSH, 3000 m) or normoxia 
(RSN, 485 m). Before (Pre-) and after (Post-) training, muscular levels of selected mRNAs were 
analyzed from resting muscle biopsies and RSA tested until exhaustion (10-s sprint, work-to-rest 
ratio 1:2) with muscle perfusion assessed by near-infrared spectroscopy. From Pre- to Post-, the 
average power output of all sprints in RSA was increased (p<0.01) to the same extent (6% vs 7%, 
NS) in RSH and in RSN but the number of sprints to exhaustion was increased in RSH (9.4 ± 
4.8 vs. 13.0 ± 6.2 sprints, p<0.01) but not in RSN (9.3 ± 4.2 vs. 8.9 ± 3.5). mRNA 
concentrations of HIF-1ử (+55%), carbonic anhydrase III (+35%) and monocarboxylate 
transporter-4 (+20%) were augmented (p<0.05) whereas mitochondrial transcription factor A (-
40%), peroxisome proliferator-activated receptor gamma coactivator 1α (-23%) and 
monocarboxylate transporter-1 (-36%) were decreased (p<0.01) in RSH only. Besides, the 
changes in total hemoglobin variations (∆[tHb]) during sprints throughout RSA test increased to 
a greater extent (p<0.01) in RSH.  
Our findings show larger improvement in repeated sprint performance in RSH than in RSN with 
significant molecular adaptations and larger blood perfusion variations in active muscles. 
 - 135 -     
Introduction  
Hypoxic conditions can be characterized in working muscle by a decreased oxygen tension (e.g., 
lower myoglobin oxygen saturation and intramyocellular oxygen partial pressure) [1]. There are 
some evidences that exercising in hypoxia affects muscular functions [2] and a large number of 
genes mediated by hypoxia-inducible factors (HIFs) [3]. These transcription factors have been 
demonstrated to control the expression of over 70 targets in response to a reduction in oxygen 
concentration. Intermittent hypoxic training (IHT) has been reported to evoke cellular responses 
via HIF1-ử [4,5] but without demonstrating substantial performance benefits in endurance 
athletes [6-8]. Actually, training intensity in hypoxia per se modulates molecular adaptations at 
muscular level with “adaptations that compensate for the reduced availability of oxygen during 
exercise” [9].  Then, any limitation in O2 availability (e.g., exercising in hypoxia) induces a 
compensatory vasodilation shifting blood flow upward to keep constant O2 delivery to the 
muscle. This latter mechanism is also influenced by the exercise intensity [10]. For example, 
during supramaximal efforts, an increase in skeletal muscle blood flow allows matching the 
augmented O2 demand tightly [11]. 
Indeed, repeated sprints (RS) consist in maximal intensity exercise bouts with incomplete 
recoveries and could potentially challenge these adaptive mechanisms if performed in hypoxia. 
RS require huge energy amounts over short periods of time provided primarily by anaerobic 
glycolysis [12] with a progressive rise in the energy contribution of the aerobic metabolism [13]. 
One may therefore speculate that HIF-mediated molecular adaptations induced by repeated 
maximal efforts in hypoxia may challenge the functional reserve in muscle oxygen diffusing 
capacity likely utilized in hypoxia [14]. 
Besides, fast-twitch fibers (FT), preferentially recruited while sprinting [15], may better adjust to a 
high energetic demand with a greater fractional O2 extraction than their slow twitch counterparts 
[16] if oxygen tension falls in the muscle (e.g., in hypoxia). Consequently it can be hypothesized 
that RS training in hypoxia (RSH) could induce beneficial adaptations at the muscular level with 
an improved blood perfusion level inducing an enhanced O2 utilization by FT. 
Nonetheless, to our knowledge, these mechanisms and the potential associated benefits for the 
ability to repeat sprints in normoxia have never been investigated in a randomized blind 
controlled study. The goal of our study was therefore to test putative additional benefit on 
systemic repeated sprint ability performance of RS training in hypoxia vs. normoxia and to assess 
blood perfusion and molecular responses at the muscular level. 
Methods 
Subjec ts .  50 moderately trained male cyclists (age 35 ± 7 years, height 179 ± 5 cm, mass 75 ± 9 
kg) volunteered in the study and provided their written informed consent after the state Medical 
Ethics Committee approved the protocol (Commission Cantonale Valaisanne d'Ethique 
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Médicale, CCVEM, Agreement 07/10, Sion, Switzerland). Subjects were all non-smokers 
lowlanders. None of the subjects were acclimatized or recently exposed to altitude and were 
asked to avoid any exposure to an altitude of more than 1500 m during the protocol.  
Study des ign.  Experimental protocol consisted in two testing sessions before (Pre-) and after 
(Post-) a four-week supervised specific training period (8 training sessions). Subjects were 
randomly assigned to one of the two treatment groups with repeated sprint training either in 
normoxia (RSN, n=20) or hypoxia (RSH, n=20). A control group (CON, n=10) completed only 
Pre- and, after four weeks without specific training, Post-. Subjects were not specifically 
accustomed with 10 s cycling sprints but they were familiar with laboratory testing and longer 
high intensity cycling intervals. Protocol was run in single-blind fashion, as subjects both in RSH 
and RSN were told that all training sessions were held at altitude (without any accurate 
information on the altitude level). When asked, 95% of the subjects in RSH and 85% in RSN 
declared that their training was performed in hypoxia. Analyzes of blood samples and muscle 
biopsies were performed double-blinded. 
Supervised training protoco l .  Volunteers completed eight specific cycling training sessions with 
repeated sprints during four weeks starting the week after Pre- and finishing the week before 
Post-. Two sessions per week were completed in a hypoxic chamber (ATS Altitude, Sydney, 
Australia) built in our laboratory at an altitude of 485 m (Sion, Switzerland). The hypoxic 
chamber is a well-ventilated 30 cu. m room (2.4 m x 5.0 m x 2.5 m) with transparent glass panels. 
The system consists in a compressor storing air in pressurized tanks with serial connection to air 
filters allowing oxygen reduction (altitude simulation) in the air input flow to the chamber. For 
RSH, inspired oxygen fraction (FiO2) was set to 14.6 % to simulate an altitude of 3000 m and 
controlled regularly with an electronic device (GOX 100 oximeter, Greisinger, Regenstauf, 
Germany). In order to blind subjects to altitude, the system was also run for RSN with a 
normoxic airflow into the chamber. Air input flow (up to 1000 l/min) was sufficient for safe, 
comfortable and stable training conditions. Temperature inside the chamber was maintained at 
25° in average and three fans and crushed ice buckets were used to cool subjects.  
Training sess ions .  Following 10 min warm-up at 120 W, all training sessions consisted in 3 sets 
of 5 x 10 s all-out repeated sprints with a 5 min recovery period at 120 W between sprints and 
sets and ending with 10 min recovery at 120 W (Fig. 1). Subjects were instructed to perform all-
out sprints trying to reach and maintain the highest power output for every sprint. Each session 
lasted 36 min 30 s and subjects spent ~40 min in the chamber for every training session (320 min 
during the 4-weeks training period). Up to four subjects trained simultaneously in the chamber 
using their own road bicycle equipped with a power meter (Powertap Pro+ Wheel, Cycleops, 
Madison, USA) mounted on a stationary trainer with magnetic resistance (Powertap 
Supermagneto Pro, Cycleops, Madison, USA). Power output and heart rate were recorded for 
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each training session. Electrolytes-carbohydrates sports drink (Isotonic, Sponser, Wollerau, 
Switzerland) and water were provided to ensure appropriate hydration and carbohydrate intake 
during training. After each session, subjects reported their rate of perceived exertion (RPE, Borg 
Scale, 6-20) and ticked the level of pain in the legs on a continuous visual analogic scale (VAS). 
Training sessions were scheduled with at least one day of rest in between for optimal recovery. 
Outside of the laboratory, volunteers were asked to maintain their usual endurance training 
avoiding any intense training and to fill a training diary.  
 
 
Figure 1 Description of a typical training session. 
 
 
Base l ine (Pre-)  and f inal  (Post - )  t es ts .  During the 48 h prior to each testing session, subjects 
were asked to refrain from any training or exhaustive activity. Due to the extreme intensity of the 
tests, subjects were asked not to report to the laboratory on an empty stomach. A standard 
breakfast (cornflakes or muesli with milk, bread with jam and water) was therefore advised. In all 
cases, subjects were asked to fill a nutritional diary for three days before each test and reproduce 
the last meals avoiding alcohol and caffeine intakes during the 24 h before each test. Tap water 
was provided ad libitum during the tests. Pre- and Post- trials were performed in the exact same 
sequence in normoxia in the well-ventilated laboratory at a constant temperature of 24 °C. 
Blood sampling and musc le  biopsies .  Upon arrival in the morning, subjects were weighed and a 
2,5 ml blood sample was then taken from the antecubital vein for immediate hematocrit and 
hemoglobin concentration ([Hb]) evaluation. Gold standard hematocrit measurement was done 
by centrifugation of heparinized capillaries during 5 min at 13000 rpm (Haematokrit 210 
Centrifuge, Hettich, Germany). [Hb] was assessed with a photometry device (Hemocue 201, 
Ängeholm, Sweden). Blood lactate concentration ([La]) was measured from a capillary fingertip 
sample (Lactate Pro, Arkray, Japan) at rest and immediately after each test.  
 - 138 -     
Resting skeletal muscle microbiopsy samples were taken under local anaesthesia (Rapidocaine®, 
1% plain) of the left leg from the belly of the vastus lateralis muscle using percutaneous needle 
biopsy technique (Pro-Mag, Medical Device Technologies Inc., Gainsville, USA) [17]. Three 
individual muscle samples (between 60 and 90 mg of muscle) were taken within less than 1 min 
from one single incision. The muscle samples were washed in saline solution then immediately 
frozen in liquid nitrogen for RNA and protein extraction. For practical reasons muscle biopsies 
were taken in 5 subjects only in CON. 
RNA extract ion and real  t ime quanti tat ive  PCR.  RNA from skeletal muscle (approximately 
25 mg of muscle) was extracted using a commercially available preparation, peqGOLD Tri-Fast 
(Peqlab, Germany).  Five micrograms of RNA were reverse transcribed to cDNA using Random 
Hexamer primers (Promega AG, Switzerland) and AffinityScript Multiple Temperature Reverse 
Transcriptase (Agilent Technologies Inc, Santa Clara, CA, USA), while quantitative PCR was 
performed using an MX3000p thermal cycler system and Brilliant SYBER Green QPCR Master 
Mix (Agilent Technologies). PCR primers sequences are listed in Table 1 and PCR conditions 
were used as published previously by our research group [17,18]. To control for any variations 
due to efficiencies of the reverse transcription and PCR, acidic ribosomal phosphoprotein P0 
(RPLP0 or 36B4) was used as an internal control. All PCR runs were performed in triplicate. 
Enzyme act iv i t i es .  20 mg of tissue were used to measure enzyme activities of interest in RSH 
and RSN but not in CON. Lactate dehydrogenase (LDH) activity was determined using a 
colorimetric method developed by BioAssay system (QuantiChrom) according to manufacturer’s 
instructions.  The non-radioactive colorimetric LDH assay is based on the reduction of the 
tetrazolium salt MTT in a NADH-coupled enzymatic reaction to a reduced form of MTT which 
exhibits an absorption maximum at 565 nm [19]. Measurement of citrate synthase (CS) activity 
was performed by linking the release of Coenzyme-A to the colometric agent DTNB 5,5-
dithiobis-2-nitrobenzoate. Changes in absorbance were followed at 412 nm [20].  
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Gene Sequence 5–3 Temperature 
MCT-1 Sense CCA AGG CAG GGA AAG ATA AGT CT 60 
 Anti  ATC TTT TTT CAC ACC AGA TTT TCC A   
MCT-4 Sense  GCA CCC ACA AGT TCT CCA GT 60 
 Anti  CAA AAT CAG GGA GGA GGT GA  
CA3 Sense  GTC CTC TCC CTG GAC CCT AC 60 
 Anti  TTG TCC AAT GCA TCA AGG AA  
Tfam Sense  CCA AAA AGA CCT CGT TCA GCT TA 60 
 Anti  TGC GGT GAA TCA CCC TTA GC  
Mb Sense  GCA TGC CAC CAA GCA CAA G 60 
 Anti  TGA TGC ATT CCG AGA TGA ACT C  
PGC-1a Sense  GGT CTC TCC TTG CAG CAC AAG 60 
 Anti  CTG GGA TGA CCG AAG TGC TT  
VEGF Sense  CCT TGC TGC TCT ACC TCC AC 60 
 Anti  ATC TGC ATG GTG ATG TTG GA  
HIF-1a Sense  TCC ATG TGA CCA TGA GGA AA 60 
 Anti  CCA AGC AGG TCA TAG GTG GT  
RPLP0 Sense  GTG ATG TGC AGC TGA TCA AGA CT 60 
 Anti  GAT GAC CAG CCC AAA GGA GA  
Table 1 Quantitative PCR primer sequences. 
MCT-1, monocarboxylate transporter 1; MCT-4, monocarboxylate transporter 4; CA3, carbonic 
anhydrase III ; Tfam, transcription factor A mitochondrial ; Mb, myoglobin ; PGC-1a, peroxisome 
proliferator-activated receptor gamma, coactivator 1 alpha; VEGF, vascular endothelial growth factor A; 
HIF-1, hypoxia inducible factor 1, alpha subunit; RPLP0, ribosomal protein large P0. 
 
Exerc ise  per formance t es t s  and measurements . An electronically braked cycling ergometer 
(Lode Excalibur Sport, Groninge, The Netherlands) equipped with clip-on pedals was used for 
all performance tests. Seating and handlebar positions were adjusted individually for all subjects 
and reproduced for all tests. For each performance test, maximal instantaneous power output and 
pedaling frequency (PF) were recorded and average power output calculated. All tests were 
performed against an individual fixed torque of 0.8 Nm.kg-1 with the ergometer in manufacturer’s 
“Wingate mode” unless otherwise specified. RPE and leg pain were assessed as described above.  
Near- infrared spec troscopy measurements .  Muscle oxygenation was assessed using a near-
infrared spectroscopy (NIRS) technique well described elsewhere [21]. The NIRS device 
(Oxymon Mk III, Artinis, Zetten, The Netherlands intramuscular oxygenation) was used to 
measure changes in muscle oxygenation by placing a double optode sensor on m. vastus lateralis on 
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the right leg, at mid thigh with an interoptode spacing of 40mm. The probe was attached to the 
skin with double-sided tape and firmly fastened with an opaque cotton elastic band wrapped 
around subjects’ thigh.  Position of the probe was marked during Pre- with a permanent pen for 
accurate repositioning in the Post-trial. A standard differential pathlength factor (DPF) of 4.0 was 
used in lack of any clear standard value for human quadriceps muscle during cycling sprints 
[22,23]. All signals were recorded with a sampling frequency of 50 Hz. They were down sampled 
at 10 Hz using Matlab (Matlab Software, Nattick (MA) USA) routine resample. Then a 10th-
order low-pass zero-phase Butterworth filter (cutoff frequency 0.1 Hz) was applied to the 
resampled signals in order to remove possible artifacts and smooth the pedaling-induced 
perturbations. Automatic detection of the starting and end times of the successive sprints was 
obtained by estimating the filtered desoxyhemoglobin signal upper and lower envelopes using 
local minima and maxima in a sliding window of length 400 samples (4 s). The starting and end 
times were obtained as the times of contact between the envelopes and the signal. This allowed 
the determination of maximum and minimum for each signal during the successive sprint and 
recovery phases. Concentrations for oxyhemoglobin ([O2Hb]), desoxyhemoglobin ([HHb]) and 
total hemoglobin/myoglobin ([tHb]) were determined. Figure 2 illustrates the typical signals 
recorded by NIRS. Since [HHb] values were proposed to be less sensitive than [O2Hb] to blood 
flow variations [24] and changes in O2Hb signals might be confounded by rapid blood volume 
changes during sprints [25] only [HHb] and [tHb] were analyzed for relevant interpretations. 
Differences between maximum and minimum concentrations were defined as the amplitude of 
the variation for each sprint (∆[tHb] and ∆[HHb]). Thus, for example, at the beginning of each 
sprint a minimum value for [HHb] is measured whereas [HHb] reaches a maximum at the end of 
each sprint. Conversely, a maximum in [tHb] is observed at the beginning of each sprint (i.e. end 
of each recovery period) and [tHb] decreases to reach a minimum value at the end of each sprint. 
The amplitudes of the first sprint were standardized as 100%. Amplitudes during the following 
sprints and the average value for all sprints throughout the RSA test (i.e. ∆[HHb]av and ∆[tHb]av) 
were calculated. The same analysis was performed during the successive recovery phases. In 
addition, the ∆[tHb]/Power was calculated as the ratio between ∆[tHb] and mean power for each 
sprint as an index of blood perfusion relative to the intensity of each sprint. 
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Figure 2 Typical signals recorded by near-infrared spectroscopy during repeated sprint ability test after 
signal treatment, maximum and minimum determination and smoothing. Concentrations of O2Hb, HHb 
and tHb are expressed as changes in µM from resting baseline set to 0 µM. 
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Electromyography acquis i t ion and analys i s . Surface EMG of the vastus lateralis (VL) and 
biceps femoris (BF) muscles on the right leg were recorded during the tests using MP36 hardware 
(Biopac Systems Inc., Santa Barbara, CA) with specific electrodes (EL-503, Biopac) with a 
diameter of 35 mm pasted longitudinally on the distal part of the muscle belly with an center-to-
center distance of 25 mm. A ground electrode was located on the patella. Prior to electrode 
placement, skin on the surface of these muscles was carefully shaved, abraded and cleaned 
(impedance < 5 kΩ). EMG cables running inside subjects’ cycling tights prevented cables 
movement. The myoelectric signal was collected at 2000 Hz, amplified and filtered (pass band 5–
500 Hz, gain = 1000). EMG parameters were then computed in a dedicated software 
(AcqKnowledge 4.1.0, Biopac Systems Inc., Santa Barbara, CA). During RS, each muscle activity 
was determined by calculating the mean value of the root mean square (RMS) of the signal for 
each sprint. Average values were then calculated for the entire duration (10 s) of each sprint. 
Repeated spr int  abi l i ty  t es t .  Approximately 20 min after the resting biopsy, subjects performed 
a 5 min warm-up at 120 W at their preferred PF followed by an isolated 10 s sprint, 4 min 50 s 
recovery at 120 W and a second isolated 10 s sprint. 15 s after this second sprint, subjects were 
asked to stop pedaling and rest keeping the right leg motionless and straight during 5 min for 
NIRS baseline measurement. Subjects then started pedaling for 45 s against a 20 W resistance at a 
PF of approximately 85 rpm followed immediately by the repeated sprint ability (RSA) test with a 
1:2 work-to-rest ratio (10 s all-out sprint and 20 s rest). Immediately after each sprint, the 
ergometer switched automatically to a resistance of 20 W during the 20 s active recovery phase. 
Subjects were given very strong verbal encouragement and performed as many sprints as possible 
until exhaustion (i.e. task failure). To avoid any protective pacing strategy, average power during 
the first two sprints was controlled to reach at least 95% of the best average of the two isolated 
sprints, which was the case in all subjects. Subjects were never given any indication on the 
number of sprints performed. A minimal PF of 70 rpm after 5 s or less of sprinting was set as a 
criterion to stop subjects’ test. However, volitional exhaustion was observed in all subjects before 
this criterion was reached. Unfinished sprints (subjects not being able to turn pedals anymore) 
where not taken into consideration. 
3 min All-Out tes t .  45 min after the RSA test, subjects performed a 3-min all-out test following 
a protocol well described elsewhere [26] in order to determine 3-min average power output. 
Strong verbal encouragement was given throughout the test and PF was instructed to be as high 
as possible all time to elicit maximal all-out performance. Information about elapsed time was 
only given during the final minute every 15 seconds in order to prevent pacing and further 
motivate subjects. A peak in oxygen consumption (VO2peak) was calculated as the highest 30 s 
average value during the test with a gas exchange analyzer (Metalyzer, Cortex Medical, Leipzig, 
Germany). Although residual fatigue from the RSA test was probable, this test was performed for 
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all subjects at the same moment of the testing sequence allowing for a good comparison of 
subjects’ aerobic capacity (average power during 3 min). For this test, the ergometer was set in 
linear mode (power output increases as PF increases). 
30 s Wingate tes t .  Prior to the first and last training sessions, subjects performed a standard 30 
s Wingate test [27] after a 6 min warm-up at 120 W and the average power during the 30 s was 
recorded. 
Stat is t i ca l  analyses .  Data are presented as mean (SD). Performance and blood perfusion 
changes during RSA test were first evaluated with a 2-way (training group x sprint number) 
general linear model repeated-measures ANOVA with all pairwise multiple comparison 
procedures (Holm-Sidak method). Performance improvement, muscle oxygenation during RSA, 
mRNA concentrations, blood lactate and other single variables test were then evaluated with 2-
way (training group x time (Pre- vs. Post-)) general linear model repeated-measures ANOVAs 
with all pairwise multiple comparison procedures (Holm-Sidak method). All analyses were made 
using Sigmaplot 11.0 software (Systat Software, CA, USA). Null hypothesis was rejected at 
p<0.05. 
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Results 
Total work and training intensity during supervised RS training were similar during RSN and 
RSH, with only the mean heart rate being higher in RSH (Table 3). In addition to specific training 
in the laboratory, subjects trained similarly for 5.0 ± 2.5 h and 5.1 ± 2.2 h for the RSH and RSN 
groups, respectively. 
 
RSN RSH CON 
 
Pre- Post- Pre- Post- Pre- Post- 
Body mass (kg) 73.7 ± 7.7 73.7 ± 8.1 76.8 ± 10.4 76.5 ± 10.1 76.4 ± 11.0 75.8 ± 11.3 
Hematocrit (%) 45.6 ± 2.7 45.4 ± 2.2 44.2 ± 2.7 44.8 ± 2.4 44.9 ± 2.6 45.7 ± 2.7 
Hemoglobin (g.l-1) 152 ± 12 154 ± 12 153 ± 12 154 ± 16 154 ± 8 157 ± 9 
VO2peak (l
.min-1) 3.8 ± 0.5 4.0 ± 0.4 3.8 ± 0.4 3.8 ± 0.4 3.9 ± 0.5 3.9 ± 0.5 
Table 2 Subjects’ characteristics before (Pre-) and after (Post-) repeated sprint training in hypoxia (RSH), 
in normoxia (RSN) or in the control group (CON). 
VO2peak, peak in oxygen consumption measured during 3-min all-out test. 
 
 
RSH RSN 
Total work (kJ)  2728 ± 242 2738 ± 335 
Mean peak power output (W) 960 ± 117 1003 ± 146 
Mean heart rate (bpm) 151 ± 12 141 ± 12# 
Mean RPE 16.2 ± 1.4 16.7 ± 1.5 
« Pain in the legs » VAS 7.0 ± 1.9 7.6 ± 0.9 
Table 3 Total work and measured parameters during all training sessions in the hypoxic (RSH) and 
normoxic (RSN) training groups 
RPE, Rate of perceived exertion (Borg 6-20 scale); VAS, Visual analogic 1-10 scale 
# p< 0.05 for difference with RSH 
 
Performance .  From Pre- to Post-, the average power of all sprints during the RSA test increased 
(p<0.01) to the same extent (6 ± 7% vs. 7 ± 8%, NS) in RSH and in RSN, respectively, but not 
in CON (2 ± 5%, NS). The number of sprints prior to exhaustion was increased in RSH (9.4 ± 
4.8 vs. 13.0 ± 6.2, p<0.01) but not in RSN (9.3 ± 4.2 vs. 8.9 ± 3.5, NS) nor in CON (11.0 ± 7.1 
vs. 10.3 ± 6.2, NS). In Post- compared to Pre-, 10-s average power in the successive sprints was 
significantly improved till the ninth sprint in RSH and till the seventh in RSN. In RSH, this 10-s 
power output was significantly better (p<0.01) in the 10th and 11th sprints in Post- than the 
ninth sprint in Pre- (Fig. 3). Significant group (RSH vs. RSN) by time (Pre- vs. Post-) 
interactions were found in the number of sprints (F=24.22; p<0.001) and total work 
(F=27.07; p<0.001) performed during the RSA test. Subjects reached volitional exhaustion at 
the same relative power output (e.g., % of the best sprint) in RSH (67 ± 11% vs. 69 ± 8% for 
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Pre- vs. Post-, respectively, NS) and in RSN (65 ± 7% vs. 68 ± 9%, NS).  From Pre- to Post-, 
average PF during the last 5 s of all successive sprints was improved to the same extent (p<0.01) 
in RSH (96 ± 14 vs. 104 ± 11) and in RSN (100 ± 11 vs. 110 ± 10) but not in CON (103 ± 2 vs. 
103 ± 3, NS). The maximal PF of each sprint was higher (p<0.01) in Post- both in RSH (124 ± 
11 vs. 130 ± 8) and in RSN (125 ± 8 vs. 131 ± 8) but not in CON (129 ± 3 vs. 130 ± 4, NS).  
The average power during the 3-min all-out test as well as hematocrit and hemoglobin 
concentration at rest were unchanged between Pre- and Post- in all groups (Tables 3 and 4). RSH 
and RSN improved single 10-s sprint and Wingate performances (p<0.01) similarly whereas it did 
not change in CON (Table 4).  
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Figure 3 Average power output (W) in successive sprints during the repeated sprint test before (Pre-) and 
after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group 
(CON). 
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RSH RSN CON 
 
Pre- Post- Pre- Post- Pre- Post- 
Single 10-s sprint 
average power (W) 
870 ± 132 925 ± 120** 879 ± 131 940 ± 131** 890 ± 151 877 ± 163 
RSA Peak Power (W) 1365 ± 311 1500 ± 217** 1351 ± 226 1427 ± 275* 1357 ± 275 1377  ± 322 
RSA Peak  heart rate 
(bpm) 
173 ± 14 175 ± 11 172 ± 8 172 ± 8 171 ± 10 171 ± 11 
RSA Best average 
power (W) 
870 ± 133 925 ± 120** 879 ± 131 940 ± 131** 870 ± 151 877 ± 163 
RSA Mean power of 
all sprints (W) 
699 ± 97 737 ± 84** 693 ± 120 734 ± 104** 726 ± 115 747 ± 125 
RSA [La] (mmol.l-1) 15.0 ± 2.3 15.4 ± 2.1 14.2 ± 1.7 14.8 ± 1.6 14.8 ± 2.0 13.8 ± 1.5 
RSA Average RPE 17.3 ± 1.5 17.4 ± 1.7 17.8 ± 1.4 17.8 ± 1.5 17.8 ± 1.0 17.6 ± 0.8 
RSA Average « Pain 
in the legs » VAS 
5.2 ± 2 6.7 ± 1.9** 5.8 ± 1.9 7.7 ± 1.7** 6.4 ± 2.3 6.1 ± 1.8 
30 s Wingate average 
power (W) 
699 ± 102 718 ± 94** 688 ± 75 723 ± 86** 670 ± 86 689 ± 105 
30 s Wingate [La] 
(mmol.l-1) 
11.0 ± 2.2 12.0 ± 2.0 11.3 ± 2.3 11.0 ± 2.2 10.8 ± 3.0 11.4 ± 2.5 
30 s Wingate  Average 
RPE 
15.3 ± 2.0 16.1 ± 1.9 16.3 ± 1.6 17.0 ± 1.6 15.8 ± 1.7 16.0 ± 0.9 
3-min all-out average 
power (W) 
368 ± 45 383 ± 39 371 ± 49 382 ± 47 385 ± 48 378 ± 48 
3-min all-out [La] 
(mmol.l-1) 
14.7 ± 2.1 15.0 ± 1.9 14.5 ± 2.0 15.1 ± 2.0 14.2 ± 2.6 13.8 ± 2.4 
3-min all-out RPE 17.5 ± 1.7 18.0 ± 1.7 18.1 ± 1.8 18.7 ± 1.1 17.8 ± 1.0 17.9 ± 1.0 
Table 4 Performance results before (Pre-) and after (Post-) repeated sprint training in hypoxia (RSH), in 
normoxia (RSN) or in the control group (CON). 
RSA, repeated sprint ability test; [La] Blood lactate concentration after repeated sprint test; RPE, rate of 
perceived exertion (Borg 6-20 scale); VAS, visual analogic scale (1-10) score. 
** p< 0.01, * p<0.05 for difference with Pre- 
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Muscle  oxygenat ion . Repeated sprints. After training, ∆[tHb]av increased to a greater extent 
(F= 15.8, p<0.01) in RSH than in RSN and was not different in Pre- and in Post- in CON (Fig. 
4B). 
Meanwhile, ∆[HHb]av increased similarly in RSH (from 79 ± 6% to 98 ± 5%, p<0.01) and in 
RSN (from 106 ± 3% to 120 ± 10% , p<0.01) but was not different in Pre- and in Post- in CON 
(118 ± 9% vs. 121 ± 13%, NS). 
The average ∆[tHb]/Power ratio increased to a greater extent (F=9.1, p<0.05) in RSH (from 1.64 
± 0.25 to 2.23 ± 0.35, p<0.01) than in RSN (from 1.68 ± 0.15 to 1.98 ± 0.30, p<0.05) and was 
not different Pre- compared to Post- in CON (1.61 ± 0.26 vs. 1.56 ± 0.33, NS). 
Recovery phases. After training, ∆[tHb]av increased to a similar extent in RSH and in RSN but 
was not different Pre- compared to Post- in CON (Fig. 5B). 
Meanwhile, ∆[HHb]av increased significantly only in RSH (from 98 ± 7 to 115 ± 12%, p<0.05) 
but not in RSN (105 ± 12% vs. 116 ± 10%, NS) nor in CON (109 ± 8% vs. 113 ± 13%, NS). 
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Figure 4 ∆[tHb]: successive changes in total hemoglobin concentrations’ amplitude during sprints 
(expressed in percent compared to the first sprint) measured by near infrared-spectroscopy (A) and 
∆[tHb]av: average of all changes during the repeated sprint test to exhaustion (B) before (Pre-) and after 
(Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) or in control group 
(CON). 
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Figure 5 ∆[tHb]: successive changes in total hemoglobin concentrations’ amplitude during recovery 
phases between sprints (expressed in percent compared to the first recovery phase) measured by near 
infrared-spectroscopy (A) and ∆[tHb]av: average of all changes during the repeated sprint test to 
exhaustion (B) before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in 
normoxia (RSN) or in control group (CON). 
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Elextromyographic  act iv i ty .  From Pre- to Post-, average RMS activity of the VL muscle was not 
different in RSH (0.53 ± 0.23 vs. 0.50 ± 0.16 mV, NS), in RSN (0.49 ± 0.15 vs. 0.51 ± 0.12 mV, 
NS) or in CON (0.53 ± 0.21 vs. 0.51 ± 0.19 mV). Similarly, from Pre- to Post-, average RMS 
activity of the BF muscle was not different in RSH (0.22 ± 0.09 vs. 0.24 ± 0.10 mV, NS), in RSN 
(0.20 ± 0.08 vs. 0.22 ± 0.09 mV, NS) or in CON (0.22 ± 0.05 vs. 0.24 ± 0.18 mV, NS). RMS 
activity of the VL across the RSA test decreased relatively to the first sprint (set to 100%) but to a 
similar extent in RSH (91 ± 8% vs. 89 ± 9%, NS), RSN (86 ± 11% vs. 87 ± 12%, NS) or in 
CON (89 ± 10% vs. 88 ± 6%, NS) in Pre- vs. Post-, respectively 
 mRNA selec ted gene transcr ipts  and enzyme act iv i ty .  Figure 6 displays Pre- and Post- mRNA 
expression levels in RSH, RSN and CON groups. In Post- compared to Pre-, mRNA gene 
concentrations of hypoxia inducible factor (HIF-1ử, +55%, p<0.05), carbonic anhydrase III 
(CA3, +35%, p<0.05), monocarboxylate transporter-4 (MCT-4, +20%, p<0.05) and lactate 
dehydrogenase (LDH, +12%, p<0.05) were augmented in RSH only. Conversely, mitochondrial 
transcription factor A (TFAM), peroxisome proliferator-activated receptor gamma coactivator 1α 
(PGC-1ử) and monocarboxylate transporter-1 (-36%, p<0.01) concentrations were decreased in 
RSH only (-40% and -23% respectively, p<0.01) (Fig. 6). From Pre- to Post-, LDH activity was 
increased in RSH (63.6 ± 13.8 vs. 71.3 ± 14.2, p<0.05) but not in RSN (56.3 ± 14.8 vs. 61.7 ± 
16.2, NS). Citrate synthase activity was not different and did not vary significantly in RSH (8.6 ± 
2.5 vs. 10.6 ± 2.7, NS) and in RSN (8.5 ± 3.1 vs. 8.5 ± 3.8).  
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Figure 6 Relative mRNA expression of selected gene transcripts after 4 weeks of specific repeated sprint 
training before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia 
(RSN) or in control group (CON). Open bars represent Pre- values and solid bars Post- values of mRNA 
concentrations in vastus lateralis muscle. Post- values were expressed in % compared to Pre- values (set to 
100%). HIF-1ử, hypoxia inducible factor-1ử; VEGF, vascular endothelial growth factor; MB, myoglobin; 
PGC1-ử, proliferator-activated receptor gamma coactivator-1ử; TFAM, mitochondrial transcription factor 
A; CA3, carbonic anhydrase III; MCT-1, monocarboxylate transporter-1; MCT-4, monocarboxylate 
transporter-4; LDH, lactate dehydrogenase. 
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Discussion 
The principal novel finding of this investigation is that repeated sprint training in hypoxia allows 
further enhancement of repeated‐sprint performance to exhaustion than the same training in 
normoxia. Second, in RSH, the amplitude of blood flow variations during sprint phases was 
increased. Third, the increased mRNA expression of factors involved in pH regulation and 
glycolysis as well as the decrease in factors involved in mitochondrial biogenesis after RSH 
suggest a potential enhancement of the glycolytic (but not oxidative) activity in muscle. 
Repeated spr int  abi l i ty  and cyc l ing  per formance improvement .  RSH and RSN elicited similar 
significant power improvements (~6-7%) but hypoxic training only additionally delayed the 
decrease of power output and therefore extended the number of sprints performed. The ability 
to reach a higher PF and maintain it high during the last 5 s of the successive sprints explains the 
power improvements both in RSH and RSN. Indeed, maximal power production (e.g., during 
repeated sprints) is related to the ability to recruit more FT at very high PF [28] and FT are 
known to be essential in the power production when intensity increases [29]. Consequently, the 
observed increase in power can be attributed to an improved muscle recruitment strategy (e.g., 
additional FT motor units [30]) and inter-muscle coordination [22]. Noteworthy, like RSH, RSN 
improved average and maximal power output of the sprints; so the specific training performed is 
useful compared to CON in improving power during repeated sprints. 
In addition, the aerobic performance (3-min all-out) was not modified after training (Table 4). 
Similarly, improvement of single 10-s sprint and Wingate performance did not differ between 
RSH and RSN. This was expected since intermittent training in hypoxia is known to be rather 
inefficient for additional performance improvements in endurance athletes, when compared to 
similar training performed in normoxia [6].   
Blood f low variat ions and de layed exhaust ion during RSA test . 
∆[tHb] represents changes in blood volume in the muscle (i.e. blood perfusion) [31] so it is 
expected to vary widely during the RSA test. Since PF was higher in Post- and ∆[tHb] is 
influenced by cycle frequency [32], the increase in ∆[tHb]av was expected and could contribute to 
higher power production both in RSH and RSN. Then, during the repeated sprint test, fatigue 
appeared rapidly, highlighted by the power decrement (~33-35%, Fig. 3) throughout the set. At 
the muscular level, waste metabolites accumulation and energy supply are certainly essential 
limiting factors in RSA performance [33]. During RS phosphocreatine breakdown is very high 
[12] and inorganic phosphate (Pi) accumulates in muscle. Since increased Pi levels may decline 
force, especially in FT recruited during such fatiguing exercise [34], an improved waste 
metabolites removal when blood flow is raised [35] might delay fatigue during a RSA test. This is 
in accordance with the greater increase in ∆[tHb]av during sprints in RSH compared to RSN and 
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the increase of the ∆[tHb] to power ratio, so it can be argued that blood perfusion was improved 
in RSH and could explain additional sprints performed in RSH.  
Moreover, during sprinting, due to the high PF, FT are predominantly recruited [28,36]. FT are 
mainly glycolytic [37] and contribute highly to the energy supply during RS [33]. More sprints in 
RSH could then be explained by an improved behavior of FT although it requires to optimize the 
contribution of anaerobic glycolysis known to be impaired as sprints are repeated [33]. Indeed, 
due to the poorer O2 delivery to working FT (compared to slow twitch (ST)) and their greater 
fractional O2 extraction if highly perfused [16], these fibers are likely to benefit more from the 
higher blood perfusion during sprints in RSH. This could help enhancing microvascular O2 
delivery to FT, minimizing substrate level phosphorylation and intracellular perturbation (e.g., Pi 
accumulation and decreased pH), thereby “making FT to behave more like their oxidatively 
efficient ST counterparts” [38]. Then, with more FT recruited and working with less anaerobic 
energy dependence, fiber fatigue could potentially be diminished [39].  
Interestingly, a recent study underlined a higher decrease in power output but with similar [tHb] 
kinetics during a RSA test performed in hypoxia compared to normoxia [40]. However, during 
our supervised training, RS power output did not decrease more in RSH than in RSN (since total 
work was similar (Table 3)). This could be explained by the training including only sets of 5 
repeated sprints and therefore limiting power decrements. Then the improved [tHb] kinetics (i.e. 
∆[tHb]) we observed might have been elicited by the greater exercise:rest ratio used (1:2) 
inducing shortened recoveries.  
When exercising, the O2 availability to demand ratio is lowered and muscle tissue oxygen delivery 
is maintained by an increased extraction of O2 in blood [41]. A more severe reduction of the ratio 
(e.g., during repeated sprints) requires an adapted arterial flow control (e.g., vasodilatation) to 
ensure adequate tissue perfusion [10]. In addition, during exercise in hypoxia the compensatory 
vasodilatation (with an increase in blood perfusion) aims at maintaining constant the total O2 
delivery to the muscle [10]. Alongside, in hypoxia there is an increased sympathetic 
vasoconstrictor activity directed towards skeletal muscle [42] that occurs to a greater extent 
within FT (glycolytic type II fibers in rat) [43]. However, “the compensatory vasodilatation 
prevails over the vasoconstrictor response” and exercise intensity is essential in the amplitude of 
this compensatory vasodilatation [10]. So, maximal exercise intensities (e.g., in sprints) may 
maximize this amplitude. Though muscle fatigue attenuates the vasodilatory responsiveness [44] 
and the delayed fatigue during RSA test in RSH could then partly be due to an improved 
responsiveness of the vascular bed. Interestingly, blood flow and vascular conductance were 
shown to be augmented mostly in FT after dietary nitrate supplementation [43]. In accordance 
with the increase in ∆[tHb]av in RSH (Fig. 4B), one may finally hypothesize that RSH enhancing 
predominantly FT behavior could participate to the improved blood perfusion through nitric 
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oxide mediated vasodilatation mechanisms [10]. However, it must be admitted that data collected 
by NIRS might only represent muscle perfusion indirectly and should be interpreted with care. In 
addition, we did not observe significant differences in thigh muscle electromyography between 
groups. Nevertheless voluntary activation was reported not to differ during short-term hypoxia 
even at a higher altitude [45].  
Still, the proposed mechanism based on the preferential recruitment and modified behavior of 
FT with an enhanced vasodilatory compensation induced in RSH is appealing as it could also 
explain why previous IHT studies [6-8] with lower exercise intensities failed to demonstrate 
additional benefits to endurance performance when compared to similar normoxic training. In 
these latter studies, FT fibers recruitment might not have been high enough since intensity was 2-
4 fold lower than with the present RS training. 
Molecular adaptat ions af ter  spec i f i c  t raining.  Besides, performance and blood perfusion 
results are in accordance with the expression levels of some mRNAs. Our protocol including 
only brief periods of hypoxic training was sufficient for inducing a significant upregulation of 
HIF-1ử. Such elevation in HIF-1ử mRNA leads to a downstream activation of HIF-1 dependent 
pathway [46]. The subsequent increase in mRNA expression of CA3 and improved activity of 
LDH additionally suggests an increased capacity for pH regulation [47], although no significant 
difference in blood lactate was observed between Pre- and Post-. Indeed we also observed a 
decrease in mRNA expression of genes implicated in mitochondrial biogenesis such TFAM and 
PGC‐1ử while LDH concentration was increased. Moreover, citrate synthase activity was not 
different between RSH and RSN suggesting that oxidative capacity was not different. Our study 
therefore indicates a shift from aerobic to anaerobic glycolytic activity in the muscle not in line 
with the previously suggested enhanced oxidative capacity after IHT [4,5,48]. In addition, we 
observed an upregulation of MCT-4 and a downregulation of MCT-1 in RSH. MCT-4 is mostly 
expressed in glycolytic tissues (i.e. FT) where it mediates lactic acid efflux [49] from the cells 
whereas MCT-1 is adapted to supply lactate to the cells for energy production [50]. Again, as 
MCT-4 (but not MCT-1) is upregulated by hypoxia [49], our results are in line with the 
hypothesis that more sprints performed during RSA were due mainly to modified FT fibers 
behavior. Although this study confirms an elevated HIF1-ử mRNA expression after exercising at 
high-intensity during short exposures in hypoxia (and not in normoxia), the observed changes are 
largely different than the previously reported HIF-1 mediated muscle adaptations after IHT 
[5,48] but underlines specific adaptations in RSH. Yet we also confirm the key role of exercise 
intensity per se during hypoxic training [9]. Overall, the upregulation of genes involved in oxygen 
signaling (HIF-1a), oxygen carrying (Mb) and pH regulation (CA3) and the concomitant 
downregulation of genes implicated in mitochondrial biogenesis (TFAM and PGC-1ử) suggest a 
shift from aerobic to anaerobic glycolytic activity in the muscle. 
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Conclusions 
This study is the first to observe larger performance improvement after repeated sprint training 
in hypoxia than for to the same training in normoxia. Our main novel findings were that repeated 
sprint training in hypoxia leads to i) increased variations of blood perfusion possibly delaying 
fatigue during a RSA test and ii) specific molecular adaptations large enough for inducing further 
improvement in systemic RSA performance. Our results suggest an improved vascular 
conductance in repeated sprints to exhaustion where fast-twitch fibers are likely better utilized. 
Fatigue could potentially be delayed through FT working with less anaerobic energy dependence. 
In parallel to the increased blood perfusion and potentially better waste metabolites removal, 
modifications at the molecular level support a shift towards improved anaerobic glycolytic 
activity following RS training in hypoxia only. 
In conclusion, this study reports the effectiveness of RSH for improving intermittent exercises 
performed in normoxia. The mechanisms are likely largely different than those previously 
associated to the inefficient IHT. 
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Correspondence 
We read with great interest the recent review of our colleagues, Francois Billaut et al.,[1] on the 
highly debated topic of ‘altitude training in team sports’. While we acknowledge the authors for 
their excellent comprehensive review of the scarce literature that confirms, to a large extent, 
some of our previous views,[2] we wish to comment on two points of importance (i) the relative 
differences between hypobaric (HH) and normobaric (NH) hypoxia; and (ii) the difference 
between intermittent hypoxic training (IHT) and repeated sprints (RS). 
We believe that these two points are para- mount for understanding the potential benefits of 
hypoxic training on RS and, more generally, on team-sport athlete performance and, therefore, 
that further investigation of these points should also be recommended prior to any evidence-
based recommendations being made. 
1. Physiological Differences between Hypobaric and Normobaric Hypoxia? 
Although an increasing body of literature[3-10] suggests that physiological responses both to 
exercise and at rest are slightly different between HH and NH, and despite the obvious 
consequences in terms of periodization and practical use of the various types of the presented 
hypoxic methods, this point has been completely ignored in the review,[1] and therefore assumes 
that HH and NH can be used interchangeably, since the same inspired oxygen pressure (PIO2) 
would potentially produce the same physiological responses and benefits. However, differences 
in cardio-respiratory responses, fluid balance and nitric oxide metabolism have been described 
between NH and HH.[3-10] Importantly, for an equivalent partial pressure in O2, the reduction 
in O2 arterial content (CaO2) seems to be more marked in HH than in NH.
[11] Regarding ‘living 
high-training low’ (LHTL), one may observe that the recommended minimal ‘altitude’ is generally 
higher for NH than for HH[2,12,13] and that some adjustments are sometimes integrated in 
experimental design.[14] We did report[5] that most of the LHTL studies conducted in NH did 
not induce any additional performance benefits (i.e. significant difference between the 
experimental hypoxic and the control normoxic groups),[14-20] in opposition to the LHTL 
studies conducted in HH[21-24] where, generally, benefits in both erythropoietic responses 
and/or performance were noted. The results of a meta-analysis[25] support the significantly 
larger additional benefits in performance (estimated by change in power output) in elite athletes 
for LHTL in ‘terrestrial’ HH than that in ‘artificial’ NH (4.0% vs 0.6%). However, since there is 
no data supporting any clinical difference regarding the efficiency of either ‘living low-training 
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high’ (LLTH) or LHTL in HH when compared with NH, any evidence-based recommendation 
would not be relevant at this stage. 
Based on the recent literature,[3,26] another point to be questioned is the recommendation that 
IHT might ‘‘enhance endurance performance when subsequent exercise is conducted in 
hypoxia’’[1] and the efficiency of pre-acclimatization strategies using LLTH or LHTL in NH for 
preparing matchplay at altitude. Fulco et al.[3] reported that pre-acclimatization in NH (assumed 
to be effective as shown by large increase in arterial saturation in O2 [SaO2] or decrease in end-
tidal pressure in O2 [PETCO2] between the first and last pre-acclimatization exposure in NH) 
induced only minimal benefits (e.g., negligible decrease in PETCO2 or reduction in acute 
mountain sickness prevalence) in HH (Pikes Peak, 4300 m). More importantly, NH pre-
acclimatization did not induce any reduction in the acute performance decrement (cycling or 
treadmill time trial) observed during the first 24 hours after arrival at 4300 m, whereas the 
improvement is ~15–20% in HH pre-acclimatized athletes (when compared with non-pre-
acclimatized or sham groups, for whom impairment in endurance performance can be 60% or 
greater, when compared with sea level). To our knowledge, there are no well-controlled crossover 
studies comparing the efficiency of any HH versus NH pre-acclimatization on the change in 
performance during acute or longer exposure to real altitude in elite athletes. However, the 
influence of the barometric pressure is highlighted by both the study of Fulco et al.[3] showing a 
very low transfer of the benefits induced by an NH-acclimatization to HH responses and our 
recent study[10] where nitric oxide bioavailability was impaired while oxidative stress was 
increased in HH versus NH. 
2. Intermittent Hypoxic Training or Repeated Sprints? 
Our group recently showed that RS training in hypoxia allowed further enhancement of RS 
performance than the same training in normoxia.[27] By using a sprint to rest ratio of 1 : 2, we 
confirmed some molecular adaptations at the skeletal muscle level after hypoxic training cited by 
Billaut et al.[1] but showed for the first time that these adaptations are large enough for inducing 
further improvement in systemic RS performance. Our data highlight an upregulation of genes 
involved in oxygen signalling (HIF-1a), oxygen carrying (Mb) and pH regulation (CA3) and the 
concomitant downregulation of genes implicated in mitochondrial biogenesis (TFAM and PGC-
1a) suggesting a shift from aerobic to anaerobic glycolytic activity in the muscle and a more 
efficient use of fast twitch (FT) muscle fibres after hypoxic RS training. This type of maximal-
intensity intermittent training (e.g., RS) induces a large recruitment of the FT fibres. It is known 
that, relative to slow twitch (ST) muscle, FT muscle fibres experienced a greater 
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fractional O2  extraction because of a poorer O2 delivery to working FT fibres.
[28] We believe 
that RS in hypoxia would lead to an enhanced microvascular O2 delivery to FT, minimizing 
substrate level phosphorylation and intracellular perturbation (e.g., inorganic phosphate 
accumulation and pH), thereby making FT fibres behave more like their oxidatively efficient ST 
counterparts.[29] Then, with FT work- ing with less anaerobic energy dependence, fibre fatigue 
could potentially be diminished[30] and RS performance augmented. This hypothesis is 
appealing, as it could also explain why most of the previous IHT studies[31-34] conducted at 
non-maximal intensity (and therefore with a lower FT recruitment) failed to demonstrate any 
additional positive effects when compared with similar normoxic training. Despite the prudence 
of the authors ‘‘there is no clear trend about the effect of IHT on endurance performance,’’[1] we 
question the fact that team-sport performance could be enhanced with IHT by improving 
endurance. So far, ‘‘it is safe to conclude that IHT does not increase exercise performance at sea 
level in endurance athletes any more than simply training at sea level.’’[34] 
Since the exercise-to-rest ratio influencing, to a large extent, the oxidative versus glycolytic 
component[35,36] during RS is different between team sports (e.g., football vs ice hockey), one 
may hypothesize that the effectiveness of RS training in hypoxia will differ between these sports, 
but this remains to be investigated! 
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Abstract 
 
Purpose Repeated sprint training in hypoxia (RSH) was recently shown to improve repeated 
sprint ability (RSA) in cycling. This phenomenon is likely to reflect fiber-type dependent, 
compensatory vasodilation and, therefore, our hypothesis was that RSH is even more beneficial 
for activities involving upper-body muscles, such as double-poling during cross-country skiing. 
Methods In double-blinded fashion, 17 competitive cross-country skiers performed 6 sessions of 
repeated sprints (each consisting of 4 sets of 5 10-s sprints, with 20-s intervals of recovery) either 
in normoxia (RSN, 300 m, FiO2 = 20.9%, n=8) or normobaric hypoxia (RSH, 3000 m, FiO2 = 
13.8 %, n=9). Before (Pre-) and after (Post-) training, performance was evaluated with a RSA test 
(10 s all-out sprints - 20 s recovery, until peak power output declined by 30%) and a simulated 
team sprint (TS, 3 x 3 min all-out with 3 min rest) on a double-poling ergometer. Triceps brachii 
oxygenation was measured by near-infrared spectroscopy. 
Results From Pre- to Post-, peak power output in the RSA was increased (p<0.01) to the same 
extent (29 ± 13% vs. 26 ± 18%, NS) in RSH and in RSN while the number of sprints performed 
was enhanced in RSH (10.9 ± 5.2 vs. 17.1 ± 6.8, p<0.01) but not in RSN (11.6 ± 5.3 vs. 11.7 ± 
4.3). Additionally, the amplitude in total hemoglobin variations during sprints throughout RSA 
rose more in RSH (p<0.01). During TS, power output improved by 11 ± 9% in RSH and 15 ± 
7% in RSN 
Conclusion Our findings reveal greater improvement in the performance of repeated double-
poling sprints, together with larger variations in the perfusion of upper-body muscles in RSH 
compared to RSN. 
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Introduction 
For many years now, coaches and athletes have combined the stress of training with hypoxia to 
elicit even greater physiological adaptations (11, 14, 26, 38, 40). First, using low-intensity aerobic 
exercise designed to enhance oxygen transport; and, more recently, with high-intensity interval-
training or repeated sprints.  
However, a recent review concludes that the additional benefits for sea-level performance of 
intermittent hypoxic training (IHT) compared to similar training under normoxic conditions are 
strikingly small (13). At the same time, three interesting investigations reveal that a novel 
approach involving repeated sprint training in hypoxia (RSH) does provide additional systematic 
benefits in comparison to the same training under normoxic conditions (14, 16, 32).  
Since RSH is based on repetition of “all-out” efforts of short (≤30 s) duration separated by short 
periods of incomplete recovery, the efficiency of this strategy probably depends on the maximal 
intensity of the successive bouts of sprinting (separated by very short periods of recovery) to 
evoke potent adaptations at the molecular level and, possibly, in the delivery of O2 to the 
mitochondria (14). Indeed, the intensity of hypoxic training per se appears to modulate muscle 
performance at the molecular level with “adaptations that compensate for the reduced availability 
of oxygen during exercise”(24). Moreover, the limitation of O2 delivery during exercise triggers 
compensatory vasodilation, shifting blood flow upwards in attempt to maintain sufficient delivery 
of O2 to muscles to an extent dependent on the intensity of the exercise (9).  
Repeated sprints under hypoxic conditions may benefit from such adaptive mechanisms, perhaps 
stimulating the diffusion of O2 into working muscles (9, 14). We have reported that the repeated 
sprint ability (RSA) of trained cyclists improved significantly after as few as 8 sessions of RSH 
(14). In that study, the additional benefit of RSH was thought to involve improved O2 extraction 
by the fast-twitch fibres (FT) (which are those predominantly recruited during sprints (21)) as a 
result of the high-intensity repeated sprinting (27). Greater amplitudes of muscle blood perfusion 
variations suggesting enhanced muscle blood flow supported this hypothesis of a greater O2 
utilization by FT after RSH.  
Accordingly, physical activity involving extensive recruitment of FT may benefit most from RSH. 
Of interest in this context is the fact that upper-arm muscles contain a high proportion of FT 
(25). For example, in professional tennis players, 2/3 of all the fibers in the m. triceps brachii are 
fast-twitch, while the corresponding value for the m. vastus lateralis is only 1/3 (33).  Moreover, in 
elite cross-country (XC) skiers the proportions of FT in the triceps brachii and vastus lateralis are 
48% and 32%, respectively (31).  
Consequently, if RSH improves the extraction of O2 by FT, the benefits seen in trained cyclists 
should certainly occur in XC skiers as well.. During double-poling XC skiing, upper-body 
muscles contribute substantially to power production (23) and even if this sport is thought to be 
primarily aerobic, recent developments include the introduction of shorter racing formats, such 
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as individual and team-sprints. Such events require greater anaerobic capacity and upper-body 
power (34) and, together with the repeated changes in velocity and intermittent sprints that occur 
during mass-start races, underline the decisive role of sprinting ability for the outcome of a 
competition. Clearly, improving RSA may give XC skiers (including top athletes) a competitive 
edge. 
Nonetheless, the potential associated benefits for the ability to repeat sprints in normoxia after 
specific RSH vs. RSN have never been investigated in a randomized, double-blind controlled 
study in XC skiers. We hypothesized that repeated sprint training in hypoxia improves the 
performance of competitive XC skiers more than the same training under normoxic conditions. 
 
Methods 
Subjects. 17 highly trained XC skiers (11 males and 6 females – Table 1) were recruited within 
Swedish national and regional cross-country and biathlon teams to volunteer in this study. 
Subjects were familiar to the double-poling ergometer and to high intensity exercise bouts from 
their usual training practice and competitive background. Subjects were all non-smokers 
lowlanders. None of the subjects were acclimatized or recently exposed to altitude and were not 
exposed to an altitude of more than 500 m during the protocol. Subjects provided their written 
informed consent after the state medical ethics committee approved the experiment (Regionala 
etiksprövningsnämden, Agreement 2013-72-31M, Umeå, Sweden) performed according to the 
Declaration of Helsinki.  
Study design. Experimental protocol consisted in two testing sessions before (Pre-) and after 
(Post-) a specific repeated-sprints training period of two weeks (3 sessions per week). Subjects 
were assigned into a specific training group: repeated sprint training in hypoxia (RSH, n=9, 6 
males, 3 females) or repeated sprint training in normoxia (RSN, n=8, 5 males, 3 females).  
Training protocol Training consisted in six sessions of repeated double-poling sprint over 2 
weeks on a XC ski ergometer including each time 4 sets of 5 sprints of 10 s interspersed with 20 s 
of recovery (Figure 1). Warm up and recovery periods between sets were performed with an 
individualized resistance of 1 W.kg-1. 
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Figure 1 Description of one training session 
 
For all training sessions, subjects wore a comfortable oro-nasal mask allowing normal breathing. 
Subjects breathed either room air (for RSN) or hypoxic air (for RSH) provided via the mask 
through a hose (suspended to the ceiling by a supportive elastic band) connected with a three-
way valve to an altitude simulation device (Altitrainer, SMTech, Nyon, Switzerland). For RSH, 
ambient air was mixed with nitrogen (from pressurized tanks) and inspired oxygen fraction was 
reduced to 13.8 ± 0.1% in order to simulate an altitude of 3000 m. Two independent researchers 
assigned subjects randomly to RSN or RSH with groups matched upon subjects’ peak oxygen 
uptake measured during the team sprint simulation aerobic test in Pre-. Helpers then handled the 
altitude simulation device to provide either normal air or hypoxic air during training by turning 
the three-way valve so that two subjects training simultaneously inspired either air from the 
altitude simulator or from the room in the well-ventilated laboratory at a constant temperature of 
~24 °C. This way, the altitude simulator (with the nitrogen outlet sounding) was running during 
all training sessions. Subjects and investigators were subsequently unable to know if training was 
performed in hypoxia or normoxia and the protocol was run double-blinded. Subjects were asked 
to avoid any strenuous training outside of the protocol but to keep their usual aerobic training 
sessions that were reported in a training diary. 
Subjects filled a questionnaire reporting their physical activity and food and drinks intake during 
the 48 h prior each testing session. During these 48 h, subjects were asked to refrain from any 
training or exhaustive activity. Due to the extreme intensity of the tests, subjects were asked not 
to report to the laboratory on an empty stomach. A standard breakfast (bread with jam and 
water) was therefore advised. Subjects were asked to reproduce the last meals avoiding alcohol 
and caffeine intakes during the 24 h before each test. A preliminary visit allowed subjects to 
familiarize with the ergometer by completing a 15 min trial including two times 3 repeated sprints 
of 10 s. 
10 s all-out 
sprints 
20 s active  
recoveries  
 1    2     3    4    5                    6     7    8    9   10                          11   12  13  14  15                  16  17  18   19  20 
Warm up       
10 min @ 
1W/kg 
Recovery 
9’50’’ 
@1 W/kg      
Recovery 
4’50’’  
@1 W/kg      
Recovery 
9’50’’  
@1 W/kg      
Recovery 
4’50’’  
@1 W/kg      
0min           10min      17min          29min   36min                                             48min
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Performance tests 
Repeated sprint ability test RSA was tested with 10 s all-out double-poling sprints repeated with 
incomplete recoveries of 20 s until task failure. 
Subjects first performed a 4 min 50 s aerobic warm-up at 1 W.kg-1followed by an isolated 10 s all-
out sprint, 4 min 50 s active recovery at 1 W.kg-1and a second isolated 10 s all-out sprint. After 10 
min passive recovery seated (including 5 min with the right arm kept still to calibrate the NIRS 
device) the RSA test started with 1 min at 1 W.kg-1before the first sprint. 
Subjects were given very strong verbal encouragement to perform as many sprints as possible 
until task failure. Task failure was set at 70% of the highest peak power reached. Subjects were 
given a warning when they did not reach that value the first time and the test was ended the 
second time. Subjects were not told the criterion for task failure or any indication on the number 
of sprints performed. In addition, to avoid any protective pacing strategy, peak power during the 
first two sprints was requested to reach at least 95% of the best peak power of the two isolated 
sprints, which was the case in all subjects. Unfinished sprints (subjects not being able to pull 
anymore) were not taken into consideration. 
Team sprint simulation aerobic test Exactly 45 minutes after the end of the RSA test, subjects were 
asked to warm-up again by completing three incremental steps of 4 min at 1, 1.5 and 2 W.kg-1. 
Then, after additional 5 min passive rest, subjects were asked to perform a team sprint simulation 
(TS) consisting of 3 bouts of 3 min all-out interspersed with 3 min active recovery at 0.5 W.kg-1. 
Strong verbal encouragement was given throughout the test and poling frequency was instructed 
to be as high as possible all time to elicit maximal all-out performance. Information about elapsed 
time was only given during the final minute every 15 seconds in order to prevent pacing and 
further motivate subjects. A peak in oxygen consumption (!!!!"#$ ) was calculated as the 
highest 30 s average value during the test. Although residual fatigue from the RSA test was 
probable, TS was performed for all subjects at the same moment of the testing sequence allowing 
for a good comparison of subjects’ aerobic capacity (average power of all 3 min bouts). 
Equipment and measured variables A specially designed double-poling ergometer (SkiErg, 
Concept2, Morrisville, USA) was used for all training sessions and performance tests. The 
ergometer is equipped with cross-country ski handles and straps (Leki, Kirchheim, Germany). 
Power is produced by pulling cords spinning a wind resistance flywheel. A damper located on the 
flywheel housing controls the airflow and thus the necessary work to accelerate the flywheel 
during each stroke. The flywheel deceleration rate (called drag factor by the manufacturer) 
displayed digitally on the ergometers interface was used to set and reproduce the resistance 
individually for each test and training session. Drag factor was set at 130% and 110% of body 
weight in male and female subjects, respectively. To simulate natural XC skiing double-poling 
movement subjects stood with their own cross-country ski boots in bindings screwed in a 
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wooden plate. The distance between the bindings and the ergometer was freely chosen by the 
subjects to mimic their habitual position and reproduced for each test and training session. A 
wide belt around subjects’ hips was additionally attached to the wall behind them with an elastic 
band in order to induce some resistance at the hips to better simulate the double-poling sprinting 
movement (Figure 2). 
 
Figure 2 Ergometer setup for cross-country ski double-poling 
 
The ergometer displays instantaneous power output and cycle frequency for each stroke that 
were recorded externally in a spreadsheet (Excel, Microsoft, Redmond, USA) using a Microsoft 
ActiveX® software component to extract data live. 
A peak in oxygen consumption (!!!!"#$) was determined during TS in Pre- and Post- with an 
ergospirometry device (AMIS 2001, Innovision A/S, Odense, Denmark) as the highest 30 s 
average measured.  
Muscle oxygenation, blood lactate, blood pH, hematocrit, blood hemoglobin concentration, 
arterial oxygen saturation, heart rate and rate of perceived exertion were measured at rest and at 
the end of each performance test as well as during the first and sixth training session (at rest and 
after the final sprint). 
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Muscle oxygenation was measured using a near-infrared spectroscopy (NIRS) technique as 
described elsewhere (5). The NIRS device (Portamon, Artinis, Zetten, The Netherlands) was 
used to measure changes in muscle oxygenation by placing a triple optode sensor on the muscle 
belly of the right arms m. triceps brachii with an interoptode spacing of 40 mm. The probe was 
protected with a thin transparent plastic sheet and then attached to the skin with double-sided 
tape and firmly fastened with an opaque cotton elastic band wrapped around subjects’ arm.  
Position of the probe was marked during Pre- with a permanent pen for accurate repositioning. 
Differential pathlength factor (DPF) was set to 3.79 and 4.67 in male and females respectively 
(12). All signals were recorded with a sampling frequency of 20 Hz. They were down sampled at 
10 Hz using Matlab (Matlab Software, Nattick (MA) USA) routine resample. Then a 10th-order 
low-pass zero-phase Butterworth filter (cutoff frequency 0.1 Hz) was applied to the resampled 
signals in order to remove possible artifacts and smooth the movement-induced perturbations. 
Automatic detection of the start and end times of the successive sprints was obtained by 
estimating the filtered deoxyhemoglobin signal upper and lower envelopes using local minima 
and maxima in a sliding window of length 400 samples (4 s). The starting and end times were 
obtained as the times of contact between the envelopes and the signal. This allowed the 
determination of maximum and minimum for each signal during the successive sprint and 
recovery phases. Concentrations for oxyhemoglobin ([O2Hb]), deoxyhemoglobin ([HHb]) and 
total hemoglobin/myoglobin ([tHb]) were recorded. Since [HHb] values were proposed to be less 
sensitive than [O2Hb] to blood flow variations (10) and changes in O2Hb signals might be 
confounded by rapid blood volume changes during sprints (6) only [HHb] and [tHb] were 
analyzed for relevant interpretations. Differences between maximum and minimum 
concentrations were defined as the amplitude of the variation for each sprint (∆[tHb] and 
∆[HHb]) and ∆[tHb] was used as an index of blood perfusion (14). Thus, for example, at the 
beginning of each sprint a maximum in [tHb] is observed at the beginning of each sprint (i.e. end 
of each recovery period) and [tHb] decreases to reach a minimum value at the end of each sprint. 
The concentration recorded during a 3-min seated rest with no arm movement was set as 100% 
for standardization (Fig. 4). So amplitudes for each sprint (i.e. ∆[tHb] and ∆[HHb]) and the 
average value for all sprints throughout the RSA test (i.e. ∆[tHb]av and ∆[HHb]av ) were 
calculated.  
Surface electromyography (EMG) signals were recorded from the triceps brachii, latissimus dorsi, 
rectus abdominis, and soleus muscles from one side of the body (randomized, right or left) using 
surface electrodes (Ambu A/S, Ballerup, Denmark), TeleMyo 2400 T G2™ data logger 
(Noraxon, Cologne, Germany) and MyoResearch XP Master Edition® Software V.1.08.27 
(Noraxon, Scottsdale, USA). Surface electrodes (Ambu® Blue Sensor N, Ambu A/S, DK) were 
positioned with 20 mm of inter-electrode distance on the prepared skin (impedance<5kΩ) after 
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muscle belly identification by palpation of the contracted muscle and marked for proper 
repositioning during Post- testing. Athletes performed a series of previously practiced 5 s 
maximal isometric voluntary contractions (MVC) to normalize the data to each individual. Prior 
to calculation of EMG variables, all raw signals were processed first to determine the MVC using 
the IIR filter with a bandpass 20 – 400 Hz Butterworth approximation, then treated with a EMG 
reduction in the latissimus dorsi channel, followed by RMS smoothing with a window of 100ms, 
and amplitude normalization to the peak value with a window of 250ms. Calculations were 
performed to assess the mean amplitude expressed in % of MVC during both performance tests. 
Analyses of the RSA included calculation of the average of all cycles performed during each 10 s 
sprint period. 30 s averages were used for the analysis of the TS data.  
Blood lactate concentration was measured using a Biosen lactate measurement device (C-Line 
Sport, EKF Industrial Electronics, Magdeburg, Germany) from 20 µL fingertip capillary blood. 
Blood pH, haematocrit, haemoglobin concentration and arterial oxygen saturation (SO2) were 
assessed by collecting 20 µL earlobe capillary blood analysed immediately in a blood analyser 
(ABL800 CO-OX Flex, Radiometer, Copenhagen, Denmark). Heart rate was recorded at 1 Hz by 
telemetry (RS800, Polar OY, Kempele Finland). Rate of perceived exertion was assessed for the 
legs, the arms and breathing using a 6-20 Borg scale. 
Statistical analyses Data are presented as mean (SD). Performance and blood perfusion 
changes during RSA test were first evaluated with a 2-way (training group x sprint number) 
general linear model repeated-measures ANOVA with all pairwise multiple comparison 
procedures (Holm-Sidak method). Performance improvement, muscle oxygenation during RSA, 
blood lactate and other single variables test were then evaluated with 2-way (training group x time 
(Pre- vs. Post-)) general linear model repeated-measures ANOVAs with all pairwise multiple 
comparison procedures (Holm-Sidak method). All analyses were made using Sigmaplot 11.0 
software (Systat Software, CA, USA). Null hypothesis was rejected at p<0.05. 
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Results 
Total work and training intensity during supervised training were similar during RSN and RSH 
(Table 2). In addition to specific training in the laboratory, subjects completed a similar amount 
of aerobic training between Pre- and Post- of 16.6 ± 6.6 h and 16.3 ± 6.5 h in RSH and RSN, 
respectively. Total hypoxic exposure was 4.8 ± 0.2 h in RSH. 
RSA Performance .  Performance results at Pre- and Post- are summarized in Table 3. No 
significant differences between groups were observed in any variable in Pre-. During the RSA 
test, peak power output (29 ± 13% vs. 26 ± 18%, NS) and likewise the average power of all 
sprints (18 ± 16% vs. 22 ± 14%, NS) increased (p<0.01) to the same extent from Pre- to Post- in 
RSH and in RSN. The number of sprints prior to exhaustion was increased in RSH (from 10.9 ± 
5.2 to 17.1 ± 6.8, p<0.01) but not in RSN (11.6 ± 5.3 and 11.7 ± 4.3, NS) (Figure 3). In Post-, 
compared to Pre-, 10-s peak power in the successive sprints was significantly improved till the 
fifteenth sprint in RSH and till the eleventh in RSN. Significant group (RSH vs. RSN) by time 
(Pre- vs. Post-) interactions were found in the number of sprints (F=11.22; p=0.004) and total 
work (F=8.11; p=0.01) performed during the RSA test. 
Isolated 10-s sprint peak power output and TS performance increased (p<0.01) similarly in RSH 
and RSN (Table 3). 
Muscle  oxygenat ion.  Successive values in ∆[tHb] during the RSA test are displayed in Figure 4. 
After training, ∆[tHb]av increased to a greater extent (F=35.9, p<0.001) in RSH (from 212 ± 12% 
to 713 ± 21%, Pre- to Post-) than in RSN (from 186 ± 19% to 361 ± 30%, Pre- to Post-) (Figure 
4B). From Pre- to Post-, ∆[HHb]av increased significantly in RSH (+225%, p<0.01) but decreased 
in RSN (-27 %, p<0.01). There was a significant training group x time interaction for ∆[HHb]av 
(F=551.8, p<0.001) .  
Surface Elec tromyography.   From Pre- to Post-, the mean amplitude of the activity of all 
muscles taken together (expressed as the sum of the % of MVC of all muscles) did not change in 
RSA test neither in RSH (119.1±22.2 vs. 121.6±17.7%, NS) nor in RSN (118.2±27.7 vs. 
121.3±76.2%, NS). Similarly, the mean amplitude (all 3-min bouts taken together) did not change 
during TS neither in RSH (205.8 ± 76.0 vs. 216.9 ± 69.6%, NS) nor in RSN (204.0 ± 49.8 vs. 
176.0 ± 34.0%, NS). 
! !
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RSN (n=8) RSH (n=9) 
 
Pre- Post- Pre- Post- 
Body mass (kg) 74.7 ± 7.8 74.7 ± 7.6 72.2 ± 7.0 72.3 ± 7.1 
Hematocrit (%) 46.0 ± 3.2 45.7 ± 2.3 46.5 ± 2.0 46.1 ± 1.8 
Hemoglobin (g.l-1) 154 ± 13 152 ± 15 156 ± 7 152 ± 12 
VO2peak (l
.min-1) 4.2 ± 0.8 4.0 ± 0.8 4.1 ± 0.6 4.2 ± 0.7 
Table 1 Subjects’ characteristics before (Pre-) and after (Post-) repeated sprint training in normoxia (RSN) 
or in hypoxia (RSH). 
VO2peak, peak oxygen consumption 
 
 
RSN RSH 
Total work of all training sessions (kJ)  1290 ± 197 1335 ± 137 
Mean peak power output (W) 482 ± 149 481 ± 131 
Mean heart rate (bpm) 149 ± 11 144 ± 13 
Mean SO2 after last sprint of each session (%) 94.3 ± 1.3 86.0 ± 4.2# 
Mean RPE « Arms » 17.6 ± 0.7 16.9 ± 1.1 
Mean RPE « Legs » 16.7 ± 1.4 17.0 ± 1.8 
Mean RPE « Breathing» 18.3 ± 0.4 18.0 ± 1.0 
Table 2 Parameters measured during supervised training in the normoxic (RSN) and hypoxic (RSH) 
training groups 
SO2, Arterial oxygen saturation ; RPE, Rate of perceived exertion (Borg 6-20 scale). p<0.01 for difference 
with RSN 
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RSN RSH 
 
Pre- Post- Pre- Post- 
Single 10-s sprint average power (W) 441 ± 153 539 ± 158** 421 ± 122 534 ± 123** 
RSA Peak Power (W) 437 ± 156 532 ± 158** 415 ±117 528 ± 121** 
RSA Best average power (W) 365 ± 124 440 ± 128** 350 ± 91 437 ± 98** 
RSA Mean power of all sprints (W) 315 ± 107 376 ± 111** 308 ± 94 352 ±78** 
RSA Total work of all sprints (kJ) 33.1 ± 11.9 42.0 ± 16.6 30.6 ± 12.8 58.8 ± 24.4**# 
RSA [La] (mmol.l-1) 11.0 ± 2.5 12.6 ± 2.1 11.1 ± 2.0 12.3 ± 2.9 
RSA SO2 (%) 93.2 ± 0.8 93.6 ± 1.4 94.2 ± 1.2 93.5 ± 2.2 
RSA Blood pH 7.23 ± 0.04 7.22 ± 0.06 7.21 ± 0.05 7.22 ± 0.04 
3x3- average power (W) 218 ± 62 239 ± 64** 219 ± 49 240 ± 46** 
3x3- average power during first minute (W) 239 ± 64 264 ± 69** 243 ± 49 272 ± 50** 
3x3- stroke rate (‘.min-1) 60 ± 4 57 ± 4 64 ± 8 62 ± 9 
3x3- [La] (mmol.l-1) 11.7 ± 3.0 11.9 ± 2.8 13.1 ± 2.2 14.1 ± 2.9 
Table 3 Performance results before (Pre-) and after (Post-) repeated sprint training in normoxia (RSN) or 
in hypoxia (RSH) 
RSA, repeated sprint ability test; [La] Blood lactate concentration; SO2 Oxygen saturation. RSA 
parameters measured immediately after repeated sprint test. 
3x3, 3 times 3-min all-out team sprint simulation 
** p< 0.01 for difference with Pre- # p<0.05 for difference with RSN 
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Figure 4 Peak power output (W) in successive sprints during the repeated sprint test before  (Pre-) and 
after (Post-) specific repeated sprint training in hypoxia (RSH, A) or in normoxia (RSN, B) 
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Figure 5 ∆[tHb]: successive changes in total hemoglobin concentrations’ amplitude during sprints 
(expressed in percent compared to the resting baseline set to 100%) measured by near infrared-
spectroscopy (A) and ∆[tHb]av: average of all changes during the repeated sprint test to exhaustion (B) 
before (Pre-) and after (Post-) the specific repeated sprint training in hypoxia (RSH), in normoxia (RSN) 
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Discussion 
The main finding of the present investigation was that with competitive XC skiers repeated 
double-poling sprint training in hypoxia (involving large upper body muscle groups) resulted in 
greater improvement in repeated sprint performance than analogous normoxic training (RSN). 
Secondly, the amplitude of variations in blood perfusion during sprints increased to a greater 
extent in RSH than in RSN. And third, these differences were specific to repeated sprinting, i.e., 
performance in connection with an aerobic simulated team sprint is enhanced to a similar degree 
by RSH and RSN. 
The present study confirms the potential of RSH as an innovative hypoxic training in line with 
similar benefits and underpinning mechanisms recently reported in cyclists (14). Interestingly, 
RSH in XC skiers appeared to delay fatigue during a RSA test with 58% more sprints performed 
after training. This represents a 20% greater benefit in sprint repetition compared to the results 
reported in cycling in a strictly similar RSA test (10s:20s) (14). While the cyclists in the latter 
performed sprints to exhaustion, XC skiers in this study were stopped during RSA when maximal 
power output during sprinting did not reach 70% of the best sprint anymore. In fact, this 
threshold was similar in the cycling study so it can be argued that RSH in XC skiers was more 
efficient than in cyclists. This was expected since we hypothesized that the maximal solicitation 
of FT during sprints in RSH would challenge adaptive mechanisms at the muscular level for 
sufficient O2 extraction/delivery. With a higher proportion of FT in upper arms muscles (31, 33) 
contributing greatly to power production during double-poling (23), the mechanism of 
compensatory vasodilation particularly important in FT when O2 tension falls (9) is enhanced 
after RSH and may explain why fatigue was more delayed during RSA in XC skiers than in 
cyclists. 
Interestingly, a recent update of the current panorama of the hypoxic training methods now 
distinguishes RSH from traditional IHT methods, predominantly based on other expected 
adaptive mechanisms (e.g., improvement of the muscle oxidative or buffering capacities) (29). 
Indeed, a current review questioned the efficiency of IHT and highlighted that out of 20 studies 
involving IHT, only 4 bring additional benefits in performance-related variables compared to 
similar training in normoxia (13).  
We hypothesized that cross-country double-poling would substantially benefit from fiber-type 
selective mechanisms allowing a better O2 extraction by FT after RSH since upper body muscles 
are largely contributing to power production (23) and especially upper arms muscle comprising a 
high proportion of FT (25, 31, 33).  
Mechanistically, the increase in cardiac output (!) tightly matches the O2 delivery by elevating 
blood flow and interestingly the rise in ! is mainly regulated by peripheral vasodilation changes 
(with less importance of HR increase) (2). Then, high-intensity intermittent training (e.g., knee-
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extension) was reported to increase the capacity for maximal exercise vasodilation by 20-30% (8). 
The latter may in turn explain partly the two-fold higher amplitude of blood perfusion variations 
observed after RSN (Fig. 4B). While vascular conductance may not be a limitation to O2 
transport to the thigh muscle (1), arm muscles may incur a blood flow limitation when other 
muscles are involved during the exercise (39) like during intense double-poling exercise known to 
recruit greatly upper body muscles but also trunk and leg muscles (23). This hypothesis is in 
accordance with the vasoconstrictor signals opposing the vasodilatory metabolites observed 
during upright whole body exercise (7). 
Furthermore, hypoxia per se was shown to increase blood flow and vascular conductance during 
exercise with a regulation by the carotid chemoreceptors (35). Consequently, the three-fold 
increase in arm muscle (triceps brachii) perfusion variations during repeated sprinting observed 
after RSH (Fig. 4B) indicates the cumulative role of hypoxia possibly challenging to a further 
extent the adaptations observed in RSN. Accordingly, a recent study reported a 16% increase in 
arm blood flow and 6% in arm O2 extraction after prolonged low-intensity (60% of max HR) 
training (4). Since FT have been shown to optimally increase their fraction O2 extraction during 
intensive exercise (27), RSH may thus recruit FT maximally and maximize vascular conductance 
and O2 extraction to delay fatigue during subsequent RSA in normoxia. 
However, the NIRS measurement methods allowed to record local variations in total 
hemoglobin/myoglobin content (∆[tHb[) in the muscle, thus reflecting blood perfusion and 
possibly blood flow variations (19, 37). So this method provided only an indirect estimation of 
muscle perfusion variations (and thus blood flow) and our interpretations should be considered 
with care. Nevertheless, the gains in the amplitude of the variations after RSH were far higher 
when measured here in m. triceps brachii compared to m. vastus lateralis we reported recently (14). 
Eventually, the latter is in accordance with our hypothesis that performing RSH in activities 
soliciting more FT fibers (e.g., cross country double-poling with the upper body comprising more 
FT (21)) would potentiate larger benefits in RSA performance gains.  
In addition, we stated that the exercise-to-rest ratio play an important role in the putative benefits 
following RSH (28) because it modifies the energetic contribution of glycolysis and the FT 
recruitment/activation during high intensity exercise (3, 36). Then the rate of post-sprint 
phosphocreatine (PCr) resynthesis is paramount for maintaining power production during 
sustained RSA (17). If RSH allows increasing muscle blood perfusion and vascular conductance 
as mentioned above, it may in turn also elevate locally microvascular PO2 that is known to reduce 
PCr breakdown and speed up PCr resynthesis (20). Since hypoxia per se was shown to modulate 
PCr recovery (22), RSH may accordingly optimally delay fatigue during RSA if an optimal 
exercise-to rest ratio is found. In addition, the lack of differences in both groups from Pre- to 
Post- in the surface electromyography measurements supports the hypothesis of an improved 
metabolic glycolytic activity rather than higher power outputs due to greater recruitment of 
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motor units. Besides, the lack of difference in the aerobic team sprint test between RSH and RSN 
illustrated that a prolonged intense effort (that is more aerobic by definition) does not benefit to 
the same extent from RSH with the lesser activation of FT. However, we point out that both 
isolated sprint and team sprint were improved similarly after RSH and RSN and that there is no 
down-regulation in maximal anaerobic alactic or aerobic exercises after RSH.  
Finally, a recent study investigated different severity of the hypoxic stress (e.g., at simulated 
altitude of 2000, 3000 and 4000 m) highlighting that “the higher may not be the better” in the 
training quality for RSH to improve of repeated sprint performance (18). Further studies could 
consequently focus on the exercise-to-rest ratio to optimize RSH benefits and find the optimal 
balance between maximal exercise intensity and the added hypoxic stress. So far, we can only 
observe that the chosen simulated altitude (e.g., normobaric hypoxia) of 3000 m appears 
providing a stimulus large enough for inducing additional benefits in RSH. One cannot rule out 
that in hypobaric hypoxia the adaptations would be even higher (30) since we reported different 
responses in nitrosative and oxidative stress between normobaric and hypobaric hypoxia at 3000 
m (15).  
In conclusion, our present findings demonstrate for the first time that greater improvement in 
the performance of repeated double-poling sprints can be attained with RSH compared with 
RSN with larger variations in the perfusion of active muscles in the former. This adds to the 
accumulating evidence that RSH represents a promising and potent training strategy promoting 
repeated-sprint performance enhancement by adding a hypoxic stress to repeated-sprint training. 
However, further examination is required to confirm that the underlying mechanisms are fiber- 
specific as well as to firmly establish the potential of such training to improve the performance of 
team sports. We propose that by including RSH sessions in their training regimen, XC skiers can 
improve their work capacity during sessions of repeated sprints. 
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Abstract 
Over the past two decades, intermittent hypoxic training (IHT), that is, a method where athletes 
live at or near sea level but train under hypoxic conditions, has gained unprecedented popularity. 
By adding the stress of hypoxia during ‘aerobic’ or ‘anaerobic’ interval training, it is believed that 
IHT would potentiate greater performance improvements compared to similar training at sea 
level. A thorough analysis of studies including IHT, however, leads to strikingly poor benefits for 
sea-level performance improvement, compared to the same training method performed in 
normoxia. Despite the positive molecular adaptations observed after various IHT modalities, the 
characteristics of optimal training stimulus in hypoxia are still unclear and their functional 
translation in terms of whole-body performance enhancement is minimal. To overcome some of 
the inherent limitations of IHT (lower training stimulus due to hypoxia), recent studies have 
successfully investigated a new training method based on the repetition of short (<30 s) ‘all-out’ 
sprints with incomplete recoveries in hypoxia, the so-called repeated sprint training in hypoxia 
(RSH). The aims of the present review are therefore threefold: first, to summarise the main 
mechanisms for interval training and repeated sprint training in normoxia. Second, to critically 
analyse the results of the studies involving high-intensity exercises performed in hypoxia for sea-
level performance enhancement by differentiating IHT and RSH. Third, to discuss the potential 
mechanisms underpinning the effectiveness of those methods, and their inherent limitations, 
along with the new research avenues surrounding this topic. 
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Introduction 
Prolonged altitude sojourns using the ‘live high-train high’ or the ‘live high-train low’ models1 ,2 
have been increasingly used in athletes involved in endurance and, more recently, in intermittent 
(eg, team and racket sports) disciplines in an attempt to gain a competitive edge.2 ,3 However, the 
question as to how effectively prolonged altitude exposure can improve athletic performance and 
its underpinning physiological mechanisms and signalling pathways remains contentious.4 ,5 
Over the past two decades, intermittent hypoxic training (IHT), that is, a method where athletes 
live at or near sea level but train under hypoxic conditions, has gained large popularity. Hence, 
IHT presents the advantages of minimal travel and relatively low expense and causes limited 
disruption to the athletes’ normal training environment and lifestyle. Another advantage is that it 
also avoids the deleterious effect (decreased muscle excitability) of an extended stay in altitude.6 
By adding the stress of hypoxia during ‘aerobic’ or ‘anaerobic’ interval training (INT), it is 
believed that IHT would potentiate greater performance improvements compared to similar 
training at sea level. For long, erythrocytosis was believed to be the primary factor benefiting 
putative sea-level performance improvement after a sufficient (several weeks) hypoxic stimulus.4 ,5 
,7 However, IHT viewed this from a new perspective with evidence that exercising even for a 
short period in hypoxia affects a large number of genes mediated by hypoxia-inducible factors 
(HIFs)8 and the exercise performance with muscular adaptations arising (and not necessarily an 
improved oxygen carrying capacity).9–12 Nevertheless, in other IHT studies, any potentiating effect 
of hypoxia in addition to training was ambiguous.3 ,13–16 Although an improvement in anaerobic 
performance after IHT has been mentioned in four studies,17–20 it is noteworthy that these studies 
were ‘uncontrolled’, and therefore the effects of training cannot be distinguished from those of 
hypoxia.13 As such, it seems that after decades of research, “IHT does not increase exercise 
performance at sea level in endurance athletes any more than simply training at sea level.”21 
Until now, only scarce literature has assessed the potential benefits of altitude training in 
intermittent sports.16 ,22 ,23 Therefore, the relevance of altitude training in team-sport athletes for 
improving players’ specific fitness (repeated sprint ability (RSA)) has not been scientifically 
sounded as yet. Team-sport players (eg, football) perform a large number of high-intensity 
actions, including numerous sprints, often with incomplete recoveries, during the course of a 
game. As a consequence, developing their ability to repeatedly perform intense exercise bouts for 
sustained periods is important for crucial match actions.24 For example, failure to recover after a 
sequence of intense actions may leave the team more vulnerable defensively by decreasing the 
chances to reach passes or increasing the time to take up a defensive position (tackles). Sport-
specific training methods for team sports using the stress of hypoxia as a strong additional 
stimulus with specifically designed training models are arguably promising methods. For instance, 
repeated sprint training in hypoxia (RSH), defined as the repetition of several short (≤30 s) ‘all-
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out’ exercise bouts in hypoxia interspersed with incomplete recoveries (exercise-to-rest ratio 
<1:4), could be considered as such a sport-specific training strategy. Although RSH could be 
considered as a form of IHT, its efficacy is presumably based on different mechanisms than on 
the existing IHT methods (discussed below), therefore justifying the addition of the RSH 
modality in the altitude training nomenclature.25 
The aims of the present review are threefold: first, to summarise the main mechanisms for INT 
and repeated sprint training in normoxia (RSN). Second, to critically analyse the results of the 
studies involving high-intensity exercises performed in hypoxia for sea-level performance 
enhancement by differentiating IHT and RSH. Third, to discuss the potential mechanisms 
underpinning the effectiveness of those methods, and their inherent limitations, along with new 
research avenues surrounding this topic. 
A computer-based literature search was conducted in April 2013 using the PubMed electronic 
database using combinations of specific keywords: ‘altitude’, ‘hypoxic’, ‘training’, ‘intermittent 
hypoxia’, ‘repeated sprints’, ‘interval training’, ‘exercise’ and ‘performance’. Recently, an 
international consensus group of the IOC26 underlined the further need “to study the effects of 
training in hypoxia and live high-train low modalities on performance at sea level, low and 
moderate altitude using a placebo-controlled double-blind design.” Well aware of the 
methodological issues (ie, importance of ruling out placebo effects21 ,27) pertaining to the 
conclusion of some altitude training studies, the present review is limited to studies including a 
control (CON) group in their experimental design, allowing the effects of training and hypoxic 
stimulus to be clearly differentiated. 
INT versus RSN 
The efficiency of INT28 ,29 has been investigated extensively. It can broadly be subdivided into (1) 
short or long aerobic28 versus anaerobic29 INT and (2) short or long intervals versus sprint 
intervals.30 INT consists of ‘repeated short-to-long bouts of rather high-intensity exercise 
interspersed with recovery periods’.28 While any INT session will naturally challenge the 
metabolic and neuromuscular systems, it is beyond the scope of this review to detail all the 
stressed factors.24 ,30–32 However, we support the recent statement that “the cardiorespiratory (ie, 
VO2) data, but also cardiovascular work, stored energy and cardiac autonomic stress responses 
are the primary variables of INT”, whereas “anaerobic glycolytic energy contribution and 
neuromuscular load/musculoskeletal strain are secondary.”30 Indeed, the expected benefits of 
INT are primarily to maximise VO2max and therefore cardiac output and the arterial-mixed venous 
oxygen difference32 as well as the VO2 kinetics,
31 which are important determinants of endurance 
performance. Overall, INT performed at intensities33 and exercise-to-rest ratios34 that elicit 
maximal volume and pressure overloads on the myocardium and VO2 responses near maximal 
oxygen uptake (VO2max) are quite likely optimal in terms of cardiac output, blood flow, shear 
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stress, recruitment and increased oxidative capacity of fast twitch (FT) fibres. This imposes the 
need to maintain the longest time >90% VO2max.
35 
During repeated sprints in normoxia, the factors responsible for the performance decrements (eg, 
decline in sprint speed/power across repetitions) include limitations to energy supply (eg, 
phosphocreatine (PCr) resynthesis and aerobic and anaerobic glycolysis), metabolite 
accumulation (eg, inorganic phosphate, Pi; hydrogen ion, H+) and neural factors (eg, neural drive 
and muscle activation).36 ,37 Among these factors, the ability to resynthesise PCr is probably the 
central determinant of RSA. Hence, the oxidative pathway is essential for the PCr resynthesis 
rate,38 and the decrease in PCr concomitant to the rise in Pi and AMP stimulates the anaerobic 
glycolytic contribution at the start of a sprint. If the increase in H+ accumulation is also known to 
impair RSA, recent findings39 suggest that this fitness component is determined to a larger extent 
by the muscle energy supply (eg, short-term (<1 min) PCr resynthesis rate) than by the H+ 
removal. 
In team sports, the clinical relevance of improving RSA is debated,40 but it is a common belief 
that such adaptations would be beneficial for improved match-related physical performance. For 
instance, the mean time recorded during an RSA test predicts the distance of high-intensity 
running and the total sprint distance during a professional football match.41 Furthermore, football 
players experience temporary fatigue during a game (eg, lower amount of sprinting, high-intensity 
running and distance covered after a sequence of repeated and intense actions), which may 
determine the outcome of crucial situations (eg, decreased technical and tactical behaviour and 
wrong cognitive choices).42 ,43 This suggests that improving RSA would maximise team-sport 
physical performance and that it is important to better understand training strategies that can 
enhance this fitness component. 
Although the brief description above of the main determinants of INT versus RSN highlights 
that those training methods aim at developing predominantly the aerobic pathway and RSA, 
respectively, the practical question of their optimal combination in team sports is widely 
debated37 ,44 with two diverging approaches45; that is, an integrative ‘mixed’ method mainly based 
on IHT/RSN37 contrasting with an ‘isolated’ method based on the parallel development of 
maximal aerobic speed and maximal sprinting speed.44 The same debate was translated within the 
area of the optimal use of hypoxic training in team sports3 ,15 and needs to better describe the 
main adaptive mechanisms of IHT and RSH. This is the objective of the next sections. 
Current trends: Is it time to move beyond IHT? 
Performance improvement with IHT 
In table 1, we report 23 controlled studies (ie, 20 IHT and 3 RSH) including training protocols 
performed in hypoxia versus normoxia. Interestingly, an additional benefit on performance-
related variables of IHT compared with the same training performed in normoxia is present in 
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only four of those studies. First, Martino et al48 reported a faster 100 m swim time and larger 
improvement in peak power output during an arm Wingate test after 21 days of training 
including swim sprints at an altitude of 2800 m, compared to sea level. Since a detailed 
description of the training sessions is not available, the mechanisms inducing additional hypoxia-
related benefits cannot be ascertained. Second, Hendriksen and Meeuwsen54 highlighted a 5% 
increase in peak power output during a Wingate cycling test after 10 days of aerobic training in 
hypobaric hypoxia, while performance in the normoxic training group did not change. Third, 
Dufour et al59 reported an improved endurance performance capacity in competitive distance 
runners after 6 weeks of high-intensity aerobic training at 3000 m (ie, 5% increase in their VO2max 
and 35% longer time to exhaustion running at a speed associated with VO2max), but not 
performance change in the group training in normoxia. Finally, Manimmanakorn et al23 reported 
in one of the few studies conducted with team-sport athletes that a knee extension/flexion IHT 
performed over a 5-week period provided an additional benefit for improving maximum 
voluntary contraction torque during prolonged leg extensions. A remarkable observation across 
the above-listed studies is that the additional benefits of IHT seem to be partly related to an 
upregulation of the glycolytic potential and to an increased anaerobic capacity (eg, larger increase 
in Wingate performance). These adaptations might help athletes engaged in intermittent sports to 
improve their match-related performance. 
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Besides, in another study conducted with team-sport athletes, similar improvements in aerobic 
and anaerobic power outputs were observed when training was performed in hypoxia and 
normoxia.16 Other well-designed controlled studies highlighted the benefits of IHT on aerobic 
performance but failed to demonstrate an additional benefit of conducting the training in a 
hypoxic environment.46 ,55 ,57 ,58 ,66 With the many different training strategies and methods 
available, the possibility that IHT might “enhance endurance performance when subsequent 
exercise is conducted in hypoxia” in football players as stated in a recent comprehensive review3 
was therefore questioned by our team.15 
Physiological mechanisms and limitations of IHT 
IHT is quite likely to have a minimal effect on erythropoiesis since a large ‘hypoxic dose’ is 
required for significantly “stimulating the erythropoietic pathway to the point that it enhances 
post-altitude sea-level endurance performance.”4 ,5 In support of this assumption, previous IHT 
studies failed to observe any significant change in the total haemoglobin mass, red cell volume or 
any other red cell indices compared with a CON group62 ,67 (see ref. 2 for further discussions). 
Compared with sea-level training, IHT has the potential to induce a further physiological strain68 
and specific molecular adaptations,11 ,12 ,69 though not necessarily associated with improved 
exercise capacity. The rationale of using IHT relies on the hypothesis that these muscle 
adaptations surpass those triggered by normoxic exercise. In particular, the lower partial pressure 
of oxygen (PO2) in muscle tissue during IHT when compared with INT would lead to a larger 
upregulation of HIF-1ử.11 ,12 ,62 In untrained or moderately-trained participants, muscular 
adaptations occurring in response to IHT include—but may not be limited to—an increased 
citrate synthase activity, mitochondrial density, capillary-to-fibre ratio and fibre cross-sectional 
area as well as upregulation of factors of mitochondrial biogenesis or enzymes implicated in 
carbohydrate and mitochondrial metabolism, oxidative stress defence and pH regulation.10 ,11 ,47 ,52 
,59 ,70 ,71 However, as stated recently,9 one may question the functional significance of these 
physiological adaptations (eg, larger increase in citrate synthase activity in IHT than in INT) since 
the effects of IHT on endurance performance measured in normoxia are ‘minimal and 
inconclusive in trained athletes’.21 
Several authors have reported additional adaptations potentially favourable to high-intensity 
exercises. These include improvements in muscle O2 homeostasis and tissue perfusion induced 
by improved mitochondrial efficiency, control of mitochondrial respiration,71 ,72 angiogenesis73 
and muscle buffering capacity.74 However, the translation into enhanced performance is not 
always observed and when it does occur, it may be irrelevant for team sports. Hence, non-
specific IHT protocols or inappropriate performance tests—that is, evaluating endurance 
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capacity (with VO2max tests or time trials) but neglecting indices of match-related performance 
such as RSA—have been mainly conducted so far. 
With the exception of studies performed at an intensity corresponding to the second ventilatory 
threshold,12 ,59 ,72 where the increased expression of factors involved in glucose uptake, oxidative 
stress defence and pH regulation was associated with an increased endurance performance 
capacity, most of the IHT studies (including those with some muscle adaptations) did not report 
any additional performance benefit of IHT over INT. In untrained participants, the effect of 
training seems to predominate, overwhelming any additional effect of hypoxia.75 Furthermore, 
Levine75 convincingly argued that, compared to similar training in normoxia, IHT quite likely 
induces a lower stimulus for the active musculature since the lowered power output76 and the 
reduced oxygen flux resulting from hypoxia would be associated with a downregulation of 
muscle structure and function. 
Performance improvement with RSH 
Some of the methodological limitations related to IHT have been overcome in recent studies 
investigating a new hypoxic training strategy named RSH.63–65 RSH is based on the repetition of 
‘all-out’ efforts of short (≤30 s) duration interspersed with short incomplete recoveries. This 
model differs from IHT since the intensity of the training stimulus is maximal and therefore 
allows one to maintain high FT recruitment so that positive results can be expected when adding 
hypoxia to training. RSH is particularly interesting since, under hypoxic conditions (<3800 m), a 
single sprint performance of short duration (<10 s) is generally preserved, whereas fatigue 
resistance during RSA tests is reduced with earlier and larger decrements in mechanical work.77–79 
Recently, we65 showed that RSH delays fatigue during a repeated sprint test to exhaustion. In that 
study, 50 trained athletes were randomly dispatched in three different intervention groups (RSH: 
3000 m, FiO2 14.5%; RSN: 485 m, FiO2 20.9% and CON: no specific sprint training) and tested 
twice (before and after a 4-week training protocol including two repeated sprint training sessions 
per week) for the determination of endurance performance, anaerobic capacity and RSA. If 
endurance performance (during a 3 min ‘all-out’ time trial) was not increased, RSN and RSH 
improved the average power output during 10 s sprints (by 6–7%) and a 30 s Wingate test (by 3–
5%), although a major additional benefit of RSH compared with RSN was found. The number of 
sprints completed during an RSA test to exhaustion was improved by 40% only after RSH: an 
average of 9 sprints was performed before training in both groups but 13 after RSH and still 9 
after RSN. The relevance of the observed improvement in RSA in team-sport athletes is 
unanswered yet since the direct translation of RSA to the team game result is questionable.40 
Puype et al63 then showed that RSH improved by 7% the power output, corresponding to 4 mmol 
blood lactate during a maximal incremental test, while it did not change after RSN. However, in 
that study, the gains in power output during a 10 min time trial (6–7%) or VO2max during an 
 - 202 -       
incremental test (6%) were similar after RSH and RSN. Interestingly, the phosphofructokinase 
activity was markedly increased (59%) only after RSH, quite likely reflecting an upregulation of 
muscle glycolytic capacity. Since the performance tests were limited to longer aerobic efforts, 
they cannot be linked directly to physical performance improvement. 
Furthermore, Galvin et al64 recently showed in rugby players a 19% additional benefit of RSH 
compared with RSN in high-intensity intermittent running performance (Yo-Yo IR1 test80). This 
substantially higher performance improvement has important practical implications since the Yo-
Yo test correlates very well with physical performance and the amount of high-intensity running 
in several team sports such as soccer, basketball, rugby and handball.64 
Thus, RSH was shown to be as efficient as RSN in improving power output on a single sprint (5–
7%) when including 10 s sprints interspersed with 20 s recoveries65 or 30 s sprints with 270 s 
recoveries63 (table 1). Additionally, but only after RSH, cycling power output corresponding to 4 
mmol of lactate during an incremental test63 and high-intensity intermittent running performance 
were significantly improved64 only after RSH while fatigue development was delayed during a 
repeated cycling sprint test performed until exhaustion.65 
Physiological mechanisms and promises of RSH 
We hypothesised that RSH would induce beneficial adaptations mainly due to the improved 
blood perfusion level inducing an enhanced O2 utilisation and an improved behaviour of FT 
fibres. With maximal effort intensities, specific skeletal muscle tissue adaptations (molecular level) 
may arise through the oxygen-sensing pathway (ie, capillary-to-fibre ratio, fibre cross-sectional 
area, myoglobin content and oxidative enzyme activity such as citrate synthase) that either do not 
occur in normoxic conditions or, if they do, they do so to a lesser degree.10–12 Additionally, 
exercising in hypoxia is known to trigger a compensatory vasodilation to match an increased 
oxygen demand at the muscular level.81 
Increasing evidence indicates that neuromuscular (muscle contractility and/or activation), 
biomechanical (running economy) and metabolic (muscle and/or cerebral 
deoxygenation/reoxygenation kinetics) factors may also play key roles in the hypoxia-induced 
mechanisms in response to maximal-intensity intermittent exercises. For instance, it is generally 
accepted that neuromuscular transmission and action potential propagation along with muscle 
fibres (sarcolemma excitability) remain unchanged with acute hypoxia in relaxed muscles or 
during brief contractions.82 Indirect evidence rather suggests that the increased rate of fatigue 
seen at altitude may be the result of a more rapid accumulation of Pi during each sprint and a 
reduced rate of its removal during recovery.38 ,83 Repeated sprints result in large changes in PCr 
and H+ concentrations. However, the restoration of power output during repeated sprints seems 
to be influenced more by the muscle energy supply (eg, PCr resynthesis) than by the recovery of 
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muscle pH.39 However, enhanced buffer capacity or upregulation of genes involved in pH 
control has also been reported after RSH63 ,65 
Moreover, performance decrements are also likely to be explained by a reduced neural drive to 
the active musculature, (estimated by surface electromyography) arising secondary to a stronger 
reflex inhibition due to brain hypoxia84 or a hypoxia-induced increased level of intramuscular 
metabolites known to stimulate group III–IV muscle afferents.83 Furthermore, larger cerebral 
deoxygenation levels77 and slower reoxygenation rates during recoveries85—which strongly 
correlate with the exacerbated reduction in mechanical work in hypoxia during an RSA test—
have also been observed with acute altitude exposure. As exercise intensity increases, glycolytic 
FT muscle fibres are preferentially recruited,86 while at lower intensity (eg, <VT2) oxidative slow 
twitch (ST) and FT muscle fibres are solicited. 
During sprints in hypoxia, the compensatory vasodilation (with an increase in blood flow) that 
aims at maintaining constantly the total O2 delivery to the muscle is quite likely maximal since 
exercise intensity is essential in the amplitude of this compensatory mechanism.81 FT fibres are 
quite likely to benefit more than ST fibres from the higher blood perfusion. Hence, owing to 
their greater fractional O2 extraction if highly perfused,
87 the enhanced microvascular O2 delivery 
to FT would ‘make FT to behave more like their oxidatively efficient ST counterparts’.88 So, 
RSH efficiency is likely to be fibre-type selective and intensity dependent and therefore based on 
mechanisms presumably different from those associated with IHT. We speculate here that the 
improved responsiveness of the vascular bed and the improved blood perfusion through nitric 
oxide (NO)-mediated vasodilation mechanisms81 could be paramount in RSH. Further 
investigations into the NO pathway (neuronal NO synthase (nNOS) and endothelial NO 
synthase (eNOS)) are required in RSH to determine whether mechanisms other than NO-
mediated vasodilation are also involved. Moreover, fibre-type selective peripheral vascular effects 
of nNOS-derived NO have been reported during high-speed treadmill running, whereas these 
effects were not seen at slower speeds.89 It is, however, striking to note in two recent studies89 ,90 a 
similar fibre-type mechanism on dietary nitrate (NO3−) supplementation that enhances blood 
flow. With NO3− supplementation, blood flow and vascular control were indeed augmented 
mostly in FT,90 partly due to the lower microvascular PO2 in contracting FT.
87 Interestingly, an 
elevated microvascular PO2 is known to reduce PCr breakdown
38 and speed PCr recovery 
kinetics. 
Adding a hypoxic stimulus to training can modulate the PCr resynthesis during exercise. In 
support of this suggestion, Holliss et al62 reported that single leg-extension IHT results in a faster 
PCr recovery from high-intensity exercise in hypoxia (with only a tendency observed in 
normoxia). However, exercise tolerance during an incremental test to the limit of exhaustion 
either in normoxia or hypoxia was not different between IHT and INT. The authors speculated 
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that the faster PCr resynthesis observed after IHT was probably not due to an enhanced 
mitochondrial biogenesis but most likely due to a greater enhancement of muscle O2 delivery. 
Overall, a faster PCr resynthesis resulting from RSH would manifest because of better 
maintenance of power production (better recovery between efforts) during intermittent, high-
intensity exercises. 
The latter could arguably contribute to the increased RSA performance observed in normoxia 
after RSH.65 By challenging the functional reserve in the muscle oxygen diffusing capacity most 
likely utilised in hypoxia,91 repeated maximal efforts in hypoxia have the potential to stimulate 
beneficial adaptations in terms of PCr resynthesis and oxygen utilisation mediated by HIFs at the 
muscular level. By extension, the positive impact of RSH on glycolytic performance and skeletal 
muscle adaptations may lead to putative strong benefits for team sports like football, rugby union 
or Australian football, where the ability to repeat high-speed runs during an entire game is 
essential for overall performance.92 At this stage, however, specific mechanisms that may enhance 
performance with RSH are still to be determined with further studies. 
 
Conclusion 
A thorough analysis of studies that have used IHT leads to strikingly poor benefits for sea-level 
performance improvement, compared to the same training protocol performed in normoxia. 
Despite the positive molecular adaptations observed after various IHT modalities, the 
characteristics of optimal training stimulus in hypoxia are still unclear and their functional 
translation in terms of whole-body performance enhancement is minimal. 
To overcome some of the inherent limitations of IHT (lower training stimulus due to hypoxia), 
recent studies have investigated a new training method based on the repetition of ‘all-out’ sprints 
in hypoxia, the so-called RSH. The succession of maximal efforts under hypoxic conditions was 
shown to be beneficial for maximal performance improvement and especially to delay fatigue 
when sprints with incomplete recoveries were repeated until exhaustion. 
RSH is therefore proposed as a promising training strategy in intermittent sports to eventually 
improve match-related performance. Since team sports are characterised by intense exercise 
bouts repeated throughout a game, delaying fatigue and improving the ability to repeat sprints are 
crucial for the improved physical involvement of players. 
Until now, there is scant evidence of the additional benefits of high-intensity training performed 
in hypoxia compared to the same training in normoxia on RSA. Until new evidence is provided, 
it is felt that compared to IHT, RSH is based on different fundamental mechanisms that are likely 
to be fibre-type selective, while the positive adaptations are probably dependent on the 
compensatory vasodilatory effects on the behaviour of FT fibres. 
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Yet, further studies with large sample sizes and double-blinded designed protocols are needed to 
endorse the efficacy of RSH. Then, in order to robustly assess the true benefits of RSH versus 
traditional IHT, both training strategies must be directly compared in the same experimental test 
setting. Judging the impact of RSH on athletic performance in various team sports could be best 
improved by testing, for example, specific work-to-rest ratios or the efficacy of different ‘hypoxic 
doses’. Finally, if the efficacy of RSH is confirmed in more ecological situations (including 
overground sprints in hypoxic marquees rather than cycling an ergometer), it could then be 
readily implemented in the yearly periodisation of intermittent disciplines. 
 
 
What are the new findings 
• This review critically analyses the results of the studies involving high-intensity 
exercises performed in hypoxia for sea-level performance enhancements by 
differentiating intermittent hypoxic training (IHT) and repeated sprint training in 
hypoxia (RSH).  
• IHT leads to strikingly poor benefits for sea-level performance improvement, 
compared to the same training protocol performed in normoxia.  
• RSH is a promising training strategy that has been shown to delay fatigue when 
sprints with incomplete recoveries are repeated until exhaustion.  
How might it impact on clinical practice in the near future 
• This review will help athletes and teams in intermittent sports by providing an 
overview of the current scientific knowledge about intermittent hypoxic training and 
repeated sprint training in hypoxia (RSH).  
• New studies are proposed to judge the efficacy of RSH in team sports and to 
determine the specific mechanisms that may enhance the team game results with 
RSH.  
 
Footnotes 
Contributors RF, OG and GPM drafted the article, revised it critically for important intellectual 
content and approved the version to be published.  
Competing interests None.  
Provenance and peer review Not commissioned; externally peer reviewed. 
  
 - 206 -       
References 
1. Wilber RL. Application of altitude/hypoxic training by elite athletes. Med Sci Sports Exerc 
2007;39:1610–24.   
2. Millet GP, Roels B, Schmitt L, et al. Combining hypoxic methods for peak performance. Sports 
Med 2010;40:1–25.   
3. Billaut F, Gore CJ, Aughey RJ. Enhancing team-sport athlete performance: is altitude training 
relevant? Sports Med 2012;42:751–67.   
4. Levine BD, Stray-Gundersen J. Dose-response of altitude training: how much altitude is enough? 
Adv Exp Med Biol 2006;588:233–47.   
5. Wilber RL, Stray-Gundersen J, Levine BD. Effect of hypoxic ‘dose’ on physiological responses 
and sea-level performance. Med Sci Sports Exerc 2007;39:1590–9.  
6. Aughey RJ, Clark SA, Gore CJ, et al. Interspersed normoxia during live high, train  low 
interventions reverses an early reduction in muscle Na+, K+ ATPase activity in  well-trained 
athletes. Eur J Appl Physiol 2006;98:299–309.  
7. Wilber RL. Current trends in altitude training. Sports Med 2001;31:249–65.  
8. Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression by HIF-1.  Novartis 
Found Symp 2006;272:2–8; discussion 8–14, 33–6.  
9. Lundby C, Calbet JA, Robach P. The response of human skeletal muscle tissue to  hypoxia. Cell 
Mol Life Sci 2009;66:3615–23.  
10. Hoppeler H, Vogt M. Muscle tissue adaptations to hypoxia. J Exp Biol 2001;  204(Pt 18):3133–9.  
11. Vogt M, Puntschart A, Geiser J, et al. Molecular adaptations in human skeletal  muscle to 
endurance training under simulated hypoxic conditions. J Appl Physiol  2001;91:173–82.  
12. Zoll J, Ponsot E, Dufour S, et al. Exercise training in normobaric hypoxia in  endurance runners. 
III. Muscular adjustments of selected gene transcripts. J Appl Physiol 2006;100:1258–66.      
13. Bartsch P, Dvorak J, Saltin B. A rebuttal. Scand J Med Sci Sports 2009;19:608.  
14. Gatterer H, Faulhaber M, Netzer N. Hypoxic training for football players. Scand J  Med Sci 
Sports 2009;19:607; author reply 08.  
15. Millet GP, Faiss R. Hypoxic conditions and exercise-to-rest ratio are likely  paramount. Sports 
Med 2012;42:1081–3.  
16. Morton JP, Cable NT. Effects of intermittent hypoxic training on aerobic and  anaerobic 
performance. Ergonomics 2005;48:1535–46.  
17. Daniels J, Oldridge N. The effects of alternate exposure to altitude and sea level on  world-class 
middle-distance runners. Med Sci Sports 1970;2:107–12.  
18. Friedmann B, Frese F, Menold E, et al. Individual variation in the erythropoietic  response to 
altitude training in elite junior swimmers. Br J Sports Med  2005;39:148–53.  
19. Gore CJ, Hahn A, Rice A, et al. Altitude training at 2690m does not increase total  haemoglobin 
mass or sea level VO2max in world champion track cyclists. J Sci Med  Sport 1998;1:156–70.  
20. Mizuno M, Juel C, Bro-Rasmussen T, et al. Limb skeletal muscle adaptation in  athletes after 
training at altitude. J Appl Physiol 1990;68:496–502.  
21. Lundby C, Millet GP, Calbet JA, et al. Does ‘altitude training’ increase exercise  performance in 
elite athletes? Br J Sports Med 2012;46:792–5.  
22. Hamlin MJ, Marshall HC, Hellemans J, et al. Effect of intermittent hypoxic training  on 20 km 
time trial and 30s anaerobic performance. Scand J Med Sci Sports  2010;20:651–61.  
23. Manimmanakorn A, Hamlin MJ, Ross JJ, et al. Effects of low-load resistance training  combined 
with blood flow restriction or hypoxia on muscle function and  performance in netball athletes. J 
Sci Med Sport 2013;16:337–42.  
24. Iaia M, Rampinini E, Bangsbo J. High-intensity training in football. Int J Sports  Physiol Perform 
2009;4:291–306.  
25. Millet GP, Faiss R, Brocherie F, et al. Hypoxic training and team sports: a challenge  to 
traditional methods? Br J Sports Med 2013;47:i6–7.  
26. Bergeron MF, Bahr R, Bartsch P, et al. International Olympic Committee consensus  statement 
on thermoregulatory and altitude challenges for high-level athletes. Br J  Sports Med 
2012;46:770–9.  
 - 207 -       
27. Bonetti DL, Hopkins WG. Sea-level exercise performance following adaptation to  hypoxia: a 
meta-analysis. Sports Med 2009;39:107–27.  
28. Billat V. Interval training for performance: a scientific and empirical practice. Part 1:  aerobic 
interval training. Sports Med 2001;31:13–31.  
29. Billat V. Interval training for performance: a scientific and empirical practice. Part 2:  anaerobic 
interval training. Sports Med 2001;31:75–90.  
30. Buchheit M, Laursen PB. High-intensity interval training, solutions to the programming  puzzle: 
part I: cardiopulmonary emphasis. Sports Med 2013;43:313–38.  
31. Burnley M, Jones AM. Oxygen uptake kinetics as a determinant of sports  performance. Eur J 
Sport Sci 2007;7:63–79.  
32. Midgley AW, McNaughton LR, Wilkinson M. Is there an optimal training intensity  for 
enhancing the maximal oxygen uptake of distance runners? Empirical research findings, current 
opinions, physiological rationale and practical recommendations. Sports Med 2006;36:117–32.  
33. Millet GP, Libicz S, Borrani F, et al. Effects of increased intensity of intermittent training in 
runners with differing VO2 kinetics. Eur J Appl Physiol 2003;90:50–7.  
34. Millet GP, Candau R, Fattori P, et al. VO2 responses to different intermittent runs at velocity 
associated with VO2max. Can J Appl Physiol 2003;28:410–23.  
35. Midgley AW, Mc Naughton LR, Wilkinson M. Criteria and other methodological considerations 
in the evaluation of time at VO2max. J Sports Med Phys Fitness 2006;46:183–8.  
36. Girard O, Mendez-Villanueva A, Bishop D. Repeated-sprint ability—part I: factors contributing 
to fatigue. Sports Med 2011;41:673–94.  
37. Bishop D, Girard O, Mendez-Villanueva A. Repeated-sprint ability—part II: recommendations 
for training. Sports Med 2011;41:741–56.  
38. Haseler LJ, Hogan MC, Richardson RS. Skeletal muscle phosphocreatine recovery in exercise-
trained humans is dependent on O2 availability. J Appl Physiol 1999;86:2013–18.  
39. Mendez-Villanueva A, Edge J, Suriano R, et al. The recovery of repeated-sprint exercise is 
associated with PCr resynthesis, while muscle pH and EMG amplitude remain depressed. PLoS 
ONE 2012;7:e51977.  
40. Carling C. Interpreting physical performance in professional soccer match-play: should we be 
more pragmatic in our approach? Sports Med 2013;43:655–63.  
41. Rampinini E, Bishop D, Marcora SM, et al. Validity of simple field tests as indicators of match-
related physical performance in top-level professional soccer players. Int J Sports Med 
2007;28:228–35.  
42. Mohr M, Krustrup P, Bangsbo J. Fatigue in soccer: a brief review. J Sports Sci 2005;23:593–9.  
43. Garvican LA, Hammond K, Varley MC, et al. Lower running performance and exacerbated 
fatigue in soccer played at 1600m. Int J Sports Physiol Perform 2013 May 22. [Epub ahead of 
print].  
44. Buchheit M. Should we be recommending repeated sprints to improve repeated-sprint 
performance? Sports Med 2012;42:169–72.  
45. Hoffmann JJ Jr, Reed JP, Leiting K, et al. Repeated sprints, high intensity interval training, small 
sided games: theory and application to field sports. Int J Sports Physiol Perform 2013 May 22. 
[Epub ahead of print].  
46. Roskamm H, Landry F, Samek L, et al. Effects of a standardized ergometer training program at 
three different altitudes. J Appl Physiol 1969;27:840–7.   
47. Terrados N, Melichna J, Sylven C, et al. Effects of training at simulated altitude on performance 
and muscle metabolic capacity in competitive road cyclists. Eur J Appl Physiol Occup Physiol 
1988;57:203–9.   
48. Martino M, Myers K, Bishop P. Effects of 21 days training at altitude on sea-level anaerobic 
performance in competitive swimmers. Med Sci Sports Exerc 1995;27(5 Suppl ):S7(abstract 37). 
Emonson DL, Aminuddin AH, Wight RL, et al. Training-induced increases in sea level VO2max 
and endurance are not enhanced by acute hypobaric exposure. Eur J Appl Physiol Occup Physiol 
1997;76:8–12. 
 - 208 -       
49. Katayama B, Sato Y, Ishida K, et al. The effects of intermittent exposure to hypoxia during 
endurance exercise training on the ventilatory responses to hypoxia and hypercapnia in humans. 
Eur J Appl Physiol Occup Physiol 1998;78:189–94. 
50. Bailey DM, Castell LM, Newsholme EA, et al. Continuous and intermittent exposure to the 
hypoxia of altitude: implications for glutamine metabolism and exercise performance. Br J Sports 
Med 2000;34:210–12. 
51. Geiser J, Vogt M, Billeter R, et al. Training high—living low: changes of aerobic performance 
and muscle structure with training at simulated altitude. Int J Sports Med 2001;22:579–85.  
52. Karlsen T, Madsen o, Rolf S, et al. Effects of 3 weeks hypoxic interval training on sea level 
cycling performance and hematological parameters. Med Sci Sports Exerc 2002;34(5 Suppl 
1):S224.   
53. Hendriksen IJ, Meeuwsen T. The effect of intermittent training in hypobaric hypoxia on sea-level 
exercise: a cross-over study in humans. Eur J Appl Physiol 2003;88:396–403.  
54. Truijens MJ, Toussaint HM, Dow J, et al. Effect of high-intensity hypoxic training on sea-level 
swimming performances. J Appl Physiol 2003;94:733–43.  
55. Ventura N, Hoppeler H, Seiler R, et al. The response of trained athletes to six weeks of 
endurance training in hypoxia or normoxia. Int J Sports Med 2003;24:166–72.  
56. Roels B, Millet GP, Marcoux CJ, et al. Effects of hypoxic interval training on cycling 
performance. Med Sci Sports Exerc 2005;37:138–46.  
57. Roels B, Bentley DJ, Coste O, et al. Effects of intermittent hypoxic training on cycling 
performance in well-trained athletes. Eur J Appl Physiol 2007;101:359–68.  
58. Dufour SP, Ponsot E, Zoll J, et al. Exercise training in normobaric hypoxia in endurance runners. 
I. Improvement in aerobic performance capacity. J Appl Physiol 2006;100:1238–48.   
59. Lecoultre V, Boss A, Tappy L, et al. Training in hypoxia fails to further enhance endurance 
performance and lactate clearance in well-trained men and impairs glucose metabolism during 
prolonged exercise. Exp Physiol 2010;95:315–30.   
60. Mao TY, Fu LL, Wang JS. Hypoxic exercise training causes erythrocyte senescence and 
rheological dysfunction by depressed Gardos channel activity. J Appl Physiol 2011;111:382–91. 
Holliss BA, Fulford J, Vanhatalo A, et al. Influence of intermittent hypoxic training on muscle 
energetics and exercise tolerance. J Appl Physiol 2013;114:611–19.  
61. Puype J, Van Proeyen K, Raymackers JM, et al. Sprint interval training in hypoxia stimulates 
glycolytic enzyme activity. Med Sci Sports Exerc 2013;In press.  
62. Galvin HM, Cooke K, Sumners DP, et al. Repeated sprint training in normobaric hypoxia. Br J 
Sports Med 2013;47:i74–9.  
63. Faiss R, Leger B, Vesin JM, et al. Significant molecular and systemic adaptations after repeated 
sprint training in hypoxia. PLoS ONE 2013;8:e56522.  
64. Katayama K, Sato Y, Morotome Y, et al. Ventilatory chemosensitive adaptations to intermittent 
hypoxic exposure with endurance training and detraining. J Appl Physiol 1999;86:1805–11.  
65. Gore CJ, Rodriguez FA, Truijens MJ, et al. Increased serum erythropoietin but not red cell 
production after 4 wk of intermittent hypobaric hypoxia (4,000–5,500m). J Appl Physiol 
2006;101:1386–93. 
66. Buchheit M, Kuitunen S, Voss SC, et al. Physiological strain associated with high-intensity 
hypoxic intervals in highly trained young runners. J Strength Cond Res 2012;26:94–105. 
67. Kime R, Karlsen T, Nioka S, et al. Discrepancy between cardiorespiratory system and skeletal 
muscle in elite cyclists after hypoxic training. Dyn Med 2003;2:4.  
68. Desplanches D, Hoppeler H, Linossier MT, et al. Effects of training in normoxia and 
normobaric hypoxia on human muscle ultrastructure. Pflugers Arch 1993;425:263–7.   
69. Roels B, Thomas C, Bentley DJ, et al. Effects of intermittent hypoxic training on amino and fatty 
acid oxidative combustion in human permeabilized muscle fibers. J Appl Physiol 2007;102:79–86.  
70. Ponsot E, Dufour SP, Zoll J, et al. Exercise training in normobaric hypoxia in endurance runners. 
II. Improvement of mitochondrial properties in skeletal muscle. J Appl Physiol 2006;100:1249–
57.   
 - 209 -       
71. Toffoli S, Roegiers A, Feron O, et al. Intermittent hypoxia is an angiogenic inducer for 
endothelial cells: role of HIF-1. Angiogenesis 2009;12:47–67.   
72. Gore CJ, Hahn AG, Aughey RJ, et al. Live high:train low increases muscle buffer capacity and 
submaximal cycling efficiency. Acta Physiol Scand 2001;173:275–86.   
73. Levine BD. Intermittent hypoxic training: fact and fancy. High Alt Med Biol 2002;3:177–93. 
74. Brosnan MJ, Martin DT, Hahn AG, et al. Impaired interval exercise responses in elite female 
cyclists at moderate simulated altitude. J Appl Physiol 2000;89:1819–24.    
75. Smith KJ, Billaut F. Influence of cerebral and muscle oxygenation on repeated-sprint ability. Eur 
J Appl Physiol 2010;109:989–99.  
76. Balsom PD, Gaitanos GC, Ekblom B, et al. Reduced oxygen availability during high intensity 
intermittent exercise impairs performance. Acta Physiol Scand 1994;152:279–85.  
77. Bowtell JL, Cooke K, Turner R, et al. Acute physiological and performance responses to repeated 
sprints in varying degrees of hypoxia. J Sci Med Sport 2013;13:00142–4.  
78. Bangsbo J, Iaia FM, Krustrup P. The Yo-Yo intermittent recovery test: a useful tool for 
evaluation of physical performance in intermittent sports. Sports Med 2008;38:37–51.  
79. Casey DP, Joyner MJ. Compensatory vasodilatation during hypoxic exercise: mechanisms 
responsible for matching oxygen supply to demand. J Physiol 2012; 590(Pt 24):6321–6.  
80. Perrey S, Rupp T. Altitude-induced changes in muscle contractile properties. High Alt Med Biol 
2009;10:175–82.  
81. Hogan MC, Richardson RS, Haseler LJ. Human muscle performance and PCr hydrolysis with 
varied inspired oxygen fractions: a 31P-MRS study. J Appl Physiol 1999;86:1367–73.  
82. Katayama K, Amann M, Pegelow DF, et al. Effect of arterial oxygenation on quadriceps 
fatigability during isolated muscle exercise. Am J Physiol Regul Integr Comp Physiol 
2007;292:R1279–86.  
83. Billaut F, Buchheit M. Repeated-sprint performance and vastus lateralis oxygenation: effect of 
limited O2 availability. Scand J Med Sci Sports 2013;23:e185–93. 
84. Laughlin MH, Armstrong RB. Muscular blood flow distribution patterns as a function of running 
speed in rats. Am J Physiol 1982;243:H296–306. 87 McDonough P, Behnke BJ, Padilla DJ, et al. 
Control of microvascular oxygen pressures in rat muscles comprised of different fibre types. J 
Physiol 2005;563(Pt 3):903–13. 
85. Cleland SM, Murias JM, Kowalchuk JM, et al. Effects of prior heavy-intensity 
86. exercise on oxygen uptake and muscle deoxygenation kinetics of a subsequent heavy-intensity 
cycling and knee-extension exercise. Appl Physiol Nutr Metab 2012;37:138–48. 
87. Copp SW, Holdsworth CT, Ferguson SK, et al. Muscle fibre-type dependence of neuronal nitric 
oxide synthase-mediated vascular control in the rat during high speed treadmill running. J Physiol 
2013;591(Pt 11):2885–96. 
88. Ferguson SK, Hirai DM, Copp SW, et al. Impact of dietary nitrate supplementation via beetroot 
juice on exercising muscle vascular control in rats. J Physiol 2013; 591(Pt 2):547–57. 
89. Calbet JAL, Lundby C. Air to muscle O2 delivery during exercise at altitude. High Alt Med Biol 
2009;10:123–34. 
90. Hoff J, Helgerud J. Endurance and strength training for soccer players: physiological 
considerations. Sports Med 2004;34:165–80.  
  
 
